https://www.accc-cancer.org 2026-03-30T16:28:45.713Z daily 1 https://www.accc-cancer.org/about-accc 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/acccbuzz-blog 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/advertising 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/authors 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/cancer-buzz-podcast 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/cancer-buzz-tv 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/contact 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/education-and-resources 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/events 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/membership 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/news 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/news/news-releases 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/news/oncology-news 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/partners 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/policy-advocacy 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/presentations-abstracts 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/projects 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/publications 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/state-societies/calendar 2026-03-30T16:28:45.713Z weekly 0.8 https://www.accc-cancer.org/view/fda-approves-relacorilant-with-nab-paclitaxel-for-platinum-resistant-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer 2026-03-26T20:18:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-with-chemotherapy-for-previously-untreated-hodgkin-lymphoma 2026-03-26T20:13:00.000Z monthly 0.6 https://www.accc-cancer.org/view/representing-veterans-in-clinical-trials-through-public-private-partnerships-a-q-a-with-navref 2026-03-26T13:15:00.000Z monthly 0.6 https://www.accc-cancer.org/view/confronting-a-lethal-cancer-duke-launches-multidisciplinary-pancreatic-cancer-center-for-earlier-detection-and-better-outcomes 2026-03-25T14:45:00.000Z monthly 0.6 https://www.accc-cancer.org/view/from-hospital-to-home-a-solution-for-proactive-symptom-monitoring-and-precise-care 2026-03-23T14:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/a-candid-conversation-about-the-power-of-early-palliative-care 2026-03-19T14:45:00.000Z monthly 0.6 https://www.accc-cancer.org/view/transforming-palliative-care-in-oncology-video-podcast-ep-227 2026-03-18T21:00:13.643Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-teclistamab-in-combination-with-daratumumab-hyaluronidase-fihj-for-relapsed-or-refractory-multiple-myeloma 2026-03-06T15:26:00.000Z monthly 0.6 https://www.accc-cancer.org/view/streamlining-access-to-til-cell-therapy-for-melanoma 2026-03-05T20:09:03.023Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-zongertinib-for-unresectable-or-metastatic-non-squamous-non-small-cell-lung-cancer 2026-03-04T15:44:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-traditional-approval-to-encorafenib-for-metastatic-colorectal-cancer-with-a-braf-v600e-mutation 2026-03-04T15:39:00.000Z monthly 0.6 https://www.accc-cancer.org/view/rare-but-real-lessons-from-providers-treating-bpdcn-and-mcl 2026-02-27T18:12:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-acalabrutinib-with-venetoclax-for-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma 2026-02-20T16:01:34.000Z monthly 0.6 https://www.accc-cancer.org/view/policy-in-practice-change-hits-the-clinic-podcast-ep-225 2026-02-19T21:47:03.000Z monthly 0.6 https://www.accc-cancer.org/view/highlights-from-volume-41-number-1-oncology-issues 2026-02-18T20:29:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-novocure-s-optune-pax-for-the-treatment-of-locally-advanced-pancreatic-cancer 2026-02-13T16:16:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-with-paclitaxel-for-platinum-resistant-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-carcinoma 2026-02-13T16:12:05.000Z monthly 0.6 https://www.accc-cancer.org/view/recognizing-innovation-in-cancer-prevention 2026-02-12T21:48:28.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-psychosocial-distress-with-psychedelic-inspired-therapies-podcast-ep.-224 2026-02-09T21:29:59.000Z monthly 0.6 https://www.accc-cancer.org/view/safety-labeling-update-for-capecitabine-and-fluorouracil-on-risks-associated-with-dihydropyrimidine-dehydrogenase-deficiency 2026-02-06T16:06:16.000Z monthly 0.6 https://www.accc-cancer.org/view/3-surprising-truths-about-leading-through-change-strategies-for-oncology-leaders-to-thrive-in-the-ai-era 2026-02-05T15:14:05.000Z monthly 0.6 https://www.accc-cancer.org/view/turning-action-into-outcomes-highlights-from-the-accc-2025-impact-report 2026-02-03T18:31:37.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-genentech-s-lunsumio-velo-for-subcutaneous-use-in-relapsed-or-refractory-follicular-lymphoma 2026-02-02T19:41:13.000Z monthly 0.6 https://www.accc-cancer.org/view/set-goals-in-todays-health-care-reality-ep-223 2026-01-30T22:09:56.000Z monthly 0.6 https://www.accc-cancer.org/view/plans-for-2026-a-dialogue-with-accc-s-executive-director-video-podcast-ep.-222 2026-01-30T22:04:02.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-and-hyaluronidase-fihj-with-bortezomib-lenalidomide-and-dexamethasone-for-newly-diagnosed-multiple-myeloma 2026-01-30T16:31:03.000Z monthly 0.6 https://www.accc-cancer.org/view/apps-paving-the-way-in-leadership-podcast-ep-221 2026-01-21T22:15:24.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-urges-congress-to-pass-the-multi-cancer-early-detection-act 2026-01-21T16:15:37.000Z monthly 0.6 https://www.accc-cancer.org/view/when-prevention-isn-t-enough-bridging-cervical-cancer-screening-gaps-in-appalachia 2026-01-21T15:56:31.000Z monthly 0.6 https://www.accc-cancer.org/view/sun-pharma-announces-the-availability-of-cosibelimab-ipdl-for-advanced-cutaneous-squamous-cell-carcinoma 2026-01-16T15:52:19.000Z monthly 0.6 https://www.accc-cancer.org/view/learn-about-car-t-cell-therapy-in-earlier-lines-of-treatment-for-relapsed-or-refractory-multiple-myeloma-1 2026-01-15T17:03:11.000Z monthly 0.6 https://www.accc-cancer.org/view/new-collaboration-between-american-cancer-society-and-brain-tumor-network-connects-patients-with-brain-tumors-to-free-specialized-support 2026-01-06T19:11:54.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-care-tailored-to-veterans-and-first-responders-an-nccn-patient-advocacy-summit 2025-12-22T20:58:19.000Z monthly 0.6 https://www.accc-cancer.org/view/introducing-oncology-unscripted 2025-12-19T14:51:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-amivantamab-and-hyaluronidase-lpuj-for-subcutaneous-injection 2025-12-18T17:40:48.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-regular-approval-to-rucaparib-for-metastatic-castration-resistant-prostate-cancer 2025-12-18T17:36:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-fam-trastuzumab-deruxtecan-nxki-with-pertuzumab-for-unresectable-or-metastatic-her2-positive-breast-cancer 2025-12-18T17:32:52.000Z monthly 0.6 https://www.accc-cancer.org/view/service-sacrifice-and-survival-advancing-cancer-care-for-america-s-heroes 2025-12-18T15:57:32.000Z monthly 0.6 https://www.accc-cancer.org/view/training-the-next-generation-of-oncology-leaders-mini-podcast-ep-220 2025-12-17T20:32:40.000Z monthly 0.6 https://www.accc-cancer.org/view/highlights-from-volume-40-number-6-oncology-issues 2025-12-16T16:00:05.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-niraparib-and-abiraterone-acetate-plus-prednisone-for-brca2-mutated-metastatic-castration-sensitive-prostate-cancer 2025-12-12T21:47:09.000Z monthly 0.6 https://www.accc-cancer.org/view/introducing-oncology-unscripted-podcast-ep-219 2025-12-10T20:49:56.000Z monthly 0.6 https://www.accc-cancer.org/view/car-t-cell-therapy-insights-from-the-field-mini-podcast-ep-218 2025-12-09T22:52:04.000Z monthly 0.6 https://www.accc-cancer.org/view/the-unsung-heroes-of-cancer-care-recognizing-national-oncology-navigator-day 2025-12-09T16:22:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lisocabtagene-maraleucel-for-relapsed-or-refractory-marginal-zone-lymphoma 2025-12-05T19:55:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-traditional-approval-to-pirtobrutinib-for-chronic-lymphocytic-leukemia-and-small-lymphocytic-lymphoma 2025-12-05T19:51:09.000Z monthly 0.6 https://www.accc-cancer.org/view/claudin-18-2-reshaping-gastric-cancer-treatment-podcast-ep-217 2025-12-04T20:51:30.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-voices-opposition-to-revised-definition-of-professional-degrees 2025-12-03T22:06:37.000Z monthly 0.6 https://www.accc-cancer.org/view/honoring-family-caregivers-during-national-family-caregivers-month 2025-11-26T15:07:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-durvalumab-for-resectable-gastric-or-gastroesophageal-junction-adenocarcinoma 2025-11-25T19:33:46.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-with-enfortumab-vedotin-ejfv-for-muscle-invasive-bladder-cancer 2025-11-25T19:08:00.000Z monthly 0.6 https://www.accc-cancer.org/view/navigating-r-r-fl-a-patient-centered-approach-podcast-ep-216 2025-11-24T23:01:44.000Z monthly 0.6 https://www.accc-cancer.org/view/lung-cancer-awareness-month-addressing-inequities-and-expanding-access-to-care 2025-11-24T19:41:58.000Z monthly 0.6 https://www.accc-cancer.org/view/challenging-assumptions-for-equitable-care-bladder-health-awareness-month 2025-11-21T20:16:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-traditional-approval-to-tarlatamab-dlle-for-extensive-stage-small-cell-lung-cancer 2025-11-21T15:43:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-sevabertinib-for-non-squamous-non-small-cell-lung-cancer 2025-11-21T15:41:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-traditional-approval-to-daratumumab-and-hyaluronidase-fihj-for-newly-diagnosed-light-chain-amyloidosis 2025-11-21T15:36:49.000Z monthly 0.6 https://www.accc-cancer.org/view/1st-guest-6-years-later 2025-11-19T19:53:53.000Z monthly 0.6 https://www.accc-cancer.org/view/from-blueprint-to-bedside-how-one-community-cancer-program-used-accc-s-resources-to-accelerate-bispecific-antibody-adoption 2025-11-19T14:51:40.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-epcoritamab-bysp-for-follicular-lymphoma-indications 2025-11-18T19:45:13.000Z monthly 0.6 https://www.accc-cancer.org/view/retired-nurses-supporting-the-workforce-podcast-ep-211 2025-11-17T21:17:59.000Z monthly 0.6 https://www.accc-cancer.org/view/streamlining-til-cell-therapy-accc-resources-to-improve-referral-pathways-and-academic-community-coordination 2025-11-17T18:42:47.000Z monthly 0.6 https://www.accc-cancer.org/view/united-in-care-accc-showcases-app-collaboration-and-integration-at-jadpro-live-2025 2025-11-14T16:36:53.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-new-interchangeable-biosimilar-to-perjeta 2025-11-14T15:26:35.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ziftomenib-for-relapsed-or-refractory-acute-myeloid-leukemia-with-a-npm1-mutation 2025-11-14T15:21:43.000Z monthly 0.6 https://www.accc-cancer.org/view/championing-lung-cancer-clinical-trials-in-the-va-podcast-ep-213 2025-11-13T21:57:35.000Z monthly 0.6 https://www.accc-cancer.org/view/sustainable-pathways-for-an-evolving-field-honoring-cancer-biomarker-awareness-day 2025-11-13T17:34:32.000Z monthly 0.6 https://www.accc-cancer.org/view/exploring-fgfr2b-in-gastric-and-gej-cancer-podcast-ep-212 2025-11-12T19:08:14.000Z monthly 0.6 https://www.accc-cancer.org/view/help-patients-explore-everything-car-t-cell-therapy 2025-11-12T17:25:07.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-out-of-pocket--oop--costs-for-covered-medicare-part-d-drugs-will-be-capped-in-2026 2025-11-12T17:23:43.000Z monthly 0.6 https://www.accc-cancer.org/view/considerations-for-neoadjuvant-and-adjuvant-therapy 2025-11-12T17:21:44.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-cancer-care-for-native-american-veterans-a-model-of-interagency-collaboration 2025-11-10T15:43:44.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-and-hyaluronidase-fihj-for-high-risk-smoldering-multiple-myeloma 2025-11-07T16:35:18.000Z monthly 0.6 https://www.accc-cancer.org/view/insights-across-the-americas-lessons-from-accc-s-global-exchange 2025-11-07T15:00:41.000Z monthly 0.6 https://www.accc-cancer.org/view/learn-about-car-t-cell-therapy-in-earlier-lines-of-treatment-for-relapsed-or-refractory-multiple-myeloma 2025-11-06T19:53:51.000Z monthly 0.6 https://www.accc-cancer.org/view/unlocking-esr1-mutations-in-breast-cancer-podcast-ep-211 2025-11-04T19:49:54.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-together 2025-10-29T13:19:30.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-myhealthcarefinances 2025-10-29T13:16:53.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-belantamab-mafodotin-blmf-for-relapsed-or-refractory-multiple-myeloma 2025-10-27T21:06:07.000Z monthly 0.6 https://www.accc-cancer.org/view/abemaciclib-shows-prolonged-survival-in-hr-her2--high-risk-early-breast-cancer-with-2-years-of-treatment 2025-10-27T21:01:09.000Z monthly 0.6 https://www.accc-cancer.org/view/putting-guidance-into-practice-real-world-approaches-to-relapsed-refractory-follicular-lymphoma 2025-10-24T18:24:44.000Z monthly 0.6 https://www.accc-cancer.org/view/highlights-from-the-october-2025-oncology-issues 2025-10-22T13:38:44.000Z monthly 0.6 https://www.accc-cancer.org/view/a-phase-3-study-of-elacestrant-versus-standard-endocrine-therapy-in-node-positive-er-her2--early-breast-cancer-with-high-risk-of-recurrence--elegant- 2025-10-22T13:10:34.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-insights-on-dyad-leadership-models-bridging-primary-care-and-oncology-and-solutions-in-rural-oncology 2025-10-20T18:53:13.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-creating-an-engaged-workplace-leadership-perspectives-and-sparking-innovation 2025-10-17T16:42:28.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-women-leaders-in-oncology 2025-10-17T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-the-noc-executive-director-on-unleashing-innovation 2025-10-16T18:31:56.000Z monthly 0.6 https://www.accc-cancer.org/view/2025-trending-now-in-cancer-care-part-2-podcast-ep-210 2025-10-16T16:18:13.000Z monthly 0.6 https://www.accc-cancer.org/view/2025-trending-now-in-cancer-care-part-1-podcast-ep--209 2025-10-16T16:14:35.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-the-psychosocial-oncology-professionals-symposium-and-a-fireside-chat-with-accc-s-president 2025-10-16T15:47:30.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-hot-topics 2025-10-16T12:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-serving-a-growing-patient-population-2 2025-10-16T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-psychosocial-care-alcohol-marijuana-and-more 2025-10-15T12:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/a-patient-centered-approach-to-cdk4-6-inhibitors-podcast-ep--208 2025-10-14T18:36:38.000Z monthly 0.6 https://www.accc-cancer.org/view/putting-innovation-into-practice-managing-cdk4-6-inhibitors 2025-10-13T13:36:16.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-the-psychological-burdens-of-cancer-on-world-mental-health-day 2025-10-10T14:04:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cemiplimab-rwlc-for-adjuvant-treatment-of-cutaneous-squamous-cell-carcinoma 2025-10-09T15:00:52.000Z monthly 0.6 https://www.accc-cancer.org/view/the-most-favored-nation-mandate-what-the-president-s-drug-pricing-push-means-for-the-pharmaceutical-industry-payers-and-patients 2025-10-08T15:09:02.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-executive-director-meagan-o-neill-speaks-with-the-value-health-voices-podcast-on-how-to-deliver-better-cancer-care-in-a-system-under-pressure 2025-10-08T13:31:48.000Z monthly 0.6 https://www.accc-cancer.org/view/bridging-the-aya-survivorship-gap---video-podcast-ep--57 2025-10-03T18:58:59.000Z monthly 0.6 https://www.accc-cancer.org/view/ai-s-changing-role-in-oncology-recapping-the-nccn-summit 2025-10-03T16:11:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lurbinectedin-in-combination-with-atezolizumab-or-atezolizumab-and-hyaluronidase-tqjs-for-extensive-stage-small-cell-lung-cancer 2025-10-03T14:37:32.000Z monthly 0.6 https://www.accc-cancer.org/view/real-world-models-for-app-onboarding-podcast-ep--207 2025-10-01T20:59:12.000Z monthly 0.6 https://www.accc-cancer.org/view/the-evolving-ai-landscape-in-cancer-care-an-nccn-summit 2025-10-01T14:13:05.000Z monthly 0.6 https://www.accc-cancer.org/view/expanding-care-through-genetic-testing-hereditary-cancer-awareness-week 2025-09-29T14:57:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-imlunestrant-for-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer 2025-09-26T19:48:25.000Z monthly 0.6 https://www.accc-cancer.org/view/delivering-bispecific-antibodies-in-a-complex-reimbursement-landscape 2025-09-25T18:04:21.000Z monthly 0.6 https://www.accc-cancer.org/view/workplace-culture-minipodcast-ep.-205 2025-09-24T19:07:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-and-berahyaluronidase-alfa-pmph-for-subcutaneous-injection 2025-09-24T15:19:43.000Z monthly 0.6 https://www.accc-cancer.org/view/a-patient-and-her-care-team-on-trust-clinical-trials-podcast-ep.-204 2025-09-24T14:21:31.000Z monthly 0.6 https://www.accc-cancer.org/view/blood-cancer-awareness-month-minipodcast-ep.-206 2025-09-23T18:36:43.000Z monthly 0.6 https://www.accc-cancer.org/view/targeted-therapies-and-testing-a-new-era-in-gynecologic-malignancy-management 2025-09-23T14:15:36.000Z monthly 0.6 https://www.accc-cancer.org/view/supporting-ayas-across-the-cancer-continuum 2025-09-18T14:43:55.000Z monthly 0.6 https://www.accc-cancer.org/view/bringing-phase-1-clinical-trials-to-historically-underserved-patient-populations 2025-09-16T13:44:57.000Z monthly 0.6 https://www.accc-cancer.org/view/bridging-the-gap-enhancing-cancer-care-through-financial-navigation-video-podcast-ep.-56 2025-09-11T21:00:39.000Z monthly 0.6 https://www.accc-cancer.org/view/a-children-s-book-for-families-with-mbc 2025-09-11T19:07:46.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-selumetinib-for-select-pediatric-patients-1-year-of-age-and-older 2025-09-11T15:21:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-gemcitabine-intravesical-system-for-non-muscle-invasive-bladder-cancer 2025-09-11T15:17:18.000Z monthly 0.6 https://www.accc-cancer.org/view/blood-cancer-awareness-month-tackling-communication-challenges 2025-09-11T13:58:04.000Z monthly 0.6 https://www.accc-cancer.org/view/managing-cdk4-6-inhibitor-toxicities-in-breast-cancer-podcast-ep-203 2025-09-10T17:01:41.000Z monthly 0.6 https://www.accc-cancer.org/view/understanding-patient-and-caregiver-concerns-during-first-line-cll-treatment-decisions 2025-08-28T14:46:28.000Z monthly 0.6 https://www.accc-cancer.org/view/increasing-access-and-representation-in-clinical-trials-podcast-ep-202 2025-08-26T16:11:16.000Z monthly 0.6 https://www.accc-cancer.org/view/highlights-from-the-latest-oncology-issues 2025-08-26T13:47:24.000Z monthly 0.6 https://www.accc-cancer.org/view/a-day-in-the-life-of-an-oncology-app-across-various-practice-settings 2025-08-21T16:49:53.000Z monthly 0.6 https://www.accc-cancer.org/view/getting-to-know-our-2025-noc-keynote 2025-08-19T13:49:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-zongertinib-for-non-squamous-nsclc-with-her2-tkd-activating-mutations 2025-08-18T20:18:44.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-dordaviprone-for-diffuse-midline-glioma 2025-08-08T13:55:05.000Z monthly 0.6 https://www.accc-cancer.org/view/stay-ahead-of-the-curve-on-cdk4-6-inhibitor-toxicities-mini-podcast-ep.-201 2025-08-07T17:42:22.000Z monthly 0.6 https://www.accc-cancer.org/view/setting-up-for-success-best-practices-for-oncology-app-onboarding 2025-08-06T13:57:54.000Z monthly 0.6 https://www.accc-cancer.org/view/transforming-cancer-detection-and-treatment-mini-podcast-ep-200 2025-08-05T19:17:25.000Z monthly 0.6 https://www.accc-cancer.org/view/world-lung-cancer-day-accc-innovator-award-winners-tackling-challenges-in-lung-cancer-care 2025-08-01T14:22:48.000Z monthly 0.6 https://www.accc-cancer.org/view/leading-with-grace-learning-to-fall-and-rise-with-love 2025-07-30T14:30:01.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-clinical-trial-access-and-support-a-practical-e-course-designed-for-patient-navigators 2025-07-23T14:58:58.000Z monthly 0.6 https://www.accc-cancer.org/view/the-different-colors-of-skin-cancer-brochure 2025-07-22T18:23:15.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-urges-cms-to-protect-patient-access-under-new-drug-price-negotiation-program 2025-07-18T04:45:52.000Z monthly 0.6 https://www.accc-cancer.org/view/glioblastoma-awareness-day-innovative-solutions-for-the-most-aggressive-brain-tumor 2025-07-16T13:36:24.000Z monthly 0.6 https://www.accc-cancer.org/view/adopting-machine-learning-enabled-decision-support-to-improve-oncology-end-of-life-outcomes-mini-podcast-ep-199 2025-07-15T17:16:28.000Z monthly 0.6 https://www.accc-cancer.org/view/ambulatory-care-excellence-ace-charting-a-new-path-in-ambulatory-care-model-and-coordination-podcast-ep-198 2025-07-14T13:35:44.000Z monthly 0.6 https://www.accc-cancer.org/view/shaw-at-home-an-oncology-specific-home-and-community-based-palliative-care-program 2025-07-09T14:03:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-streamlined-patient-monitoring-requirements-and-removal-of-rems-programs-within-bristol-myers-squibb-s-cell-therapy-labels 2025-07-07T15:18:35.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-sunvozertinib-for-metastatic-non-small-cell-lung-cancer 2025-07-07T15:11:05.000Z monthly 0.6 https://www.accc-cancer.org/view/optimizing-germline-and-somatic-testing-in-prostate-cancer-podcast-ep-197 2025-07-02T20:09:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-linvoseltamab-gcpt-for-relapsed-or-refractory-multiple-myeloma 2025-07-02T19:36:27.000Z monthly 0.6 https://www.accc-cancer.org/view/from-awareness-to-action-advancing-sarcoma-research-and-treatment 2025-07-02T14:40:47.000Z monthly 0.6 https://www.accc-cancer.org/view/precision-medicine-at-j-j-is-working-to-advance-cancer-care-across-multiple-diseases-with-biomarker-informed-treatments-in-oncology 2025-07-01T15:54:16.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-pharmacy-virtual-office-hours-highlight-emerging-strategies-for-implementing-bispecific-antibodies 2025-06-30T14:29:24.000Z monthly 0.6 https://www.accc-cancer.org/view/precision-at-scale-expanding-rare-molecular-subtype-trials-via-the-decentralized-model 2025-06-27T13:54:25.000Z monthly 0.6 https://www.accc-cancer.org/view/climbing-the-ladder-of-inference-self-awareness-and-authentic-leadership-through-the-lens-of-maslow-s-hierarchy 2025-06-25T17:30:22.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-datopotamab-deruxtecan-dlnk-for-egfr-mutated-non-small-cell-lung-cancer 2025-06-25T16:09:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tafasitamab-cxix-for-relapsed-or-refractory-follicular-lymphoma 2025-06-25T16:04:41.000Z monthly 0.6 https://www.accc-cancer.org/view/better-bladder-cancer-care-closer-to-home-podcast-ep-196 2025-06-24T17:59:31.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-e-poster-immune-related-adverse-events-mini-podcast-ep-195 2025-06-24T17:10:45.000Z monthly 0.6 https://www.accc-cancer.org/view/ambulatory-care-excellence-ace-charting-a-new-path-in-ambulatory-care-model-and-coordination 2025-06-23T19:41:29.000Z monthly 0.6 https://www.accc-cancer.org/view/implementing-a-structured-scalable-geriatric-oncology-program-mini-podcast-ep-194 2025-06-18T17:50:13.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-policy-summit-empowering-and-shaping-primary-care-and-oncology-partnerships 2025-06-17T14:19:36.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-rural-appalachian-lung-cancer-screening-initiative-fuels-increased-early-cancer-detection 2025-06-17T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-mitomycin-intravesical-solution-for-recurrent-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer 2025-06-12T20:13:48.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tablet-formulation-of-zanubrutinib-for-all-approved-indications 2025-06-12T20:09:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-taletrectinib-for-ros1-positive-non-small-cell-lung-cancer 2025-06-12T20:03:36.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-patient-outcomes-through-primary-care-and-oncology-collaboration-an-nccn-policy-summit 2025-06-12T14:54:24.000Z monthly 0.6 https://www.accc-cancer.org/view/shaw-at-home-an-oncology-specific-home-and-community-based-palliative-care-program-mini-podcast-ep-193 2025-06-11T17:22:17.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-care-between-clinic-visits-a-sustainable-model-for-remote-patient-monitoring 2025-06-10T17:49:05.000Z monthly 0.6 https://www.accc-cancer.org/view/new-xofigo--radium-223-dichloride--data-in-metastatic-castration-resistant-prostate-cancer-from-phase-iii-peace-iii-trial-published-in-annals-of-oncology 2025-06-09T13:04:56.000Z monthly 0.6 https://www.accc-cancer.org/view/the-coordinator-s-perspective-driving-research-growth-from-the-ground-up-video-podcast-ep-55 2025-06-05T18:50:34.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-darolutamide-for-metastatic-castration-sensitive-prostate-cancer 2025-06-03T20:00:41.000Z monthly 0.6 https://www.accc-cancer.org/view/mercy-receives-pcori-funding-to-expand-ai-driven-smart-texting-program 2025-06-03T15:02:35.000Z monthly 0.6 https://www.accc-cancer.org/view/more-than-skin-deep-elevating-prevention-early-detection-and-innovation-during-skin-cancer-awareness-month 2025-05-30T16:06:28.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-care-between-clinic-visits-a-sustainable-model-for-remote-patient-monitoring-mini-podcast-ep-192 2025-05-30T15:11:26.000Z monthly 0.6 https://www.accc-cancer.org/view/harnessing-ai-to-empower-the-community-oncology-workforce 2025-05-28T14:57:02.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-of-unknown-primary--cup--implementation-of-a-robust-pathway 2025-05-27T20:15:44.000Z monthly 0.6 https://www.accc-cancer.org/view/honoring-oncology-nurse-navigators 2025-05-22T14:45:57.000Z monthly 0.6 https://www.accc-cancer.org/view/5-ways-to-improve-oncology-clinical-trials-mini-podcast-ep-191 2025-05-21T19:07:22.000Z monthly 0.6 https://www.accc-cancer.org/view/transforming-cancer-detection-and-treatment-with-ai-driven-healthy-person-program 2025-05-20T18:43:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-retifanlimab-dlwr-with-carboplatin-and-paclitaxel-and-as-a-single-agent-for-squamous-cell-carcinoma-of-the-anal-canal 2025-05-16T14:57:09.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-telisotuzumab-vedotin-tllv-for-nsclc-with-high-c-met-protein-overexpression 2025-05-16T14:49:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-belzutifan-for-pheochromocytoma-or-paraganglioma 2025-05-16T14:37:58.000Z monthly 0.6 https://www.accc-cancer.org/view/an-unexpected-lesson-to-live-intentionally 2025-05-15T14:13:06.000Z monthly 0.6 https://www.accc-cancer.org/view/jazz-pharmaceuticals-study-for-adults-suffering-from-her2-positive-biliary-tract-cancer 2025-05-14T17:39:13.000Z monthly 0.6 https://www.accc-cancer.org/view/adopting-machine-learning-enabled-decision-support-to-improve-oncology-end-of-life-outcomes 2025-05-13T13:39:13.000Z monthly 0.6 https://www.accc-cancer.org/view/navigating-disparities-and-challenges-in-btc-care-podcast-ep-190 2025-05-09T20:21:46.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-the-combination-of-avutometinib-and-defactinib-for-select-patients-with-ovarian-cancer 2025-05-09T17:48:38.000Z monthly 0.6 https://www.accc-cancer.org/view/precision-in-progress-how-biomarkers-and-targeted-therapies-are-reshaping-ovarian-cancer-care 2025-05-08T15:55:46.000Z monthly 0.6 https://www.accc-cancer.org/view/housing-at-risk-program-mini-podcast-ep-189 2025-05-06T21:17:59.000Z monthly 0.6 https://www.accc-cancer.org/view/implementing-a-structured-scalable-geriatric-oncology-program 2025-05-05T16:34:47.000Z monthly 0.6 https://www.accc-cancer.org/view/elacestrant-in-er-her2-metastatic-breast-cancer-with-esr1-mutated-tumors 2025-05-01T18:01:46.000Z monthly 0.6 https://www.accc-cancer.org/view/breaking-barriers-with-digital-health-technologies-advancing-crs-risk-prediction 2025-04-29T19:10:48.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-penpulimab-kcqx-for-non-keratinizing-nasopharyngeal-carcinoma 2025-04-24T15:49:11.000Z monthly 0.6 https://www.accc-cancer.org/view/this-is-living-with-cancer 2025-04-24T13:18:11.000Z monthly 0.6 https://www.accc-cancer.org/view/targeting-progress-patient-perspective-on-antibody-drug-conjugates-in-gynecologic-cancer-care-podcast-ep-188 2025-04-24T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/esophageal-awareness-improved-survivorship-through-precision-medicine 2025-04-22T20:20:56.000Z monthly 0.6 https://www.accc-cancer.org/view/understanding-and-meeting-the-unique-needs-of-adolescents-and-young-adults-with-cancer-podcast-ep-187 2025-04-22T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/head-and-neck-cancer-a-multidisciplinary-approach 2025-04-18T14:29:03.000Z monthly 0.6 https://www.accc-cancer.org/view/navigating-disparities-and-challenges-in-hcc-care-podcast-ep-186 2025-04-17T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/bridging-the-gap-women-s-health-and-cancer-screening-in-indigenous-communities-mini-podcast-ep-185 2025-04-15T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-with-ipilimumab-for-unresectable-or-metastatic-hepatocellular-carcinoma 2025-04-11T14:55:37.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-full-approval-of-larotrectinib-for-adult-and-pediatric-patients-with-ntrk-gene-fusion-positive-solid-tumors 2025-04-11T13:36:49.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-pluvicto-s-metastatic-castration-resistant-prostate-cancer-indication 2025-04-08T19:05:31.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-with-ipilimumab-for-unresectable-or-metastatic-msi-h-or-dmmr-colorectal-cancer 2025-04-08T18:09:06.000Z monthly 0.6 https://www.accc-cancer.org/view/sprinting-toward-self-improvement 2025-04-08T13:48:55.000Z monthly 0.6 https://www.accc-cancer.org/view/protecting-cancer-research-and-patient-care-access 2025-04-07T22:28:44.000Z monthly 0.6 https://www.accc-cancer.org/view/shared-decision-making-in-cll-podcast-ep-184 2025-04-07T19:50:18.000Z monthly 0.6 https://www.accc-cancer.org/view/national-minority-health-month-addressing-racial-disparities-in-oncology 2025-04-03T14:15:47.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-durvalumab-for-muscle-invasive-bladder-cancer 2025-03-28T21:14:12.000Z monthly 0.6 https://www.accc-cancer.org/view/pipeline-partners-mini-podcast-ep-183 2025-03-28T18:22:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cabozantinib-for-pancreatic-and-extra-pancreatic-neuroendocrine-tumors 2025-03-26T14:15:08.000Z monthly 0.6 https://www.accc-cancer.org/view/screening-for-social-drivers-of-health 2025-03-25T19:07:29.000Z monthly 0.6 https://www.accc-cancer.org/view/transforming-oncology-care-through-technological-innovation 2025-03-21T15:12:37.000Z monthly 0.6 https://www.accc-cancer.org/view/supporting-skin-health-in-patients-with-breast-cancer 2025-03-20T15:30:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-her2-positive-gastric-or-gastroesophageal-junction-adenocarcinoma-expressing-pd-l1--cps-1- 2025-03-19T18:59:07.000Z monthly 0.6 https://www.accc-cancer.org/view/advocates-discuss-leveraging-software-to-improve-financial-assistance 2025-03-14T13:24:14.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-cancer-care-centers-announces-2025-2026-executive-committee-and-board-of-trustees 2025-03-14T01:55:20.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-cancer-care-centers-announces-2025-award-recipients 2025-03-14T01:54:07.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-leaders-barrett-and-zon-discuss-the-future-of-cancer-care 2025-03-14T01:51:15.000Z monthly 0.6 https://www.accc-cancer.org/view/geron-announces-european-commission-approval-of-imetelstat-a-first-in-class-telomerase-inhibitor-for-the-treatment-of-adults-with-transfusion-dependent-anemia-due-to-lower-risk-mds 2025-03-13T15:51:15.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-topline-takeaways 2025-03-12T17:41:57.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-ai-in-oncology 2025-03-12T17:23:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tevimbra-for-first-line-treatment-of-advanced-esophageal-squamous-cell-carcinoma-in-combination-with-chemotherapy 2025-03-12T13:28:17.000Z monthly 0.6 https://www.accc-cancer.org/view/coping-with-imposter-syndrome 2025-03-12T13:03:48.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-president-una-hopkins 2025-03-11T17:45:32.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-future-of-care-accc-asco 2025-03-10T21:06:30.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-health-care-leadership-market-dynamics-and-women-s-oncology 2025-03-10T20:44:57.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-leading-policy-change-at-the-state-level 2025-03-10T17:57:26.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-president-nadine-j.-barrett 2025-03-10T17:24:29.000Z monthly 0.6 https://www.accc-cancer.org/view/03-amccbs-lessons-in-leadership-and-a-health-policy-update 2025-03-07T22:50:25.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-the-future-of-cancer-care-delivery 2025-03-07T02:37:03.000Z monthly 0.6 https://www.accc-cancer.org/view/amtagvi-patient-identification-and-referral-process 2025-03-06T17:35:13.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-advocating-on-capitol-hill 2025-03-06T02:38:14.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-clinical-research-award-winner 2025-03-05T18:24:57.000Z monthly 0.6 https://www.accc-cancer.org/view/recognizing-leaders-in-financial-navigation 2025-03-03T16:20:18.000Z monthly 0.6 https://www.accc-cancer.org/view/key-takeaways-from-a-national-quality-improvement-initiative-to-address-disparities-in-bladder-cancer-care-video-podcast-ep-54 2025-02-26T17:04:35.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-capitol-hill-day-mini-podcast-ep-180 2025-02-21T21:14:40.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-prevention-month-the-importance-of-genetic-testing-and-early-patient-provider-conversations 2025-02-20T14:45:24.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-fam-trastuzumab-deruxtecan-nxki-for-unresectable-or-metastatic-hr-positive-her2-low-or-her2-ultralow-breast-cancer 2025-02-20T12:57:31.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-vimseltinib-for-symptomatic-tenosynovial-giant-cell-tumor 2025-02-17T21:02:26.000Z monthly 0.6 https://www.accc-cancer.org/view/anemia-in-focus-the-challenge-of-identifying-myelodysplastic-syndromes--mds--2 2025-02-17T20:38:47.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-mirdametinib-for-adult-and-pediatric-patients-with-neurofibromatosis-type-1-who-have-symptomatic-plexiform-neurofibromas-not-amenable-to-complete-resection 2025-02-12T18:11:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-brentuximab-vedotin-with-lenalidomide-and-rituximab-for-relapsed-or-refractory-large-b-cell-lymphoma 2025-02-12T18:05:00.000Z monthly 0.6 https://www.accc-cancer.org/view/implementing-bispecific-antibodies-the-blueprint-for-community-oncology-excellence-podcast-ep-179 2025-02-11T17:15:54.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-session-spotlight-growth-strategies-and-marketplace-differentiators 2025-02-11T16:41:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-treosulfan-with-fludarabine-as-a-preparative-regimen-for-allohsct-in-adult-and-pediatric-patients-with-aml-or-mds 2025-02-07T14:49:33.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-celebrates-reintroduction-of-policy-that-will-bring-early-cancer-detection-tools-to-cancer-centers-across-the-country 2025-02-06T21:39:33.000Z monthly 0.6 https://www.accc-cancer.org/view/missing-voices-increasing-black-women-s-engagement-in-patient-reported-outcomes-in-breast-cancer-treatment---podcast-ep-178 2025-02-06T20:52:22.000Z monthly 0.6 https://www.accc-cancer.org/view/pairing-women-s-health-and-oncology-at-the-51st-amccbs 2025-02-05T16:54:33.000Z monthly 0.6 https://www.accc-cancer.org/view/patients-new-to-nubeqa-will-be-subject-to-new-prior-authorization-criteria 2025-02-04T18:39:03.000Z monthly 0.6 https://www.accc-cancer.org/view/test-media-link 2025-02-03T19:04:08.881Z monthly 0.6 https://www.accc-cancer.org/view/guiding-principles-for-effective-management-for-cll 2025-01-31T21:03:28.000Z monthly 0.6 https://www.accc-cancer.org/view/consumerism-cultures-of-happiness-and-ai-in-cancer-care-mini-podcast-ep-177 2025-01-30T21:40:52.000Z monthly 0.6 https://www.accc-cancer.org/view/best-of-acccs-oncology-reimbursement-meetings-mini-podcast-ep-176 2025-01-30T14:48:25.000Z monthly 0.6 https://www.accc-cancer.org/view/foundations-of-bispecific-antibodies 2025-01-29T21:58:10.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-datopotamab-deruxtecan-dlnk-for-unresectable-or-metastatic-hr-positive-her2-negative-breast-cancer 2025-01-28T15:50:25.000Z monthly 0.6 https://www.accc-cancer.org/view/the-ripple-effect-of-leadership-inspiring-change-in-cancer-care-and-beyond 2025-01-28T14:39:54.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-safety-announcement-on-the-importance-of-dpd-deficiency-discussions-with-patients-before-capecitabine-or-5fu-treatment 2025-01-28T13:41:27.000Z monthly 0.6 https://www.accc-cancer.org/view/supportive-oncodermatology-managing-skin-hair-and-nail-toxicities-in-cancer-care-video-podcast-ep-53 2025-01-22T18:17:47.000Z monthly 0.6 https://www.accc-cancer.org/view/cervical-cancer-awareness-empowering-prevention-through-the-hpv-vaccine 2025-01-21T16:17:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-sotorasib-with-panitumumab-for-kras-g12c-mutated-colorectal-cancer 2025-01-17T19:17:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-acalabrutinib-with-bendamustine-and-rituximab-for-previously-untreated-mantle-cell-lymphoma 2025-01-17T19:14:35.000Z monthly 0.6 https://www.accc-cancer.org/view/part-7-of-a-7-part-series-advocating-for-patients-in-rural-communities-mini-podcast-ep-175 2025-01-16T19:16:09.000Z monthly 0.6 https://www.accc-cancer.org/view/centers-for-medicare-medicaid-services-has-assigned-a-permanent-j-code-for-rytelo 2025-01-16T16:04:38.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-patient-advocacy-summit-navigating-communication-health-literacy-and-misinformation 2025-01-14T16:49:05.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-cancer-care-centers-accc-announces-special-grant-to-firefighter-support-network 2025-01-13T21:08:46.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-encorafenib-combination-regimen-as-first-line-treatment-of-braf-v600e-mutant-metastatic-colorectal-cancer 2025-01-13T20:44:00.000Z monthly 0.6 https://www.accc-cancer.org/view/starting-strong-the-role-of-fellows-in-medical-advocacy-podcast-ep-174 2025-01-10T14:48:16.000Z monthly 0.6 https://www.accc-cancer.org/view/a-global-perspective-caring-for-patients-in-low--and-middle-income-countries 2025-01-07T14:32:32.000Z monthly 0.6 https://www.accc-cancer.org/view/part-6-of-a-7-part-series-barriers-to-accessing-cancer-care-in-nigeria-mini-podcast-ep-173 2025-01-06T17:46:31.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tislelizumab-jsgr-for-first-line-treatment-of-gastric-and-gastroesophageal-junction-cancers 2025-01-02T19:21:59.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-and-hyaluronidase-nvhy-for-subcutaneous-injection 2025-01-02T19:17:26.000Z monthly 0.6 https://www.accc-cancer.org/view/genentech-pro-product-access-and-disease-state-resources-for-providers-patients 2024-12-27T21:33:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-blinatumomab-for-72--and-96-hour-infusion-durations 2024-12-23T21:47:06.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-encorafenib-with-cetuximab-and-mfolfox6-for-metastatic-colorectal-cancer-with-a-braf-v600e-mutation 2024-12-23T20:40:44.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-remestemcel-l-rknd-for-steroid-refractory-acute-graft-versus-host-disease-in-pediatric-patients 2024-12-23T20:29:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ensartinib-for-alk-positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer 2024-12-23T20:24:42.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cosibelimab-ipdl-for-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma 2024-12-23T20:19:52.000Z monthly 0.6 https://www.accc-cancer.org/view/empowering-community-cancer-providers-resources-for-sarcoma-care-podcast-ep-172 2024-12-20T16:01:12.000Z monthly 0.6 https://www.accc-cancer.org/view/harnessing-artificial-intelligence-in-drug-discovery-and-development 2024-12-20T14:35:50.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-in-support-of-bipartisan-year-end-legislation 2024-12-18T17:52:41.000Z monthly 0.6 https://www.accc-cancer.org/view/where-to-start-implementing-bispecific-antibody-therapies-in-the-community-setting 2024-12-18T14:30:24.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-equitable-access-to-care-unpacking-medicare-s-new-documentation-coding-and-billing-requirements 2024-12-16T18:43:23.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-inflammaging-understanding-the-role-of-aging-and-inflammation-in-cancer 2024-12-13T14:26:52.000Z monthly 0.6 https://www.accc-cancer.org/view/part-5-of-a-7-part-series-lessons-learned-in-sweden-in-cancer-prevention-and-early-detection-mini-podcast-ep-171 2024-12-12T21:05:28.000Z monthly 0.6 https://www.accc-cancer.org/view/rare-but-treatable-sarcoma-care-in-the-community-setting 2024-12-11T20:47:12.000Z monthly 0.6 https://www.accc-cancer.org/view/challenges-and-opportunities-in-oncologic-palliative-care-insights-from-a-panel-discussion 2024-12-09T15:50:28.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-durvalumab-for-limited-stage-small-cell-lung-cancer 2024-12-06T18:49:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-zenocutuzumab-zbco-for-non-small-cell-lung-cancer-and-pancreatic-adenocarcinoma 2024-12-06T18:44:46.000Z monthly 0.6 https://www.accc-cancer.org/view/leveraging-artificial-intelligence-machine-learning-to-reduce-health-disparities 2024-12-06T14:51:06.000Z monthly 0.6 https://www.accc-cancer.org/view/part-4-of-a-7-part-series-working-to-improve-survival-rates-and-patient-education-in-egypt-mini-podcast-ep-170 2024-12-05T20:07:25.000Z monthly 0.6 https://www.accc-cancer.org/view/exploring-bispecific-antibodies-in-community-oncology-overcoming-challenges-and-harnessing-opportunities-video-podcast-ep-52 2024-12-05T19:47:48.000Z monthly 0.6 https://www.accc-cancer.org/view/a-global-perspective-overcoming-challenges-in-rural-oncology 2024-12-04T15:04:22.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-education-on-medicare-prescription-payment-plan 2024-12-02T18:19:51.000Z monthly 0.6 https://www.accc-cancer.org/view/the-transformative-impact-of-artificial-intelligence-on-cancer-care-delivery 2024-12-02T15:24:49.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-myths-and-building-confidence-towards-delivering-bispecific-antibodies-in-the-community-setting 2024-11-27T15:06:43.000Z monthly 0.6 https://www.accc-cancer.org/view/part-3-of-a-7-part-series-examining-the-public-health-landscape-in-brazil-mini-podcast-ep-169 2024-11-26T19:12:50.000Z monthly 0.6 https://www.accc-cancer.org/view/ama-cpt-coding-update-for-oncology-navigation-services-and-the-cancer-moonshot 2024-11-25T15:37:17.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-zanidatamab-hrii-for-select-cases-of-biliary-tract-cancer 2024-11-22T15:34:12.000Z monthly 0.6 https://www.accc-cancer.org/view/a-global-perspective-innovative-care-and-supporting-women-in-medicine-in-nigeria 2024-11-22T15:19:40.000Z monthly 0.6 https://www.accc-cancer.org/view/impact-of-medicare-part-d-changes-on-access-to-care-for-patients-with-cancer-podcast-ep-168 2024-11-21T17:11:37.000Z monthly 0.6 https://www.accc-cancer.org/view/part-2-of-a-7-part-series-advancing-early-detection-prevention-and-clinical-trial-diversity-in-puerto-rico-mini-podcast-ep-167 2024-11-20T20:42:18.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-updated-drug-labeling-for-fludarabine-phosphate-under-project-renewal 2024-11-20T15:51:50.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-revumenib-for-relapsed-or-refractory-acute-leukemia-with-a-kmt2a-translocation 2024-11-20T15:48:14.000Z monthly 0.6 https://www.accc-cancer.org/view/speak-clearly-care-deeply-to-personalize-care-listen-to-patients 2024-11-20T14:47:13.000Z monthly 0.6 https://www.accc-cancer.org/view/desmoid-tumor-icd-10-cm-codes-flashcard 2024-11-20T02:54:41.000Z monthly 0.6 https://www.accc-cancer.org/view/responding-to-the-iv-fluid-shortage-crisis-a-community-discussion 2024-11-18T16:09:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-obecabtagene-autoleucel-for-adults-with-relapsed-or-refractory-b-cell-precursor-acute-lymphoblastic-leukemia 2024-11-14T20:14:41.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-thought-leaders-share-their-strategies-for-equitable-cancer-care 2024-11-14T14:45:19.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-perceived-barriers-to-optimal-care-in-head-and-neck-cancer-a-mixed-methods-study 2024-11-14T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/2025-inflation-reduction-act--ira--frm 2024-11-13T18:09:18.000Z monthly 0.6 https://www.accc-cancer.org/view/empowering-voices-a-keynote-on-engaging-community-in-cancer-care 2024-11-12T14:12:37.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-care-coordination-to-address-healthcare-inequities-in-lung-cancer 2024-11-12T03:11:59.000Z monthly 0.6 https://www.accc-cancer.org/view/johnson-and-johnson-2023-u-s--pricing-transparency-report 2024-11-09T16:42:57.000Z monthly 0.6 https://www.accc-cancer.org/view/anemia-in-focus-the-challenge-of-identifying-myelodysplastic-syndromes-mds 2024-11-09T16:18:18.000Z monthly 0.6 https://www.accc-cancer.org/view/supportive-care-strategies-for-promoting-health-equity-in-patients-with-breast-cancer 2024-11-07T19:36:00.000Z monthly 0.6 https://www.accc-cancer.org/view/two-critical-tests-for-better-pancreatic-cancer-treatment-options 2024-11-07T14:30:47.000Z monthly 0.6 https://www.accc-cancer.org/view/supporting-patient-information-and-resource-needs-for-bispecific-antibody-treatments 2024-11-05T16:10:50.000Z monthly 0.6 https://www.accc-cancer.org/view/part-1-of-a-7-part-series-challenges-faced-by-patients-with-cancer-across-the-globe-mini-podcast-ep-166 2024-10-31T19:31:58.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-center-spotlights-increasing-equitable-access-to-exercise-rehabilitation-and-image-recovery-services-for-patients-with-breast-cancer 2024-10-31T13:38:01.000Z monthly 0.6 https://www.accc-cancer.org/view/a-patient-journey-focus-on-oncodermatology 2024-10-30T15:36:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-asciminib-for-newly-diagnosed-chronic-myeloid-leukemia 2024-10-29T20:17:21.000Z monthly 0.6 https://www.accc-cancer.org/view/empowering-patients-with-cancer-to-self-schedule-new-patient-consultations-mini-podcast-ep-165 2024-10-29T19:14:05.000Z monthly 0.6 https://www.accc-cancer.org/view/achieving-100-nurse-satisfaction-with-balanced-patient-assignments-lee-health-s-success-story 2024-10-29T14:03:10.000Z monthly 0.6 https://www.accc-cancer.org/view/elacestrant-in-er-her2-metastatic-breast-cancer-with-esr1-mutated-tumors-subgroup-analyses-from-the-phase-iii-emerald-trial-by-prior-duration-of-endocrine-therapy-plus-cdk4-6-inhibitor-and-in-clinical-subgroups 2024-10-28T19:15:48.000Z monthly 0.6 https://www.accc-cancer.org/view/new-insurance-codes-for-scalp-cooling-will-transform-access-for-cancer-patients 2024-10-24T14:23:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-novocure-s-optune-lua-for-the-treatment-of-metastatic-non-small-cell-lung-cancer 2024-10-24T14:17:55.000Z monthly 0.6 https://www.accc-cancer.org/view/acknowledging-breast-cancer-awareness-month 2024-10-24T14:05:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-zolbetuximab-clzb-with-chemotherapy-for-gastric-or-gastroesophageal-junction-adenocarcinoma 2024-10-21T18:08:09.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-inavolisib-with-palbociclib-and-fulvestrant-for-select-patients-with-breast-cancer 2024-10-17T17:58:15.000Z monthly 0.6 https://www.accc-cancer.org/view/breaking-down-principal-illness-navigation-services-helping-oncology-providers-and-administrators-document-code-and-bill-for-patient-navigation-services 2024-10-17T13:36:47.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-the-hawaii-cancer-consortium 2024-10-16T20:16:46.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-navigating-access-and-equity 2024-10-16T20:11:47.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-the-noc-gala 2024-10-16T20:02:25.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-enhancing-cancer-research-through-patient-advocacy 2024-10-16T19:26:14.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-realizing-innovation-what's-new-in-2024 2024-10-16T19:19:34.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-come-together-a-global-perspective-on-cancer-care-delivery 2024-10-16T19:09:56.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-culturally-tailored-survivorship-care 2024-10-16T19:01:10.000Z monthly 0.6 https://www.accc-cancer.org/view/adc-cast-is-a-non-promotional-educational-podcast-series-dedicated-to-antibody-drug-conjugates--adcs--in-breast-cancer 2024-10-16T00:24:45.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-advancing-global-health-equity 2024-10-11T22:38:12.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc 2024-10-11T02:18:13.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-financial-advocacy-and-building-sustainable-navigation 2024-10-10T01:24:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-neoadjuvant-adjuvant-nivolumab-for-resectable-non-small-cell-lung-cancer 2024-10-08T14:13:06.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-selpercatinib-for-medullary-thyroid-cancer-with-a-ret-mutation 2024-10-08T14:08:45.000Z monthly 0.6 https://www.accc-cancer.org/view/2024-trending-now-in-cancer-care-podcast-ep-164 2024-10-07T16:30:02.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-supports-congressional-resolution-creating-a-rare-cancer-day 2024-10-07T13:49:17.000Z monthly 0.6 https://www.accc-cancer.org/view/advancing-dei-in-the-cancer-workforce-a-policy-summit 2024-10-03T19:26:40.000Z monthly 0.6 https://www.accc-cancer.org/view/establishing-goals-of-treatment-in-relapsed-refractory-mantle-cell-lymphoma-video-podcast-ep-51 2024-10-02T19:40:11.000Z monthly 0.6 https://www.accc-cancer.org/view/rising-to-the-occasion-the-impact-of-outpatient-car-t-cell-therapy-at-the-froedtert-medical-college-of-wisconsin-health-network 2024-10-01T17:43:48.000Z monthly 0.6 https://www.accc-cancer.org/view/developing-a-health-equity-playbook 2024-09-30T19:56:06.000Z monthly 0.6 https://www.accc-cancer.org/view/clinical-trials-a-critical-component-of-pancreatic-cancer-care 2024-09-30T14:59:48.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-national-prostate-cancer-awareness-month 2024-09-27T15:04:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-osimertinib-for-locally-advanced-unresectable-non-small-cell-lung-cancer-following-chemoradiation-therapy 2024-09-26T19:28:23.000Z monthly 0.6 https://www.accc-cancer.org/view/highlighting-the-importance-of-the-multidisciplinary-care-team-in-skin-cancer-care 2024-09-26T16:01:48.000Z monthly 0.6 https://www.accc-cancer.org/view/learn-how-lag-3-helps-tumors-evade-the-immune-system-and-why-inhibiting-it-may-enhance-existing-immunotherapies 2024-09-26T14:50:41.000Z monthly 0.6 https://www.accc-cancer.org/view/shared-decision-making-in-relapsed-refractory-mantle-cell-lymphoma-video-podcast-ep-50 2024-09-24T15:59:34.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-isatuximab-irfc-with-bortezomib-lenalidomide-and-dexamethasone-for-newly-diagnosed-multiple-myeloma 2024-09-23T14:35:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-amivantamab-vmjw-with-carboplatin-and-pemetrexed-for-select-patients-with-non-small-cell-lung-cancer 2024-09-23T14:30:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-with-chemotherapy-for-unresectable-advanced-or-metastatic-malignant-pleural-mesothelioma 2024-09-23T13:41:41.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ribociclib-with-an-aromatase-inhibitor-and-the-ribociclib-and-letrozole-co-pack-for-early-high-risk-breast-cancer 2024-09-23T13:35:44.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-and-hyaluronidase-tqjs-for-subcutaneous-injection 2024-09-23T13:29:22.000Z monthly 0.6 https://www.accc-cancer.org/view/childhood-cancer-a-journey-beyond-treatment 2024-09-20T14:18:26.000Z monthly 0.6 https://www.accc-cancer.org/view/the-next-frontier-how-ai-will-shape-oncology-care 2024-09-19T15:17:12.000Z monthly 0.6 https://www.accc-cancer.org/view/innovative-cancer-care-operationalizing-bispecific-antibodies-in-the-outpatient-setting-at-st-luke-s-cancer-institute 2024-09-13T18:07:23.000Z monthly 0.6 https://www.accc-cancer.org/view/psychosocial-support-in-head-and-neck-cancer-care 2024-09-12T18:31:11.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-cancer-care-centers-announces-41st-national-oncology-conference 2024-09-11T13:38:05.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-cancer-care-centers-oral-presentation-and-posters-selected-for-2024-world-conference-on-lung-cancer 2024-09-11T13:18:21.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-sexual-health-in-oncology-patients 2024-09-09T18:49:04.000Z monthly 0.6 https://www.accc-cancer.org/view/leveraging-artificial-intelligence-ai-for-early-detection-of-lung-cancer-the-lung-nodule-program-at-penn-medicine-princeton-health 2024-09-06T14:54:26.000Z monthly 0.6 https://www.accc-cancer.org/view/a-powerful-practice-in-house-pantries-combat-food-insecurity-for-patients-with-cancer 2024-08-28T17:15:27.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-fast-track-designation-to-bgb-16673 2024-08-26T18:47:01.000Z monthly 0.6 https://www.accc-cancer.org/view/care-coordination-for-advanced-non-melanoma-skin-cancers 2024-08-26T16:55:50.000Z monthly 0.6 https://www.accc-cancer.org/view/community-engagement-increasing-access-to-supportive-care-services 2024-08-23T17:00:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lazertinib-with-amivantamab-vmjw-for-non-small-cell-lung-cancer 2024-08-21T20:59:51.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-neoadjuvant-adjuvant-durvalumab-for-resectable-non-small-cell-lung-cancer 2024-08-21T20:55:45.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-axatilimab-csfr-for-chronic-graft-versus-host-disease 2024-08-19T17:24:39.000Z monthly 0.6 https://www.accc-cancer.org/view/a-practice-within-a-practice-integrating-oncodermatology-into-comprehensive-cancer-care-video-podcast-ep-49 2024-08-15T21:20:43.000Z monthly 0.6 https://www.accc-cancer.org/view/small-moments-can-help-you-spot-endometrial-cancer 2024-08-12T16:37:01.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-appoints-first-woman-to-serve-as-executive-director 2024-08-12T14:18:34.000Z monthly 0.6 https://www.accc-cancer.org/view/adverse-event-management-in-relapsed-refractory-mantle-cell-lymphoma-video-podcast-ep-48 2024-08-09T15:54:11.000Z monthly 0.6 https://www.accc-cancer.org/view/a-toolkit-for-those-living-with-or-care-for-someone-with-diffuse-large-b-cell-lymphoma--dlbcl- 2024-08-08T13:14:41.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-honors-world-lung-cancer-day-where-passion-meets-innovation 2024-08-01T18:08:45.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-and-hyaluronidase-fihj-for-select-patients-with-multiple-myeloma 2024-07-31T17:41:59.000Z monthly 0.6 https://www.accc-cancer.org/view/a-one-stop-breast-clinic-improves-time-to-diagnosis-and-patient-satisfaction 2024-07-31T16:28:37.000Z monthly 0.6 https://www.accc-cancer.org/view/how-do-i-say-it-patient-provider-communication-in-diffuse-large-b-cell-lymphoma-care-video-podcast-ep-47 2024-07-30T18:01:37.000Z monthly 0.6 https://www.accc-cancer.org/view/implementing-a-quality-intervention-for-patients-with-clinical-characteristics-of-advanced-polycythemia-vera 2024-07-30T14:46:13.000Z monthly 0.6 https://www.accc-cancer.org/view/identifying-patients-with-advanced-polycythemia-vera 2024-07-30T14:43:08.000Z monthly 0.6 https://www.accc-cancer.org/view/geron-announces-updated-nccn-guidelines-recommending-imetelstat-for-the-treatment-of-symptomatic-anemia-in-patients-with-lower-risk-mds 2024-07-26T17:52:06.000Z monthly 0.6 https://www.accc-cancer.org/view/recognizing-implicit-bias-and-ways-to-overcome-it 2024-07-25T20:44:57.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-frequency-of-care-to-improve-quality-of-life-in-patients-with-low-risk-anemia-video-podcast-ep-46 2024-07-25T19:20:26.000Z monthly 0.6 https://www.accc-cancer.org/view/northwell-cancer-institute-s-molecular-diagnostics-laboratory-brings-cutting-edge-care-closer-to-home 2024-07-24T21:37:18.000Z monthly 0.6 https://www.accc-cancer.org/view/creating-a-community-wide-safety-net-for-centralized-tracking-and-management-of-incidental-lung-nodule-findings 2024-07-24T20:38:10.000Z monthly 0.6 https://www.accc-cancer.org/view/lyte-living-your-truth-empowered 2024-07-23T19:19:45.000Z monthly 0.6 https://www.accc-cancer.org/view/what-to-expect-from-your-eye-care-appointments-while-taking-elahere--mirvetuximab-soravtansine-gynx- 2024-07-18T18:13:50.000Z monthly 0.6 https://www.accc-cancer.org/view/best-practices-for-the-management-of-ocular-adverse-events-associated-with-elahere--mirvetuximab-soravtansine-gynx- 2024-07-18T18:03:27.000Z monthly 0.6 https://www.accc-cancer.org/view/empowering-laboratory-professionals-to-optimize-biomarker-testing-video-podcast-ep-45 2024-07-18T15:54:44.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-cancer-care-centers-announces-new-executive-director-meagan-o-neill 2024-07-17T19:39:40.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-july-as-sarcoma-and-bone-cancer-awareness-month 2024-07-16T19:17:34.000Z monthly 0.6 https://www.accc-cancer.org/view/a-one-stop-breast-clinic-improves-time-to-diagnosis-and-patient-satisfaction- 2024-07-16T18:36:48.000Z monthly 0.6 https://www.accc-cancer.org/view/help-patients-face-the-realities-of-life-with-metastatic-breast-cancer-through-expose-mbc 2024-07-14T14:51:26.000Z monthly 0.6 https://www.accc-cancer.org/view/important-legislation-to-promote-early-detection-of-cancer-passes-a-key-milestone-in-the-house-of-representatives 2024-07-11T18:14:39.000Z monthly 0.6 https://www.accc-cancer.org/view/defining-and-managing-erythropoietin-stimulating-agents-esas-failure-in-patients-with-low-risk-mds-video-podcast-ep-44 2024-07-11T17:39:37.000Z monthly 0.6 https://www.accc-cancer.org/view/a-call-to-reimagine-community-engagement-and-equity-in-cancer 2024-07-10T18:34:26.000Z monthly 0.6 https://www.accc-cancer.org/view/a-sustainable-model-for-improved-quality-for-pancreatic-cyst-surveillance-and-early-pancreatic-cancer-detection 2024-07-09T13:31:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-repotrectinib-for-patients-with-ntrk-gene-fusion-positive-solid-tumors 2024-07-08T14:10:21.000Z monthly 0.6 https://www.accc-cancer.org/view/smart-texting-high-risk-patients-after-chemotherapy-reduces-ed-visits 2024-07-03T16:02:14.000Z monthly 0.6 https://www.accc-cancer.org/view/loqtorzi-receives-a-permanent-j-code-effective-july-1-2024 2024-07-02T14:54:21.000Z monthly 0.6 https://www.accc-cancer.org/view/promoting-equitable-care-through-the-4r-oncology-model---video-podcast-ep-43 2024-06-28T21:06:57.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-approves-epcoritamab-bysp-for-relapsed-or-refractory-follicular-lymphoma 2024-06-27T18:31:10.000Z monthly 0.6 https://www.accc-cancer.org/view/blackfamcan-the-role-of-family-and-faith 2024-06-27T18:21:54.000Z monthly 0.6 https://www.accc-cancer.org/view/irae-workup-guidelines 2024-06-26T20:40:22.000Z monthly 0.6 https://www.accc-cancer.org/view/esr1-mutations-in-er-her2---metastatic-breast-cancer 2024-06-26T20:13:27.000Z monthly 0.6 https://www.accc-cancer.org/view/diagnosis-and-treatment-of-hematologic-cancer 2024-06-26T19:59:51.000Z monthly 0.6 https://www.accc-cancer.org/view/implementation-of-a-bispecific-t-cell-engager-therapy-program-at-a-community-cancer-center-podcast 2024-06-25T19:57:04.000Z monthly 0.6 https://www.accc-cancer.org/view/ai-and-health-equity-in-california 2024-06-25T19:27:48.000Z monthly 0.6 https://www.accc-cancer.org/view/leveraging-the-ehr-to-automate-biosimilar-selection-and-streamline-the-prior-authorization-process 2024-06-24T18:15:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-adagrasib-cetuximab-for-kras-g12c-mutated-colorectal-cancer 2024-06-24T14:25:48.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-selection-criteria-and-surgical-resection-considerations-when-evaluating-patients-with-previously-treated-advanced-melanoma 2024-06-21T20:41:32.000Z monthly 0.6 https://www.accc-cancer.org/view/a-sustainable-model-for-improved-quality-for-pancreatic-cyst-surveillance 2024-06-21T18:02:47.000Z monthly 0.6 https://www.accc-cancer.org/view/5-questions-with-accc-s-first-ever-black-female-president-nadine-j-barrett-phd-ma-mph 2024-06-21T14:58:11.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-cardiovascular-complications-in-cancer-immunotherapy-a-guide-for-providers 2024-06-20T20:28:51.000Z monthly 0.6 https://www.accc-cancer.org/view/engaging-the-generations-through-blackfamcan 2024-06-19T18:47:03.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-6079-and-poster-394-evaluating-perceived-barriers-to-optimal-care-in-head-and-neck-cancer-a-mixed-methods-study 2024-06-19T03:46:29.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-1582-and-poster-175-differences-in-perceptions-and-use-of-remote-patient-monitoring-technology-in-rural-cancer-programs 2024-06-19T03:30:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-power-of-patient-reported-outcome-measures-to-community-cancer-centers 2024-06-18T18:04:44.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-durvalumab-chemotherapy-for-endometrial-cancer 2024-06-17T21:57:44.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-chemotherapy-for-primary-advanced-or-recurrent-endometrial-carcinoma 2024-06-17T21:48:46.000Z monthly 0.6 https://www.accc-cancer.org/view/june-spotlight-a-progress-report-on-cancer-immunotherapy 2024-06-17T17:09:40.000Z monthly 0.6 https://www.accc-cancer.org/view/the-citrus-oncology-story-revolutionizing-cancer-care-by-addressing-side-effects 2024-06-13T21:09:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-selpercatinib-for-ret-fusion-positive-thyroid-cancer 2024-06-13T15:17:17.000Z monthly 0.6 https://www.accc-cancer.org/view/the-centralized-tracking-and-management-of-incidental-lung-nodule-findings 2024-06-07T18:22:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-imetelstat-for-myelodysplastic-syndromes-with-transfusion-dependent-anemia 2024-06-07T14:51:29.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lisocabtagene-maraleucel-for-relapsed-or-refractory-mantle-cell-lymphoma 2024-06-04T13:09:30.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-inequitable-access-to-clinical-trials-in-cancer-research 2024-06-03T17:06:45.000Z monthly 0.6 https://www.accc-cancer.org/view/reimbursement-changes-seek-to-reduce-disparities-in-access-to-cancer-care 2024-05-30T18:34:03.000Z monthly 0.6 https://www.accc-cancer.org/view/social-determinants-of-health-in-metastatic-breast-cancer 2024-05-30T18:20:48.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-cancer-care-centers-announces-virtual-roadmap-to-support-ehr-integration-for-biomarker-testing 2024-05-30T15:02:16.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-nurses-the-heart-of-cancer-care 2024-05-29T17:54:36.000Z monthly 0.6 https://www.accc-cancer.org/view/thoughts-from-a-community-forum-fda-oce 2024-05-28T17:16:16.000Z monthly 0.6 https://www.accc-cancer.org/view/overcoming-barriers-to-holistic-survivorship-care-for-immunotherapy-patients 2024-05-23T18:05:01.000Z monthly 0.6 https://www.accc-cancer.org/view/pathology-in-precision-medicine-collaborative-approaches-to-optimize-care 2024-05-22T15:23:47.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-optimizing-the-implementation-of-new-therapies-in-multiple-myeloma 2024-05-21T02:02:30.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tarlatamab-dlle-for-extensive-stage-small-cell-lung-cancer 2024-05-20T14:26:42.000Z monthly 0.6 https://www.accc-cancer.org/view/upcoming-webinar-practical-insights-for-operationalizing-a-lymphedema-surveillance-program 2024-05-18T20:23:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lisocabtagene-maraleucel-for-follicular-lymphoma 2024-05-16T14:30:03.000Z monthly 0.6 https://www.accc-cancer.org/view/implementation-of-a-bispecific-t-cell-engager-therapy-program-at-a-community-cancer-center 2024-05-15T16:43:34.000Z monthly 0.6 https://www.accc-cancer.org/view/integrating-genetic-counselors-in-routine-genitourinary-care 2024-05-10T20:41:38.000Z monthly 0.6 https://www.accc-cancer.org/view/leveraging-the-ehr-to-automate-biosimilar-selection 2024-05-09T21:50:29.000Z monthly 0.6 https://www.accc-cancer.org/view/a-multidisciplinary-approach-to-anemia-management-in-high-risk-mds-and-aml 2024-05-09T18:21:03.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-world-ovarian-cancer-day 2024-05-08T16:10:07.000Z monthly 0.6 https://www.accc-cancer.org/view/building-conversations-to-personalize-care-around-patient-identity 2024-05-07T19:56:18.000Z monthly 0.6 https://www.accc-cancer.org/view/new-resources-for-acute-myeloid-leukemia-care-providers 2024-05-05T19:32:57.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-care-delivery-to-patients-newly-diagnosed-with-breast-cancer 2024-05-03T18:08:46.000Z monthly 0.6 https://www.accc-cancer.org/view/community-engagement-in-the-digital-age 2024-04-30T20:20:15.000Z monthly 0.6 https://www.accc-cancer.org/view/highlights-from-the-accc-working-summit-advancing-car-t-cell-therapy-care-continuity-and-collaborative-patient-education 2024-04-30T17:38:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tisotumab-vedotin-tftv-for-recurrent-or-metastatic-cervical-cancer 2024-04-30T05:14:25.000Z monthly 0.6 https://www.accc-cancer.org/view/de-risking-cytokine-release-syndrome-in-patients-with-cancer-via-innovative-digital-tool 2024-04-29T18:45:47.000Z monthly 0.6 https://www.accc-cancer.org/view/head-and-neck-cancer 2024-04-26T19:22:41.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lutetium-lu-177-dotatate-for-pediatric-patients-with-astroenteropancreatic-neuroendocrine-tumors 2024-04-24T18:53:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nogapendekin-alfa-inbakicept-pmln-for-invasive-bladder-cancer 2024-04-24T18:48:11.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-practice-transformation-and-integration-center 2024-04-24T17:41:15.000Z monthly 0.6 https://www.accc-cancer.org/view/care-action-plans-for-people-with-cancer-ep-41 2024-04-23T14:55:53.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-alectinib-for-alk-positive-non-small-cell-lung-cancer 2024-04-19T02:13:53.000Z monthly 0.6 https://www.accc-cancer.org/view/lungevity-precision-medicine-summit-improving-biomarker-testing 2024-04-16T17:46:39.000Z monthly 0.6 https://www.accc-cancer.org/view/advocating-for-a-better-future-the-role-of-a-unique-network 2024-04-15T18:47:14.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-abecma-for-triple-class-exposed-relapsed-or-refractory-multiple-myeloma-after-two-prior-lines-of-therapy 2024-04-15T18:07:07.000Z monthly 0.6 https://www.accc-cancer.org/view/lungevity-health-equity-summit-a-focus-on-biomarker-testing 2024-04-11T18:38:51.000Z monthly 0.6 https://www.accc-cancer.org/view/the-patient-perspective-evaluating-time-and-treatment-while-living-with-metastatic-breast-cancer 2024-04-10T18:46:37.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-national-cancer-prevention-and-early-detection-month 2024-04-09T16:21:41.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-fam-trastuzumab-deruxtecan-nxki-for-unresectable-or-metastatic-her2-positive-solid-tumors 2024-04-08T15:00:19.000Z monthly 0.6 https://www.accc-cancer.org/view/examining-oral-health-screenings-for-the-prevention-of-head-and-neck-cancers 2024-04-05T18:28:27.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-challenges-in-ehr-integration 2024-04-03T20:32:29.000Z monthly 0.6 https://www.accc-cancer.org/view/beyond-the-brush-navigating-dental-care-in-head-and-neck-cancer 2024-04-02T21:47:12.000Z monthly 0.6 https://www.accc-cancer.org/view/navigating-the-operational-challenges-of-treatment-with-bispecific-antibodies 2024-03-28T15:21:13.000Z monthly 0.6 https://www.accc-cancer.org/view/policy-perspectives-on-biomarker-testing-coverage-for-2024-mini-podcast-ep-147 2024-03-26T20:04:59.000Z monthly 0.6 https://www.accc-cancer.org/view/disparities-in-accessing-care-for-aml-patients-challenges-and-solutions-mini-podcast-ep-145 2024-03-25T14:28:38.000Z monthly 0.6 https://www.accc-cancer.org/view/open-enrollment-best-practices-for-end-of-year-prep 2024-03-25T14:20:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-mirvetuximab-soravtansine-gynx-for-frα-positive-platinum-resistant-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer 2024-03-25T13:41:50.000Z monthly 0.6 https://www.accc-cancer.org/view/small-cell-lung-cancer-a-guide-for-patients-and-their-families 2024-03-25T03:27:09.000Z monthly 0.6 https://www.accc-cancer.org/view/let-s-chat-car-t 2024-03-25T03:24:35.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-safety-labeling-changes-for-fluorouracil-injection-products 2024-03-22T14:20:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-oral-suspension-ibrutinib-in-adults-with-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma 2024-03-21T18:56:21.000Z monthly 0.6 https://www.accc-cancer.org/view/clinical-meaningfulness-insights-from-a-metastatic-breast-cancer-qualitative-study 2024-03-21T18:36:18.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ponatinib-chemotherapy-for-lymphoblastic-leukemia 2024-03-20T16:02:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tislelizumabjsgr-for-the-treatment-of-advanced-or-metastatic-esophageal-squamous-cell-carcinoma 2024-03-15T12:51:40.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-inova-schar-cancer-institute-meet-with-swedish-delegates 2024-03-14T18:00:59.000Z monthly 0.6 https://www.accc-cancer.org/view/clarifying-the-role-of-maintenance-therapy-video-podcast-ep-40 2024-03-14T17:23:52.000Z monthly 0.6 https://www.accc-cancer.org/view/bridging-health-inequities-unite-for-hers-vision-for-equitable-cancer-care 2024-03-13T18:39:48.000Z monthly 0.6 https://www.accc-cancer.org/view/changes-to-ropeginterferon-alfa-2b-njft-in-updated-nccn-clinical-practice-guidelines 2024-03-13T17:55:03.000Z monthly 0.6 https://www.accc-cancer.org/view/outgoing-and-incoming-presidents-podcast-ep-144 2024-03-12T18:47:58.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-institute-for-comprehensive-cancer-care-services-mini-podcast 2024-03-11T20:09:02.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-capitol-hill-update-mini-podcast 2024-03-11T20:08:10.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-white-house-update-mini-podcast 2024-03-11T20:04:47.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-new-payments-for-patient-navigation-mini-podcast 2024-03-11T20:00:28.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-zanubrutinib-for-relapsed-or-refractory-follicular-lymphoma 2024-03-11T18:53:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-cisplatin-and-gemcitabine-for-unresectable-or-metastatic-urothelial-carcinoma 2024-03-11T18:38:58.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-amccbs-financial-advocacy-resources-mini-podcast 2024-03-11T18:36:36.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-inotuzumab-ozogamicin-for-pediatric-patients-with-acute-lymphoblastic-leukemia 2024-03-08T18:29:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-amivantamab-vmjw-for-non-small-cell-lung-cancer-indications 2024-03-08T18:19:54.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-recognizing-excellence-training-leaders 2024-03-07T04:57:51.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-words-matter-empathy-deep-dives 2024-03-06T04:49:53.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-a-day-on-the-hill 2024-02-29T22:58:30.000Z monthly 0.6 https://www.accc-cancer.org/view/building-a-precision-medicine-team-ehr-integration-for-timely-biomarker-testing 2024-02-26T20:19:49.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-finalizes-rule-to-improve-the-prior-authorization-process 2024-02-22T18:07:39.000Z monthly 0.6 https://www.accc-cancer.org/view/making-the-case-for-head-neck-cancer-patient-care-navigators-mini-podcast-ep-143 2024-02-21T22:04:24.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-osimertinib-chemotherapy-for-egfr-mutated-non-small-cell-lung-cancer 2024-02-19T15:50:10.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-lifileucel-for-unresectable-or-metastatic-melanoma 2024-02-19T15:38:48.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tepotinib-for-metastatic-non-small-cell-lung-cancer 2024-02-16T18:30:22.000Z monthly 0.6 https://www.accc-cancer.org/view/the-florez-lab-increasing-retention-and-improving-productivity-of-under-represented-in-medicine-trainees-mini-podcast-ep-142 2024-02-15T16:00:35.000Z monthly 0.6 https://www.accc-cancer.org/view/workforce-diversification-african-americans-in-healthcare 2024-02-14T18:08:50.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-irinotecan-liposome-for-first-line-treatment-of-metastatic-pancreatic-adenocarcinoma 2024-02-13T19:26:23.000Z monthly 0.6 https://www.accc-cancer.org/view/defining-effective-practices-in-quality-care-for-patients-with-acute-myeloid-leukemia 2024-02-13T19:01:09.000Z monthly 0.6 https://www.accc-cancer.org/view/brca-testing-survey-insights-a-multidisciplinary-perspective-on-testing-and-treatment-for-patients-with-breast-cancer-mini-podcast-ep-141 2024-02-08T14:10:43.000Z monthly 0.6 https://www.accc-cancer.org/view/the-importance-of-recognizing-health-equity 2024-02-07T20:13:38.000Z monthly 0.6 https://www.accc-cancer.org/view/talk-about-it-cancer-and-mental-health 2024-02-05T21:48:19.000Z monthly 0.6 https://www.accc-cancer.org/view/championing-an-institutional-culture-of-well-being-in-a-post-pandemic-oncology-workforce-mini-podcast-ep-140 2024-02-04T02:29:13.000Z monthly 0.6 https://www.accc-cancer.org/view/examining-clinical-research-for-the-treatment-of-minorities-with-aml 2024-01-30T18:20:50.000Z monthly 0.6 https://www.accc-cancer.org/view/cervical-health-awareness-month-highlighting-american-indian-alaska-natives 2024-01-25T20:59:49.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-erdafitinib-for-locally-advanced-or-metastatic-urothelial-carcinoma 2024-01-22T19:07:46.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-social-drivers-through-diversity-and-representation-in-the-healthcare-workforce 2024-01-15T22:20:10.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-crt-for-figo-2014-stage-iii-iva-cervical-cancer 2024-01-15T16:07:11.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-patient-advocacy-summit-the-significant-of-patient-navigation 2024-01-11T19:59:29.000Z monthly 0.6 https://www.accc-cancer.org/view/a-look-at-the-emerging-role-of-health-equity-institutes 2024-01-10T18:22:46.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-patient-advocacy-summit-navigating-the-care-continuum-from-screening-through-survivorship-blog 2024-01-03T20:33:57.000Z monthly 0.6 https://www.accc-cancer.org/view/missed-care-conversations-for-patients-with-dlbcl-mini-podcast-ep-139 2023-12-21T16:29:38.000Z monthly 0.6 https://www.accc-cancer.org/view/community-car-t-cell-patient-identification-framework-mini-podcast-ep-138 2023-12-18T23:01:48.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-iptacopan-for-patients-with-paroxysmal-nocturnal-hemoglobinuria 2023-12-18T18:42:17.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-enfortumab-vedotin-ejfv-pembrolizumab-for-locally-advanced-or-metastatic-urothelial-cancer 2023-12-18T17:22:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-belzutifan-for-advanced-renal-cell-carcinoma 2023-12-18T17:12:22.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-eflornithine-for-adult-and-pediatric-patients-with-hrnb 2023-12-18T16:56:05.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-bladder-cancer-care-resource-to-reduce-disparities-as-bladder-cancer-rates-rise 2023-12-15T17:56:18.000Z monthly 0.6 https://www.accc-cancer.org/view/the-cost-of-biomarker-testing-moving-from-support-based-to-sustainable-solutions 2023-12-12T18:36:55.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-evaluating-disparities-in-access-to-quality-cancer-care-for-black-women-with-triple-negative-breast-cancer-in-the-us-a-provider-perspective 2023-12-12T02:09:39.000Z monthly 0.6 https://www.accc-cancer.org/view/importance-of-biomarker-testing-patient-goals-and-education-when-treating-gastric-cancer 2023-12-06T17:38:31.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pirtobrutinib-for-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma 2023-12-04T17:36:57.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-on-appointment-of-dr.-w.-kimryn-rathmell-to-lead-nci 2023-12-01T22:08:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nirogacestat-for-desmoid-tumors 2023-11-28T05:44:17.000Z monthly 0.6 https://www.accc-cancer.org/view/pancreatic-cancer-awareness-month-is-more-than-just-purple 2023-11-21T19:51:23.000Z monthly 0.6 https://www.accc-cancer.org/view/ehr-integration-the-next-necessary-step-for-optimized-cancer-care 2023-11-17T19:54:35.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-capivasertib-fulvestrant-for-breast-cancer 2023-11-17T14:59:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-chemotherapy-for-her2-negative-gej-junction-adenocarcinoma 2023-11-17T14:47:50.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-repotrectinib-for-ros1-positive-nsclc 2023-11-17T14:44:40.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-care-coordination-for-lung-cancer-patients-the-basics 2023-11-16T18:34:30.000Z monthly 0.6 https://www.accc-cancer.org/view/the-future-of-the-patient-experience-mini-podcast-ep-137 2023-11-16T15:20:09.000Z monthly 0.6 https://www.accc-cancer.org/view/car-t-cell-therapy-a-significant-advance-for-patients-with-hematologic-malignancies 2023-11-15T19:16:49.000Z monthly 0.6 https://www.accc-cancer.org/view/integrating-age-friendly-care-into-the-oncology-continuum 2023-11-10T19:55:11.000Z monthly 0.6 https://www.accc-cancer.org/view/highlights-from-the-accc-working-summit-biomarker-testing-solutions-for-ehr-integration-mini-podcast-ep-136 2023-11-10T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-policy-summit-addressing-the-disparities-and-social-needs-of-patients-with-cancer 2023-11-09T22:16:37.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-fruquintinib-in-refractory-metastatic-colorectal-cancer 2023-11-09T20:56:48.000Z monthly 0.6 https://www.accc-cancer.org/view/become-a-welcoming-space-small-steps-make-a-great-impact 2023-11-07T20:58:01.000Z monthly 0.6 https://www.accc-cancer.org/view/comprehensive-cancer-care-the-role-of-biomarker-testing 2023-11-06T19:18:37.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-pfs-for-2024 2023-11-03T19:59:19.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-with-chemotherapy-for-biliary-tract-cancer 2023-11-01T17:32:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-toripalimab-tpzi-for-nasopharyngeal-carcinoma 2023-11-01T13:07:47.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ivosidenib-for-myelodysplastic-syndromes 2023-10-28T18:07:22.000Z monthly 0.6 https://www.accc-cancer.org/view/every-story-counts-survivors-educate-and-inspire-patients-with-pancreatic-cancer 2023-10-26T19:45:15.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-breast-cancer-awareness-month 2023-10-25T16:33:52.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-care-delivery-for-transplant-ineligible-patients-with-acute-myeloid-leukemia 2023-10-24T18:01:00.000Z monthly 0.6 https://www.accc-cancer.org/view/humility-the-most-important-attribute 2023-10-23T16:50:17.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-pediatric-indication-for-entrectinib-and-approves-new-pellet-formulation 2023-10-23T15:44:34.000Z monthly 0.6 https://www.accc-cancer.org/view/developing-a-disease-site-specific-oncology-patient-navigation-program-mini-podcast-ep-135 2023-10-19T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/germline-and-somatic-testing-for-ovarian-cancer-podcast-ep-134 2023-10-17T17:15:09.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-for-adjuvant-treatment-of-stage-iib-c-melanoma 2023-10-16T18:11:12.000Z monthly 0.6 https://www.accc-cancer.org/view/the-association-of-community-cancer-centers-launches-initiative-to-improve-access-to-and-the-provision-of-comprehensive-cancer-care-services 2023-10-13T17:57:48.000Z monthly 0.6 https://www.accc-cancer.org/view/highlights-from-the-president-s-cancer-panel-building-on-a-strong-legacy 2023-10-12T18:38:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-encorafenib-binimetinib-for-nsclc-with-a-braf-v600e-mutation 2023-10-12T13:39:13.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-superwomen-mentorship 2023-10-11T16:02:50.000Z monthly 0.6 https://www.accc-cancer.org/view/aml-care-coordination-in-the-community-setting-video-podcast-ep-39 2023-10-11T14:47:01.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-ai-in-precision-oncology---mini-podcast 2023-10-10T17:11:35.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-technology-support-for-health-care-workforce---mini-podcast 2023-10-10T17:04:26.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-accc-priorities-for-the-president-s-cancer-panel---mini-podcast 2023-10-10T16:58:44.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-recruiting-strategies---mini-podcast 2023-10-10T16:49:26.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-leadership-for-challenging-times---mini-podcast 2023-10-10T16:39:17.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-rural-appalachian-lung-screening-initiative---mini-podcast 2023-10-10T16:23:42.000Z monthly 0.6 https://www.accc-cancer.org/view/noc-preview-biomarker-testing-for-medicaid-beneficiaries---mini-podcast 2023-10-10T15:40:54.000Z monthly 0.6 https://www.accc-cancer.org/view/noc-preview-financial-advocacy-guidelines-to-mitigate-financial-toxicity---mini-podcast 2023-10-10T15:34:58.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-innovation-leadership-collaboration 2023-10-06T17:06:47.000Z monthly 0.6 https://www.accc-cancer.org/view/national-oncology-conference-financial-advocacy-and-value-based-care 2023-10-05T15:38:13.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-care-coordination-for-patients-with-lung-cancer-a-look-at-best-practices 2023-10-03T21:04:17.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-trending-now-in-cancer-care 2023-10-03T14:26:48.000Z monthly 0.6 https://www.accc-cancer.org/view/examining-shared-decision-making-in-bladder-cancer-care-podcast-ep-133 2023-09-28T18:35:59.000Z monthly 0.6 https://www.accc-cancer.org/view/a-road-map-for-newly-diagnosed-pancreatic-cancer-patients 2023-09-26T18:30:57.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-momelotinib-for-myelofibrosis-patients-with-anemia 2023-09-25T19:53:54.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-new-and-updated-indications-for-temozolomide-under-project-renewal 2023-09-21T16:18:11.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-navigation-services-promote-equitable-access-to-high-quality-care 2023-09-21T16:01:23.000Z monthly 0.6 https://www.accc-cancer.org/view/collaborative-care-a-model-for-embedding-counseling-in-oncology-and-palliative-care 2023-09-20T17:21:45.000Z monthly 0.6 https://www.accc-cancer.org/view/an-advanced-practice-radiation-therapist-role-improves-quality-efficiency-wellness-administrative-outcomes 2023-09-20T00:16:05.000Z monthly 0.6 https://www.accc-cancer.org/view/precision-medicine-in-rural-and-underserved-areas-unique-solutions-for-unique-challenges 2023-09-12T16:23:39.000Z monthly 0.6 https://www.accc-cancer.org/view/importance-of-clinical-team-to-recognize-sclc-mini-podcast-ep-132 2023-09-12T14:54:02.000Z monthly 0.6 https://www.accc-cancer.org/view/leveraging-technology-to-develop-an-express-symptom-management-program-prevent-oncology-ed-visits-mini-podcast-ep-131 2023-09-07T13:56:14.000Z monthly 0.6 https://www.accc-cancer.org/view/early-identification-and-management-of-pneumonitis-and-other-iraes-in-patients-with-nsclc 2023-09-01T16:06:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-luspatercept-aamt-for-adults-with-lower-risk-mds 2023-09-01T15:17:56.000Z monthly 0.6 https://www.accc-cancer.org/view/the-road-to-comprehensive-biomarker-access-for-all 2023-08-31T19:48:30.000Z monthly 0.6 https://www.accc-cancer.org/view/strategies-to-address-regional-barriers-to-care-in-cll-video-podcast-ep-38 2023-08-31T15:26:09.000Z monthly 0.6 https://www.accc-cancer.org/view/combatting-caregiver-isolation-through-awareness-and-education-mini-podcast-ep-130 2023-08-29T14:06:46.000Z monthly 0.6 https://www.accc-cancer.org/view/the-role-of-the-clinical-trials-navigator-mini-podcast-ep-129 2023-08-29T13:26:44.000Z monthly 0.6 https://www.accc-cancer.org/view/closing-the-testing-gap-standardization-of-comprehensive-biomarker-testing-in-nsclc 2023-08-25T17:18:03.000Z monthly 0.6 https://www.accc-cancer.org/view/a-model-for-demonstrating-sustainable-outreach-for-cancer-screening 2023-08-24T17:52:56.000Z monthly 0.6 https://www.accc-cancer.org/view/collaborative-care-a-model-for-embedding-counseling-in-oncology-and-palliative-care-mini-podcast-ep-128 2023-08-24T15:47:46.000Z monthly 0.6 https://www.accc-cancer.org/view/conflict-what-it-is-best-management-strategies 2023-08-22T17:47:04.000Z monthly 0.6 https://www.accc-cancer.org/view/practical-tips-for-providers-to-empower-caregivers-mini-podcast-ep-127 2023-08-22T13:53:23.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-leaders-issue-urgent-call-for-mental-health-support-improvements 2023-08-21T19:13:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-role-of-a-pharmacist-in-immunotherapy-related-adverse-effects 2023-08-17T19:05:28.000Z monthly 0.6 https://www.accc-cancer.org/view/standardizing-comprehensive-biomarker-testing-in-non-small-cell-lung-cancer-mini-podcast-ep-126 2023-08-17T17:57:41.000Z monthly 0.6 https://www.accc-cancer.org/view/new-ashp-survey-critical-shortages-of-cancer-drugs-pose-dangers-to-patient-care 2023-08-16T18:33:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-melphalan-as-a-liver-directed-treatment-for-uveal-melanoma 2023-08-16T18:28:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-foundationone-cdx-as-a-companion-diagnostic-for-niraparib-and-abiraterone-acetate-for-patients-with-brca-positive-mcrpc 2023-08-16T18:16:46.000Z monthly 0.6 https://www.accc-cancer.org/view/there-is-no-one-size-fits-all-care-plan-for-caregivers-mini-podcast-ep-125 2023-08-15T17:56:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-elranatamab-bcmm-for-multiple-myeloma 2023-08-15T17:30:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-niraparib-and-abiraterone-acetate-prednisone-for-brca-mutated-mcrpc 2023-08-15T17:21:24.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-talquetamab-tgvs-for-relapsed-or-refractory-multiple-myeloma 2023-08-15T17:13:59.000Z monthly 0.6 https://www.accc-cancer.org/view/pancreatic-cancer-why-clinical-trials-should-be-a-patient-s-starting-point 2023-08-15T17:04:14.000Z monthly 0.6 https://www.accc-cancer.org/view/e-consults-for-immune-related-toxicities-improve-patient-access-and-reduce-costs-mini-podcast-ep-124 2023-08-10T15:55:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pralsetinib-for-nsclc-with-ret-gene-fusions 2023-08-10T13:35:44.000Z monthly 0.6 https://www.accc-cancer.org/view/psychosocial-care-in-oncology-the-impact-of-social-determinants-of-health 2023-08-08T16:43:24.000Z monthly 0.6 https://www.accc-cancer.org/view/the-role-of-nursing-in-post-pandemic-care-of-sclc-mini-podcast-ep-123 2023-08-08T15:18:36.000Z monthly 0.6 https://www.accc-cancer.org/view/psychosocial-care-in-oncology-advocating-for-policy-changes-that-improve-the-culture-of-care 2023-08-03T17:42:27.000Z monthly 0.6 https://www.accc-cancer.org/view/a-model-for-demonstrating-sustainable-outreach-for-cancer-screening-mini-podcast-ep-122 2023-08-03T14:06:17.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-trifluridine-tipiracil-with-bevacizumab-for-previously-treated-mcrc 2023-08-02T18:48:16.000Z monthly 0.6 https://www.accc-cancer.org/view/the-importance-of-detecting-ntrk-gene-fusions 2023-08-02T17:33:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-dostarlimab-gxly-chemotherapy-for-endometrial-cancer 2023-08-02T04:11:44.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-world-lung-cancer-day-the-lasting-effect-of-a-world-war 2023-08-01T18:20:15.000Z monthly 0.6 https://www.accc-cancer.org/view/caregiving-examining-psychosocial-care-for-those-who-experience-distress-due-to-their-caregiving-role-mini-podcast-ep-121 2023-08-01T16:23:32.000Z monthly 0.6 https://www.accc-cancer.org/view/developing-an-advanced-practice-radiation-therapist-role-mini-podcast-ep-120 2023-07-27T14:13:55.000Z monthly 0.6 https://www.accc-cancer.org/view/e-consults-for-immune-related-toxicities-improve-patient-access-and-reduce-costs 2023-07-26T17:30:14.000Z monthly 0.6 https://www.accc-cancer.org/view/abc-s-of-health-disparities 2023-07-25T18:09:26.000Z monthly 0.6 https://www.accc-cancer.org/view/leveraging-technology-to-streamline-biomarker-testing-mini-podcast-ep-119 2023-07-25T13:11:09.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-quizartinib-for-newly-diagnosed-acute-myeloid-leukemia 2023-07-21T21:04:38.000Z monthly 0.6 https://www.accc-cancer.org/view/discussions-that-matter-managing-drug-shortages-and-empowering-oncology-pharmacists 2023-07-18T16:36:32.000Z monthly 0.6 https://www.accc-cancer.org/view/building-support-for-patients-with-ntrk-gene-fusion-positive-cancer-mini-podcast-ep-118 2023-07-13T18:13:20.000Z monthly 0.6 https://www.accc-cancer.org/view/pancreatic-cancer-risk-factors-symptoms-and-early-diagnosis 2023-07-11T17:41:02.000Z monthly 0.6 https://www.accc-cancer.org/view/discussions-that-matter-a-look-at-the-current-drug-shortage 2023-07-10T16:11:15.000Z monthly 0.6 https://www.accc-cancer.org/view/critical-conversation-strategies-for-patients-with-aml-video-podcast-ep-37 2023-07-06T13:19:38.000Z monthly 0.6 https://www.accc-cancer.org/view/treating-small-cell-lung-cancer-through-multidisciplinary-enhanced-supportive-care-video-podcast-ep-36 2023-06-29T15:14:24.000Z monthly 0.6 https://www.accc-cancer.org/view/subspecialty-insights-in-immuno-oncology-a-closer-look-at-apps 2023-06-27T20:43:40.000Z monthly 0.6 https://www.accc-cancer.org/view/medical-hypnosis-a-complimentary-therapy-for-patients-in-active-treatment-mini-podcast-ep-117 2023-06-23T15:34:12.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olaparib-with-abiraterone-and-prednisone-(or-prednisolone)-for-brca-mutated-metastatic-castration-resistant-prostate-cancer 2023-06-22T18:16:01.000Z monthly 0.6 https://www.accc-cancer.org/view/strategies-to-addressing-disparities-in-patients-with-aml-video-podcast-ep-35 2023-06-22T16:56:27.000Z monthly 0.6 https://www.accc-cancer.org/view/regional-disparities-in-chronic-lymphocytic-leukemia-a-gps-for-cancer-care 2023-06-22T16:51:36.000Z monthly 0.6 https://www.accc-cancer.org/view/trans-inclusive-cancer-care-why-it-s-an-important-part-of-health-equity 2023-06-21T16:14:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-talazoparib-enzalutamide-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer 2023-06-21T14:58:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-glofitamab-gxbm 2023-06-20T20:19:42.000Z monthly 0.6 https://www.accc-cancer.org/view/express-symptom-management-prevents-unnecessary-oncology-ed-visits 2023-06-15T15:54:28.000Z monthly 0.6 https://www.accc-cancer.org/view/a-new-registry-study-for-a-rare-form-of-breast-cancer-podcast-ep-116 2023-06-15T14:02:56.000Z monthly 0.6 https://www.accc-cancer.org/view/raising-cancer-awareness-in-black-communities-through-blackfamcan 2023-06-14T19:33:51.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-on-chemotherapy-drug-shortages 2023-06-14T18:00:02.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-makes-the-case-for-precision-medicine-stewardship-through-release-of-successful-case-studies-from-cancer-programs-nationwide 2023-06-14T15:19:16.000Z monthly 0.6 https://www.accc-cancer.org/view/let-s-win-pancreatic-cancer-a-partner-for-patients-and-care-teams 2023-06-13T17:11:56.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-clinical-practice-guidelines-updates-recommend-besremi-(ropeginterferon-alfa-2b-njft)-as-a-preferred-intervention-for-polycythemia-vera 2023-06-08T17:36:12.000Z monthly 0.6 https://www.accc-cancer.org/view/a-new-decade-for-advancements-in-immunotherapy 2023-06-08T16:07:06.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-announces-the-release-of-new-resources-for-the-integration-of-oral-oncolytics-into-cll-practice 2023-06-08T14:06:03.000Z monthly 0.6 https://www.accc-cancer.org/view/biomarker-testing-for-ntrk-gene-fusions-mini-podcast-ep-115 2023-06-06T19:10:05.000Z monthly 0.6 https://www.accc-cancer.org/view/national-cancer-survivors-day-stories-from-accc-staff 2023-06-01T17:34:32.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olaparib-abiraterone-and-prednisone-for-brca-mutated-metastatic-prostate-cancer 2023-05-31T20:51:15.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-releases-five-abstracts-and-poster-at-asco-annual-meeting 2023-05-31T15:06:04.000Z monthly 0.6 https://www.accc-cancer.org/view/coherus-announces-u.s.-launch-of-udenyca-autoinjector 2023-05-30T16:02:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-care-team-mental-health-normalizing-helpers-seeking-help-mini-podcast-ep-114 2023-05-25T17:20:13.000Z monthly 0.6 https://www.accc-cancer.org/view/healthcare-leadership-strategies-the-importance-of-taking-time-off 2023-05-25T15:49:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ayvakit-(avapritinib)-for-the-treatment-of-adult-patients-with-indolent-systemic-mastocytosis-(ism) 2023-05-24T13:59:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-avapritinib-for-indolent-systemic-mastocytosis 2023-05-24T13:54:16.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-national-cancer-research-month 2023-05-23T15:59:55.000Z monthly 0.6 https://www.accc-cancer.org/view/key-highlights-from-an-accc-survey-on-remote-patient-monitoring-mini-podcast-ep-113 2023-05-23T14:48:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-epcoritamab-bysp-for-dlbcl 2023-05-22T15:09:07.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-new-oncology-practice-transformation-and-integration-center-(optic)-elearning-module 2023-05-19T13:01:46.000Z monthly 0.6 https://www.accc-cancer.org/view/telehealth-improves-access-affordability-in-cancer-care 2023-05-18T17:02:41.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-bladder-cancer-awareness-month 2023-05-16T16:39:14.000Z monthly 0.6 https://www.accc-cancer.org/view/alleviating-the-psycho-social-burden-of-mpns-mini-podcast-ep-112 2023-05-16T16:19:43.000Z monthly 0.6 https://www.accc-cancer.org/view/2023-nmqf-summit-patient-education-to-achieve-health-equity 2023-05-10T16:26:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-new-resources-to-support-advanced-skin-cancer-care 2023-05-09T16:06:34.000Z monthly 0.6 https://www.accc-cancer.org/view/myelofibrosis-advances-in-treatment-and-therapy-mini-podcast-ep-111 2023-05-05T13:33:12.000Z monthly 0.6 https://www.accc-cancer.org/view/foundationone-liquid-cdx-receives-fda-approval-as-a-companion-diagnostic-for-mobocertinib 2023-05-05T02:57:14.000Z monthly 0.6 https://www.accc-cancer.org/view/novartis-ribociclib--kisqali---only-category-1-preferred-first-line-treatment-option-for-hr-her2--mbc-in-combination-with-an-ai-in-updated-nccn-clinical-practice-guidelines-in-oncology--nccn-guidelines-- 2023-05-04T21:52:31.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-s-2023-advocacy-agenda-and-priorities-mini-podcast-ep-110 2023-05-04T17:04:29.000Z monthly 0.6 https://www.accc-cancer.org/view/healthcare-burnout-an-epidemic-among-oncology-nurses 2023-05-04T16:39:22.000Z monthly 0.6 https://www.accc-cancer.org/view/2023-nmqf-summit-improving-diversity-in-cancer-clinical-trials 2023-05-03T16:38:51.000Z monthly 0.6 https://www.accc-cancer.org/view/entrepreneurs-tackle-workforce-issues-and-lung-cancer-screenings 2023-05-02T16:45:23.000Z monthly 0.6 https://www.accc-cancer.org/view/kite-s-yescarta-demonstrates-a-statistically-significant-improvement-in-overall-survival-for-initial-treatment-of-r-r-lbcl 2023-05-02T14:55:57.000Z monthly 0.6 https://www.accc-cancer.org/view/symptoms-scoring-and-risk-stratification-for-myelofibrosis-mini-podcast-ep-109 2023-04-27T19:06:42.000Z monthly 0.6 https://www.accc-cancer.org/view/managing-side-effects-and-nutritional-needs-for-patients-with-myelofibrosis 2023-04-27T18:54:07.000Z monthly 0.6 https://www.accc-cancer.org/view/returning-to-normal-the-end-of-the-covid-19-public-health-emergency 2023-04-25T16:17:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-polatuzumab-vedotin-piiq-for-previously-untreated-diffuse-large-b-cell-lymphoma 2023-04-21T18:53:09.000Z monthly 0.6 https://www.accc-cancer.org/view/utilizing-subcutaneous-and-iv-treatment-for-improved-outcomes-with-multiple-myeloma-patients-mini-podcast-ep-108 2023-04-20T19:20:11.000Z monthly 0.6 https://www.accc-cancer.org/view/achieving-health-equity-in-oncology-with-precision-medicine-stewards 2023-04-20T17:55:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-omidubicel-to-reduce-time-to-neutrophil-recovery-and-infection-in-patients-with-hematologic-malignancies 2023-04-19T15:53:45.000Z monthly 0.6 https://www.accc-cancer.org/view/strengthening-your-oncology-workforce-how-to-approach-leadership-and-team-building 2023-04-18T17:13:55.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-names-class-of-2023-fellows 2023-04-14T18:51:34.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-testicular-cancer-awareness-month 2023-04-13T16:40:29.000Z monthly 0.6 https://www.accc-cancer.org/view/a-better-patient-experience-in-the-management-of-incidental-lung-nodules-podcast-ep-107 2023-04-13T14:22:53.000Z monthly 0.6 https://www.accc-cancer.org/view/rebuilding-the-oncology-workforce-accc-president-dr-ajayi-s-2023-2024-theme 2023-04-12T17:41:26.000Z monthly 0.6 https://www.accc-cancer.org/view/health-for-all-addressing-health-equity-among-american-indians-alaska-natives 2023-04-06T17:47:18.000Z monthly 0.6 https://www.accc-cancer.org/view/in-the-know-new-treatment-guidelines-for-myeloproliferative-neoplasms-video-podcast-ep-34 2023-04-06T10:57:09.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-s-economic-impact-among-adolescents-and-young-adults 2023-04-04T16:29:44.000Z monthly 0.6 https://www.accc-cancer.org/view/mitigating-the-financial-burden-of-cancer-diagnostics-video-podcast-ep-33 2023-04-04T13:41:27.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-enfortumab-vedotin-ejfv-pembrolizumab-for-locally-advanced-or-metastatic-urothelial-carcinoma 2023-04-04T01:16:09.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-social-work-month 2023-03-30T16:15:28.000Z monthly 0.6 https://www.accc-cancer.org/view/healthy-leadership-strategies-take-a-time-out-to-walk 2023-03-29T17:23:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-expanded-indication-for-illuccix-to-include-patient-selection-for-psma-directed-radioligand-therapy 2023-03-29T16:41:21.000Z monthly 0.6 https://www.accc-cancer.org/view/first-oncology-focused-age-friendly-health-systems-action-community 2023-03-28T16:34:41.000Z monthly 0.6 https://www.accc-cancer.org/view/elahare-announces-c-code-for-mirvetuximab-soravtansine-gynx 2023-03-23T20:36:50.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-spotlights-critical-lung-cancer-screening-needs-in-appalachia 2023-03-23T17:15:34.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-retifanlimab-dlwr-for-metastatic-or-recurrent-locally-advanced-mcc 2023-03-22T18:23:18.000Z monthly 0.6 https://www.accc-cancer.org/view/an-update-on-healthcare-legislation-at-the-state-level 2023-03-22T15:54:46.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-multiple-myeloma-awareness-month 2023-03-21T17:44:14.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-dabrafenib-trametinib-for-pediatric-patients-with-lgg 2023-03-20T14:31:17.000Z monthly 0.6 https://www.accc-cancer.org/view/precision-medicine-trends-stewardship-is-on-the-rise 2023-03-16T16:00:30.000Z monthly 0.6 https://www.accc-cancer.org/view/greenlight-for-precision-medicine-ep-32 2023-03-16T04:00:06.000Z monthly 0.6 https://www.accc-cancer.org/view/effective-patient-provider-communication-for-colorectal-cancer-screening 2023-03-15T17:02:45.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-a-robotic-oncology-pharmacy-nyc-nursing-strike-more 2023-03-14T17:24:35.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-names-new-president-olalekan-ajayi-pharmd-mba 2023-03-10T21:04:50.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-the-crispr-revolution-cancer-moonshot-more 2023-03-10T16:50:52.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-pre-conference-events-featured-clinical-operational-updates-in-oncology 2023-03-09T16:53:16.000Z monthly 0.6 https://www.accc-cancer.org/view/integrated-care-on-mpns-ep-31 2023-03-09T15:26:19.000Z monthly 0.6 https://www.accc-cancer.org/view/2023-advocacy-agenda-released-at-the-accc-49th-annual-meeting-and-cancer-center-business-summit 2023-03-09T14:12:05.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-udenyca-autoinjector 2023-03-08T16:13:10.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-announces-its-2023-advocacy-agenda 2023-03-07T17:26:53.000Z monthly 0.6 https://www.accc-cancer.org/view/technology-the-ideal-future-state-of-oncology 2023-03-06T18:22:48.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-early-breast-cancer-indication-for-abemaciclib-with-endocrine-therapy 2023-03-06T14:37:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pirtobrutinib-for-relapsed-or-refractory-mantle-cell-lymphoma 2023-03-05T00:04:33.000Z monthly 0.6 https://www.accc-cancer.org/view/treatment-options-for-patients-with-multiple-myeloma-who-are-ineligible-for-transplant-podcast-ep-106 2023-03-03T20:09:53.000Z monthly 0.6 https://www.accc-cancer.org/view/best-practices-in-caring-for-patients-with-cll-in-a-post-covid-era-ep-105 2023-02-24T16:15:35.000Z monthly 0.6 https://www.accc-cancer.org/view/how-to-lead-effective-meetings 2023-02-22T19:48:54.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-national-caregivers-day-analyzing-a-mental-health-crisis 2023-02-17T16:29:18.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-trodelvy-in-pre-treated-hr-her2--metastatic-breast-cancer 2023-02-17T14:17:08.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-regional-challenges-ep-104 2023-02-16T20:07:01.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-national-cancer-prevention-month-a-focus-on-smoking-taxes 2023-02-15T16:52:32.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-regular-approval-to-dostarlimab-gxly-for-dmmr-endometrial-cancer 2023-02-10T22:23:21.000Z monthly 0.6 https://www.accc-cancer.org/view/a-first-look-at-the-118th-congress-what-to-expect-in-health-policy-in-2023 2023-02-09T17:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/lessons-from-the-pharmacy-ep-103 2023-02-08T14:07:15.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-sacituzumab-govitecan-hziy-for-hr-positive-breast-cancer 2023-02-06T15:36:49.000Z monthly 0.6 https://www.accc-cancer.org/view/robots-biologics-and-advocates-lessons-from-the-pharmacy 2023-02-02T19:53:17.000Z monthly 0.6 https://www.accc-cancer.org/view/precision-medicine-stories-ep-102 2023-02-02T01:49:35.000Z monthly 0.6 https://www.accc-cancer.org/view/biden-administration-to-end-covid-19-public-health-emergency-in-may 2023-02-01T18:48:45.000Z monthly 0.6 https://www.accc-cancer.org/view/precision-medicine-stories-from-the-crispr-revolution 2023-01-31T16:59:34.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-elacestrant-for-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer 2023-01-31T15:01:30.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-as-adjuvant-treatment-for-nsclc 2023-01-27T16:58:29.000Z monthly 0.6 https://www.accc-cancer.org/view/effective-leadership-strategies-defining-helping-others-with-their-purpose 2023-01-26T17:46:11.000Z monthly 0.6 https://www.accc-cancer.org/view/the-urgency-of-mpn-treatment-ep-30 2023-01-26T15:04:26.000Z monthly 0.6 https://www.accc-cancer.org/view/the-role-of-population-health-navigators-ep-101 2023-01-25T21:18:20.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-(accc)-announces-49th-annual-meeting-cancer-center-business-summit 2023-01-25T18:15:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-zanubrutinib-for-cll-or-sll 2023-01-20T08:38:29.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-tucatinib-with-trastuzumab-for-colorectal-cancer 2023-01-20T08:30:01.000Z monthly 0.6 https://www.accc-cancer.org/view/prioritizing-a-multidisciplinary-team-approach-in-the-care-of-patients-with-small-cell-lung-cancer-video-podcast-ep-29 2023-01-18T22:00:43.000Z monthly 0.6 https://www.accc-cancer.org/view/nurses-role-in-oral-oncolytics-for-cll-ep-28 2023-01-11T22:07:02.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-navigation-taking-stock-of-the-past-and-looking-to-the-future 2023-01-11T18:59:32.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-foundationone-liquid-cdx-as-a-companion-diagnostic-for-entrectinib 2023-01-05T21:10:39.000Z monthly 0.6 https://www.accc-cancer.org/view/strategies-for-implementing-epros-in-cancer-care 2023-01-05T19:59:07.000Z monthly 0.6 https://www.accc-cancer.org/view/cancerbuzz-podcast-hits-50-000-download-milestone-celebrates-100-episodes 2023-01-05T15:42:20.000Z monthly 0.6 https://www.accc-cancer.org/view/a-conversation-with-accc-board-member-dr.-nadine-barrett-podcast-ep-100 2023-01-04T21:43:27.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-clinical-efficiency-ehr-and-mpn10-integration-video-podcast-ep-27 2023-01-04T17:02:32.000Z monthly 0.6 https://www.accc-cancer.org/view/combatting-healthcare-workforce-issues-with-proven-leadership-skills 2023-01-03T17:04:31.000Z monthly 0.6 https://www.accc-cancer.org/view/financial-advocacy-network-2023-census-survey 2023-01-01T17:54:00.000Z monthly 0.6 https://www.accc-cancer.org/view/subspecialty-insights-in-immuno-oncology-a-closer-look-at-apps- 2022-12-27T17:00:09.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approvat-mosunetuzumab-axgb-for-r-r-follicular-lymphoma 2022-12-23T18:04:16.000Z monthly 0.6 https://www.accc-cancer.org/view/caring-for-lgbtq-patients-with-cancer-the-value-of-empathy-and-representation 2022-12-22T16:29:54.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-foundationone-liquid-cdx-for-some-tyrosine-kinase-inhibitors-in-nsclc 2022-12-21T14:46:04.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-additional-indication-for-pemetrexed-in-combination 2022-12-21T12:51:18.000Z monthly 0.6 https://www.accc-cancer.org/view/reflections-on-healthcare-leadership-in-2022-and-beyond 2022-12-20T19:01:04.000Z monthly 0.6 https://www.accc-cancer.org/view/multi-cancer-early-detection-legislative-landscape-podcast-ep-99 2022-12-20T17:24:02.000Z monthly 0.6 https://www.accc-cancer.org/view/the-innovation-center-releases-eom-factsheets 2022-12-19T20:42:46.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pafolacianine-for-lung-cancer-surgery 2022-12-19T19:36:46.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-first-gene-therapy-for-bladder-cancer 2022-12-19T16:40:40.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-updates-capecitabine-indications-and-dosing-regimens 2022-12-16T16:22:39.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-new-oncology-practice-transformation-and-integration-center-(optic)-resource-library 2022-12-16T15:28:17.000Z monthly 0.6 https://www.accc-cancer.org/view/optimizing-sclc-patient-outcomes-ep-26 2022-12-15T19:22:08.000Z monthly 0.6 https://www.accc-cancer.org/view/precision-medicine-stewards-the-next-step-in-personalized-medicine 2022-12-15T17:00:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-adagrasib-for-kras-g12c-mutated-nsclc 2022-12-13T06:59:37.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-approval-to-atezolizumab-for-alveolar-soft-part-sarcoma 2022-12-12T16:33:40.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-president-led-forum-addresses-rpm-technologies-health-equity 2022-12-08T19:15:26.000Z monthly 0.6 https://www.accc-cancer.org/view/advanced-skin-cancer-care-for-rural-populations-ep-25 2022-12-08T13:26:03.000Z monthly 0.6 https://www.accc-cancer.org/view/from-good-to-great-managing-treatment-related-adverse-events 2022-12-06T20:30:35.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olutasidenib-for-relapsed-or-refractory-aml-with-a-susceptible-idh1-mutation 2022-12-03T03:46:55.000Z monthly 0.6 https://www.accc-cancer.org/view/the-importance-of-having-difficult-conversations-with-patients-podcast-ep-98 2022-12-02T20:37:48.000Z monthly 0.6 https://www.accc-cancer.org/view/pancreatic-cancer-awareness-a-digital-community-for-patients-caregivers 2022-11-28T19:34:16.000Z monthly 0.6 https://www.accc-cancer.org/view/engaging-patients-with-small-cell-ep-24 2022-11-23T21:08:53.000Z monthly 0.6 https://www.accc-cancer.org/view/triplet-vs-quadruplet-therapy-choosing-the-right-multiple-myeloma-treatment 2022-11-23T15:42:37.000Z monthly 0.6 https://www.accc-cancer.org/view/manipulating-data-to-make-precision-medicine-magic 2022-11-22T17:50:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-a-new-dosing-regimen-for-asparaginase-erwinia-chrysanthemi 2022-11-21T15:10:24.000Z monthly 0.6 https://www.accc-cancer.org/view/social-media-as-a-platform-to-educate-ep-23 2022-11-18T21:40:50.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-observes-lung-cancer-awareness-month-highlighting-small-cell-lung-cancer-education-programs 2022-11-18T14:36:21.000Z monthly 0.6 https://www.accc-cancer.org/view/financial-measurement-streamlines-revenue-cycle-management 2022-11-17T17:46:48.000Z monthly 0.6 https://www.accc-cancer.org/view/roche-receives-fda-approval-for-ventana-folr1-(folr1-2.1)-rxdx-assay 2022-11-16T20:53:09.000Z monthly 0.6 https://www.accc-cancer.org/view/recognizing-national-nurse-practitioner-week-through-thought-leaders 2022-11-16T17:22:19.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-mirvetuximab-soravtansine-gynx 2022-11-15T20:00:33.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-brentuximab-vedotin-chemo-for-pediatric-patients-with-hodgkin-s-lymphoma 2022-11-15T19:49:55.000Z monthly 0.6 https://www.accc-cancer.org/view/providing-comprehensive-financial-advocacy-services-in-rural-america 2022-11-15T19:33:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tremelimumab-with-durvalumab-chemotherapy-for-metastatic-nsclc 2022-11-15T14:54:23.000Z monthly 0.6 https://www.accc-cancer.org/view/is-it-time-to-cancel-the-term-a-cure-for-cancer-video-podcast-ep-22 2022-11-11T22:25:36.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-honors-national-lung-cancer-awareness-month 2022-11-10T19:37:19.000Z monthly 0.6 https://www.accc-cancer.org/view/healthcare-best-practices-in-the-threat-of-recovery-from-cyberattacks 2022-11-09T16:45:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cemiplimab-chemotherapy-for-nsclc 2022-11-09T13:59:39.000Z monthly 0.6 https://www.accc-cancer.org/view/burnout-in-oncology-results-from-accc-s-2022-mini-z-survey 2022-11-08T16:31:54.000Z monthly 0.6 https://www.accc-cancer.org/view/technology-that-is-transforming-cancer-care-video-podcast-ep-21 2022-11-04T19:32:08.000Z monthly 0.6 https://www.accc-cancer.org/view/jack-s-caregiver-coalition-building-a-community-of-support 2022-11-03T17:25:38.000Z monthly 0.6 https://www.accc-cancer.org/view/better-supporting-patients-with-hr-her2--breast-cancer 2022-11-02T17:11:21.000Z monthly 0.6 https://www.accc-cancer.org/view/calendar-year-2023-medicare-physician-fee-schedule-released 2022-11-02T13:51:33.000Z monthly 0.6 https://www.accc-cancer.org/view/healthcare-digitization-looking-to-the-future 2022-11-01T16:17:28.000Z monthly 0.6 https://www.accc-cancer.org/view/cost-and-coordination-of-care-head-list-of-concerns-with-combination-iv-oral-therapy 2022-10-28T13:07:05.000Z monthly 0.6 https://www.accc-cancer.org/view/is-it-time-to-cancel-the-term-a-cure-for-cancer-video-podcast-ep-20 2022-10-27T20:17:38.000Z monthly 0.6 https://www.accc-cancer.org/view/liver-cancer-awareness-month-inspiration-from-a-blue-faery 2022-10-27T16:17:29.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-teclistamab-for-relapsed-or-refractory-multiple-myeloma 2022-10-27T14:27:18.000Z monthly 0.6 https://www.accc-cancer.org/view/overcoming-health-disparities-through-remote-patient-monitoring-podcast-ep-97 2022-10-25T20:47:59.000Z monthly 0.6 https://www.accc-cancer.org/view/rare-cancer-and-the-cancer-patient-equity-act-of-2021 2022-10-25T16:47:56.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tremelimumab-in-combination-with-durvalumab-for-unresectable-hcc 2022-10-24T18:56:34.000Z monthly 0.6 https://www.accc-cancer.org/view/the-multifaceted-role-of-an-oncology-pharmacist 2022-10-20T16:10:57.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-honoring-awardees-supporting-the-oncology-workforce 2022-10-19T16:41:02.000Z monthly 0.6 https://www.accc-cancer.org/view/financial-barriers-to-oral-cancer-therapies-vodcast-ep-19 2022-10-19T12:15:11.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-pharmacy-technician-day-a-conversation-with-danielle-duy 2022-10-18T16:27:19.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-leveraging-data-to-tackle-workforce-shortages 2022-10-17T20:26:59.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-2022-annual-award-recipients 2022-10-14T17:32:04.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-building-sustainable-coalitions-in-your-community 2022-10-14T14:14:32.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-little-big-bangs-innovation-in-action 2022-10-14T13:58:08.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-a-support-program-to-improve-staff-well-being 2022-10-13T22:57:51.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-announces-2022-innovator-award-winners 2022-10-13T16:33:30.000Z monthly 0.6 https://www.accc-cancer.org/view/acccnoc-what-does-the-future-of-cancer-care-look-like 2022-10-13T13:58:57.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-advocates-weigh-in-on-financial-advocacy-guidelines-update-mini-podcast 2022-10-12T20:57:30.000Z monthly 0.6 https://www.accc-cancer.org/view/live-from-noc-financial-advocacy-guidelines-mini-podcast 2022-10-12T18:15:01.000Z monthly 0.6 https://www.accc-cancer.org/view/finding-joy-and-hope-during-my-metastatic-breast-cancer-journey 2022-10-12T17:25:12.000Z monthly 0.6 https://www.accc-cancer.org/view/effective-practices-to-improve-equitable-cancer-screening 2022-10-11T16:28:33.000Z monthly 0.6 https://www.accc-cancer.org/view/successful-integration-of-oral-oncolytics-podcast-ep-96 2022-10-11T16:08:59.000Z monthly 0.6 https://www.accc-cancer.org/view/integrating-oral-oncolytics-into-chronic-lymphocytic-leukemia-practice 2022-10-07T12:30:08.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-adherence-to-oral-targeted-therapies-vodcast-ep-18 2022-10-06T16:49:57.000Z monthly 0.6 https://www.accc-cancer.org/view/optic-webinar-series-bridges-oncology-care-knowledge-gaps 2022-10-06T16:37:42.000Z monthly 0.6 https://www.accc-cancer.org/view/remote-patient-monitoring-of-patients-on-car-t-cell-therapy-podcast-ep-95 2022-10-04T21:02:06.000Z monthly 0.6 https://www.accc-cancer.org/view/challenges-to-advancing-cancer-risk-identification-reduction 2022-10-04T16:39:51.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-futibatinib-for-cholangiocarcinoma 2022-10-03T13:29:20.000Z monthly 0.6 https://www.accc-cancer.org/view/state-legislation-requiring-coverage-of-biomarker-testing-gains-momentum 2022-09-30T15:51:17.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-challenges-in-managing-patients-receiving-oral-therapies-for-hr-her2--breast-cancer-vodcast-ep-17 2022-09-29T21:24:31.000Z monthly 0.6 https://www.accc-cancer.org/view/leading-in-healthcare-the-importance-of-recognition 2022-09-29T17:51:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-vegzelma-for-the-treatment-of-six-types-of-cancer 2022-09-28T19:27:58.000Z monthly 0.6 https://www.accc-cancer.org/view/multiple-myeloma-considering-first-line-treatment-options 2022-09-28T17:40:07.000Z monthly 0.6 https://www.accc-cancer.org/view/technological-strategies-to-improve-health-equity 2022-09-27T16:09:57.000Z monthly 0.6 https://www.accc-cancer.org/view/quality-improvement-in-stages-iii-iv-non-small-cell-lung-cancer-care 2022-09-23T15:40:42.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-selpercatinib-approval-for-ret-fusion-positive-solid-tumors 2022-09-22T17:29:16.000Z monthly 0.6 https://www.accc-cancer.org/view/the-association-of-community-cancer-centers-mourns-the-loss-of-retired-cfo-lois-utterback 2022-09-22T17:01:35.000Z monthly 0.6 https://www.accc-cancer.org/view/converging-goals-public-health-the-cancer-moonshot-initiative 2022-09-22T15:44:41.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-announces-new-vodcast-series-optimizing-the-use-of-validated-malnutrition-screening-tools-in-cancer-care 2022-09-22T15:34:02.000Z monthly 0.6 https://www.accc-cancer.org/view/interventional-screening-tools-for-malnutrition-video-podcast-ep-16 2022-09-22T13:31:04.000Z monthly 0.6 https://www.accc-cancer.org/view/sexual-health-all-of-me-podcast-ep-94 2022-09-20T19:12:48.000Z monthly 0.6 https://www.accc-cancer.org/view/utilizing-data-in-the-pursuit-of-health-equity 2022-09-20T15:57:29.000Z monthly 0.6 https://www.accc-cancer.org/view/malnutrition-screen-or-assess-video-podcast-ep-15 2022-09-15T20:33:46.000Z monthly 0.6 https://www.accc-cancer.org/view/digital-solutions-connect-resources-to-patients-at-the-right-time 2022-09-15T16:34:02.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-2022-innovator-award-winner-the-ohio-state-university-comprehensive-cancer-center-james-cancer-hospital-and-solove-research-institute 2022-09-13T19:55:31.000Z monthly 0.6 https://www.accc-cancer.org/view/sdoh-symposium-speakers-discuss-health-equity-best-practices 2022-09-13T16:20:31.000Z monthly 0.6 https://www.accc-cancer.org/view/anti-cancer-therapy-privileging-for-apps-podcast-ep-93 2022-09-13T15:24:54.000Z monthly 0.6 https://www.accc-cancer.org/view/foundation-medicine-inc.-announces-a-call-for-grants-notification 2022-09-13T15:14:33.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-offers-ovarian-cancer-education-initiatives-aims-to-help-cancer-care-providers-overcome-barriers-to-comprehensive-quality-care-for-ovarian-cancer 2022-09-12T18:32:22.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-eflapegrastim-for-chemo-induced-neutropenia 2022-09-12T14:47:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-durvalumab-for-locally-advanced-or-metastatic-biliary-tract-cancer 2022-09-08T16:00:08.000Z monthly 0.6 https://www.accc-cancer.org/view/gsk-shares-plans-to-voluntarily-withdraw-niraparib 2022-09-07T14:10:07.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-forum-focuses-on-technology-solutions-to-mitigate-workforce-shortages 2022-09-06T17:19:12.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-enhancing-coordination-around-cancer-biomarker-and-hereditary-genetic-testing-among-members-of-the-multidisciplinary-care-team 2022-09-02T14:28:31.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-screening-in-the-covid-19-era 2022-09-01T16:13:49.000Z monthly 0.6 https://www.accc-cancer.org/view/expediting-cancer-treatment-through-a-rapid-access-app-led-diagnostic-clinic-podcast-ep-92 2022-08-30T19:56:46.000Z monthly 0.6 https://www.accc-cancer.org/view/enhancing-advanced-ovarian-cancer-care-delivery 2022-08-30T17:03:04.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pemigatinib-for-mlns-with-fgfr1-rearrangement 2022-08-30T13:51:46.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-delays-radiation-oncology-model-start-date 2022-08-30T12:48:04.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ibrutinib-for-pediatric-patients-with-chronic-graft-versus-host-disease-including-a-new-oral-suspension 2022-08-25T15:51:07.000Z monthly 0.6 https://www.accc-cancer.org/view/notes-on-nursing-when-our-hands-don-t-reach 2022-08-24T16:04:50.000Z monthly 0.6 https://www.accc-cancer.org/view/major-healthcare-and-prescription-drug-reform-bill-signed-into-law 2022-08-23T16:00:08.000Z monthly 0.6 https://www.accc-cancer.org/view/deploying-technology-across-an-interdisciplinary-team-to-improve-oral-oncolytic-compliance-podcast-ep-91 2022-08-23T14:40:55.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-2022-innovator-award-winner-as-baptist-health-s-miami-cancer-institute 2022-08-23T12:41:44.000Z monthly 0.6 https://www.accc-cancer.org/view/eisai-assistance-program 2022-08-22T17:26:52.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-oral-oncolytic-compliance-with-technology 2022-08-22T16:15:18.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-2022-innovator-award-winner-vcu-health-system-vcu-massey-cancer-center 2022-08-18T17:10:19.000Z monthly 0.6 https://www.accc-cancer.org/view/highlights-from-the-cy2023-hospital-outpatient-prospective-payment-system 2022-08-18T15:42:14.000Z monthly 0.6 https://www.accc-cancer.org/view/highlights-from-the-cy2023-medicare-physician-fee-schedule-proposed-rule 2022-08-16T17:05:36.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-2022-innovator-award-winner-ochsner-cancer-institute 2022-08-16T13:56:21.000Z monthly 0.6 https://www.accc-cancer.org/view/chemotherapy-care-companion-a-remote-patient-monitoring-program-podcast-ep-90 2022-08-16T13:43:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-guardant360-cdx-for-her2-mutant-nsclc 2022-08-15T12:57:45.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approvees-fam-trastuzumab-deruxtecan-nxki-for-her2-mutant-nsclc 2022-08-15T12:49:44.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-capmatinib-for-metastatic-nsclc 2022-08-15T12:43:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-new-acalabrutinib-formulation 2022-08-12T16:00:18.000Z monthly 0.6 https://www.accc-cancer.org/view/malnutrition-in-cancer-care-video-podcast-ep-14 2022-08-11T22:58:55.000Z monthly 0.6 https://www.accc-cancer.org/view/student-entrepreneurs-tackle-healthcare-burnout-with-technology-based-platform 2022-08-11T19:58:06.000Z monthly 0.6 https://www.accc-cancer.org/view/astrazeneca-plans-to-withdraw-an-olaparib-ovarian-cancer-indication 2022-08-11T19:31:17.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-a-label-expansion-for-the-ventana-mmr-rxdx-panel 2022-08-11T15:31:26.000Z monthly 0.6 https://www.accc-cancer.org/view/important-update-olaparib-in-4th-line-treatment-of-ovarian-cancer 2022-08-11T15:07:28.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-congratulates-monica-bertagnolli-md-on-her-appointment-to-lead-the-national-cancer-institute 2022-08-11T03:34:45.000Z monthly 0.6 https://www.accc-cancer.org/view/a-model-for-embedding-primary-care-in-oncology-podcast-ep-89 2022-08-09T20:19:38.000Z monthly 0.6 https://www.accc-cancer.org/view/optimizing-telehealth-for-older-adults-with-cancer 2022-08-09T17:44:54.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-darolutamide-docetaxel-for-the-treatment-of-mhspc 2022-08-08T14:58:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-first-targeted-therapy-for-her2-low-breast-cancer 2022-08-05T17:53:56.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tablet-formulation-of-acalabrutinib 2022-08-05T17:31:46.000Z monthly 0.6 https://www.accc-cancer.org/view/expanding-access-to-bispecific-antibodies-in-community-cancer-care 2022-08-03T18:08:49.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-celebrates-world-lung-cancer-day-10-years-strong 2022-08-01T16:43:30.000Z monthly 0.6 https://www.accc-cancer.org/view/paying-for-biomarker-testing 2022-08-01T15:54:12.000Z monthly 0.6 https://www.accc-cancer.org/view/riding-to-victory-one-man-s-journey-to-surviving-cancer 2022-07-28T15:06:56.000Z monthly 0.6 https://www.accc-cancer.org/view/oral-cancer-therapy-adverse-events-vodcast-ep-13 2022-07-28T10:00:09.000Z monthly 0.6 https://www.accc-cancer.org/view/car-t-cell-practice-profile-fox-chase-cancer-center 2022-07-27T13:35:33.000Z monthly 0.6 https://www.accc-cancer.org/view/car-t-cell-practice-profile-billings-clinic-cancer-center 2022-07-27T13:28:52.000Z monthly 0.6 https://www.accc-cancer.org/view/advocating-in-oncology-the-importance-of-state-based-grassroots 2022-07-26T19:25:04.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-social-determinants-of-health-through-a-medical-legal-partnership-podcast-ep-88 2022-07-26T13:50:23.000Z monthly 0.6 https://www.accc-cancer.org/view/diversify-your-cancer-clinical-trials-with-new-recruitment-and-retention-resources 2022-07-25T18:05:32.000Z monthly 0.6 https://www.accc-cancer.org/view/chemotherapy-care-companion-an-oncology-remote-patient-monitoring-program 2022-07-21T16:35:08.000Z monthly 0.6 https://www.accc-cancer.org/view/bms-launches-ddict-initiative-to-improve-healthcare-outcomes-for-people-with-disabilities 2022-07-21T13:24:12.000Z monthly 0.6 https://www.accc-cancer.org/view/how-does-the-eom-compare-to-the-ocm 2022-07-20T16:27:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-crizotinib-for-alk-positive-inflammatory-myofibroblastic-tumor 2022-07-19T18:37:48.000Z monthly 0.6 https://www.accc-cancer.org/view/rapid-access-diagnostic-clinic-expedites-cancer-treatment 2022-07-19T17:36:02.000Z monthly 0.6 https://www.accc-cancer.org/view/digital-literacy-in-older-adults-with-cancer-podcast-ep-87 2022-07-19T16:37:51.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-cy-2023-hopps-proposed-rule 2022-07-18T15:45:10.000Z monthly 0.6 https://www.accc-cancer.org/view/the-impact-of-oncology-financial-advocacy-a-patient-story 2022-07-14T16:33:44.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-stakeholder-call-strategic-plan-update 2022-07-14T14:34:54.000Z monthly 0.6 https://www.accc-cancer.org/view/a-collaborative-primary-and-cancer-care-model 2022-07-12T15:54:05.000Z monthly 0.6 https://www.accc-cancer.org/view/cannabis-and-cancer-developing-a-patient-clinic-podcast-ep-86 2022-07-12T14:22:09.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-cy-2023-pfs-proposed-rule 2022-07-08T16:12:38.000Z monthly 0.6 https://www.accc-cancer.org/view/advocating-for-financial-health-vodcast-ep-12 2022-07-07T18:40:34.000Z monthly 0.6 https://www.accc-cancer.org/view/vcu-s-medical-legal-partnership-meets-oncology-patients-needs 2022-07-07T17:27:48.000Z monthly 0.6 https://www.accc-cancer.org/view/mrd-testing-in-multiple-myeloma 2022-07-05T15:35:03.000Z monthly 0.6 https://www.accc-cancer.org/view/leading-in-oncology-through-change 2022-06-30T17:20:42.000Z monthly 0.6 https://www.accc-cancer.org/view/mrd-testing-in-chronic-lymphocytic-leukemia 2022-06-29T16:51:34.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-the-enhancing-oncology-model 2022-06-29T14:30:49.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-dabrafenib-trametinib-for-metastatic-solid-tumors 2022-06-29T14:17:01.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-on-the-enhancing-oncology-model 2022-06-29T12:22:19.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lisocabtagene-maraleucel-for-refractory-large-b-cell-lymphoma 2022-06-28T14:17:13.000Z monthly 0.6 https://www.accc-cancer.org/view/bringing-hospital-care-home-transitional-or-transformative 2022-06-28T14:02:08.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-pharmacy-benefit-managers-how-advocacy-led-to-action 2022-06-28T10:54:09.000Z monthly 0.6 https://www.accc-cancer.org/view/2022-accc-hill-day-members-meet-with-congress 2022-06-24T13:57:24.000Z monthly 0.6 https://www.accc-cancer.org/view/examining-lgbtq-disparities-in-cancer-care 2022-06-22T16:00:04.000Z monthly 0.6 https://www.accc-cancer.org/view/medicare-ahead-equity-accountability-sustainability 2022-06-21T15:40:36.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-promotes-cancer-awareness-through-blackfamcan 2022-06-16T16:48:30.000Z monthly 0.6 https://www.accc-cancer.org/view/pcp-insights-needed-to-improve-cancer-screening-in-rural-appalachia 2022-06-15T15:46:50.000Z monthly 0.6 https://www.accc-cancer.org/view/leading-oncology-professionals-meet-with-capitol-hill-lawmakers-to-advocate-for-improved-access-to-cancer-care 2022-06-15T14:57:25.000Z monthly 0.6 https://www.accc-cancer.org/view/financial-advocates-discuss-challenges-in-radiation-oncology 2022-06-13T17:03:38.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-infusion-wallboard-improves-the-patient-experience 2022-06-09T18:49:27.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-foundationone-cdx-for-entrectinib 2022-06-09T12:41:52.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-forms-alliance-to-improve-cancer-care-continuum 2022-06-08T18:07:10.000Z monthly 0.6 https://www.accc-cancer.org/view/hospital-at-home-success-factors-challenges 2022-06-07T16:24:57.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-ep-84-increasing-clinical-trial-access-for-blood-cancers 2022-06-07T15:38:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-tools-for-immuno-oncology-survivorship-care 2022-06-03T16:33:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pegfilgrastim-pbbk-biosimilar 2022-05-31T13:04:44.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-two-nivolumab-based-regimens-for-esophageal-squamous-cell-carcinoma 2022-05-31T12:58:47.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tisagenlecleucel-for-r-r-follicular-lymphoma 2022-05-31T12:52:02.000Z monthly 0.6 https://www.accc-cancer.org/view/speaker-reflections-attending-accc-s-oncology-reimbursement-meetings 2022-05-27T16:06:57.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-e18815-using-real-world-data-to-assess-variations-in-cost-and-healthcare-utilization-for-patients-diagnosed-with-bladder-cancer 2022-05-26T22:12:24.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-e18599-assessing-feasibility-and-utility-of-an-implicit-bias-training-program-for-addressing-disparities-in-cancer-clinical-trial-participation 2022-05-26T20:28:44.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-10609-building-a-multidisciplinary-consortium-in-iowa-to-advance-genetic-counseling-and-testing-in-patients-with-cancer 2022-05-26T20:26:18.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-e23017-national-organization-addresses-multidisciplinary-oncology-team-burnout-and-resiliency-through-multifaceted-presidential-theme-education-initiative 2022-05-26T20:23:11.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-11040-a-collaborative-peer-based-experience-to-support-meaningful-professional-development-in-the-evolving-standards-of-care-for-her2-metastatic-breast-cancer 2022-05-26T20:22:48.000Z monthly 0.6 https://www.accc-cancer.org/view/achieving-health-equity-in-bladder-cancer-care 2022-05-26T16:20:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ivosidenib-in-combination-for-acute-myeloid-leukemia 2022-05-26T12:19:10.000Z monthly 0.6 https://www.accc-cancer.org/view/study-highlights-need-for-medicare-advantage-prior-authorization-reform 2022-05-24T17:31:26.000Z monthly 0.6 https://www.accc-cancer.org/view/leading-national-cancer-organizations-release-wide-ranging-recommendations-to-expand-diverse-participation-in-cancer-clinical-trials 2022-05-19T20:24:32.000Z monthly 0.6 https://www.accc-cancer.org/view/combatting-the-great-resignation-strategies-for-healthcare-organizations 2022-05-19T16:50:27.000Z monthly 0.6 https://www.accc-cancer.org/view/fam-trastuzumab-deruxtecan-nxki-approved-for-patients-with-her2-mbc 2022-05-17T13:19:23.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-83-expanding-the-role-of-advanced-practitioners-to-address-the-care-gap 2022-05-17T00:53:50.000Z monthly 0.6 https://www.accc-cancer.org/view/eisai-announces-lenvatinib-dose-exchange-program-expansion 2022-05-12T18:23:43.000Z monthly 0.6 https://www.accc-cancer.org/view/nola-pathways-partnership-meeting-patients-needs-locally 2022-05-11T15:45:08.000Z monthly 0.6 https://www.accc-cancer.org/view/the-effects-of-her2-positivity-on-invasive-lobular-carcinoma-of-the-breast 2022-05-10T17:42:40.000Z monthly 0.6 https://www.accc-cancer.org/view/estimated-out-of-pocket-costs-for-cancer-directed-and-supportive-care-medications-for-older-adults-with-advanced-pancreatic-cancer 2022-05-10T17:28:59.000Z monthly 0.6 https://www.accc-cancer.org/view/chemotherapy-refusal-and-subsequent-survival-in-older-women-with-high-genomic-risk-estrogen-receptor-positive-breast-cancer 2022-05-10T17:23:48.000Z monthly 0.6 https://www.accc-cancer.org/view/primary-breast-amyloidosis-case-report-and-literature-review 2022-05-10T17:11:07.000Z monthly 0.6 https://www.accc-cancer.org/view/smarc-a4-brg1-deficient-lung-carcinoma-complicated-by-treatment-related-immune-mediated-pneumonitis 2022-05-10T17:01:49.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-efforts-to-address-screening-cancer-care-challenges-in-appalachia 2022-05-10T14:26:14.000Z monthly 0.6 https://www.accc-cancer.org/view/the-promise-of-mrd-testing-in-hematologic-malignancies 2022-05-05T19:06:42.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-regular-approval-to-fam-trastuzumab-deruxtecan-nxki-for-breast-cancer 2022-05-05T12:45:25.000Z monthly 0.6 https://www.accc-cancer.org/view/optimizing-cancer-care-delivery-in-2022-part-2 2022-05-03T17:33:49.000Z monthly 0.6 https://www.accc-cancer.org/view/asco's-guideline-update-includes-oncotype-dx-in-early-stage-breast-cancer 2022-05-02T20:24:04.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-principles-to-preserve-provider-and-patient-choice-in-cancer-treatment 2022-04-29T19:41:21.000Z monthly 0.6 https://www.accc-cancer.org/view/local-action-improves-access-to-key-oncology-services 2022-04-28T17:45:20.000Z monthly 0.6 https://www.accc-cancer.org/view/optimizing-cancer-care-delivery-in-2022-part-1 2022-04-26T18:45:13.000Z monthly 0.6 https://www.accc-cancer.org/view/act-locally-no-one-is-left-alone 2022-04-20T15:44:18.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-82-liquid-biopsy-cancer-detection-future-synergies 2022-04-19T11:07:04.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-bevacizumab-maly-biosimilar-for-colorectal-cancer 2022-04-18T20:38:18.000Z monthly 0.6 https://www.accc-cancer.org/view/secretary-of-hhs-extends-covid-19-public-health-emergency 2022-04-14T19:57:44.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-national-minority-health-month 2022-04-12T17:43:54.000Z monthly 0.6 https://www.accc-cancer.org/view/meeting-the-needs-of-cancer-program-staff-to-ultimately-improve-patient-outcomes 2022-04-08T13:36:15.000Z monthly 0.6 https://www.accc-cancer.org/view/leading-with-my-heart 2022-04-07T16:55:53.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-81-two-accc-presidential-themes-converge-at-one-annual-meeting 2022-04-05T15:24:19.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-axicabtagene-ciloleucel-for-large-b-cell-lymphoma 2022-04-04T13:03:46.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-national-colorectal-cancer-awareness-month 2022-03-30T19:59:16.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-80-the-promise-of-mrd-testing-in-multiple-myeloma-cll 2022-03-29T13:51:21.000Z monthly 0.6 https://www.accc-cancer.org/view/tips-for-assisting-uninsured-patients-with-treatment-costs 2022-03-24T16:59:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lutetium-lu-177-vipivotide-tetraxetan-for-prostate-cancer 2022-03-24T13:09:10.000Z monthly 0.6 https://www.accc-cancer.org/view/expanding-awareness-of-multiple-myeloma 2022-03-23T16:12:35.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-79-state-advocacy-matters 2022-03-22T12:23:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-advanced-endometrial-carcinoma 2022-03-22T12:04:30.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-honors-first-class-of-fellows-with-f.a.c.c.c.-designation 2022-03-21T15:48:42.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-and-relatlimab-rmbw-for-melanoma 2022-03-21T15:29:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-foundationone-cdx-in-non-small-cell-lung-cancer 2022-03-17T12:25:34.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-new-resources-to-support-quality-care-delivery-for-patients-with-ovarian-cancer 2022-03-16T14:33:06.000Z monthly 0.6 https://www.accc-cancer.org/view/recap-accc-s-48th-annual-meeting-and-cancer-center-business-summit-part-2 2022-03-15T15:57:50.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-78-jacks-caregiver-coalition 2022-03-15T00:42:33.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-bracanalysis-cdx-in-early-stage-breast-cancer 2022-03-14T12:37:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olaparib-for-high-risk-early-breast-cancer 2022-03-14T12:27:27.000Z monthly 0.6 https://www.accc-cancer.org/view/congress-passes-bills-to-extend-telehealth-and-fund-cancer-research 2022-03-11T22:16:57.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-on-telehealth-extension-in-omnibus-package 2022-03-11T21:32:17.000Z monthly 0.6 https://www.accc-cancer.org/view/recap-accc-s-48th-annual-meeting-and-cancer-center-business-summit 2022-03-09T16:31:24.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-77-virtual-integrative-services 2022-03-08T02:06:57.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-in-combination-for-early-stage-nsclc 2022-03-07T17:52:45.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-amccbs-live-precision-medicine-reimbursement 2022-03-04T22:55:20.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-amccbs-live-care-measurement 2022-03-04T18:30:57.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-amccbs-live-cancer-moonshot 2022-03-03T21:47:19.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-amccbs-live-industry-reconfiguration-trends 2022-03-03T18:52:18.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-position-on-the-cancer-moonshot-relaunch 2022-03-02T19:54:57.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pacritinib-for-myelofibrosis 2022-03-01T19:00:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ciltacabtagene-autoleucel-for-r-r-multiple-myeloma 2022-03-01T13:07:31.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-updates-financial-advocacy-services-guidelines 2022-02-28T16:00:53.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-11-digital-patient-assistance-guide 2022-02-24T13:14:01.000Z monthly 0.6 https://www.accc-cancer.org/view/acs-national-consortium-announces-recommendations-to-increase-screening-rates 2022-02-23T20:55:35.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-foundationone-cdx-to-identify-msi-h-solid-tumors 2022-02-22T14:00:16.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-supports-biden-s-moonshot-plans-offers-resources-and-tools-to-white-house-effort 2022-02-15T18:30:37.000Z monthly 0.6 https://www.accc-cancer.org/view/servier-announces-new-ndc-number-for-ivosidenib 2022-02-14T18:22:05.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-(accc)-announces-48th-annual-meeting-cancer-center-business-summit 2022-02-11T18:28:57.000Z monthly 0.6 https://www.accc-cancer.org/view/black-history-month-addresses-health-and-wellness-in-oncology-and-beyond 2022-02-09T23:20:06.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-ep-76-improving-pathology-reports 2022-02-08T02:26:14.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-moonshot-reignites 2022-02-07T22:26:38.000Z monthly 0.6 https://www.accc-cancer.org/view/the-long-road-to-recovery-part-iv-cancer-screening-in-the-u-s-munson-healthcare-michigan 2022-02-04T15:48:21.000Z monthly 0.6 https://www.accc-cancer.org/view/world-cancer-day-how-accc-is-helping-close-the-cancer-care-gap 2022-02-03T05:19:25.000Z monthly 0.6 https://www.accc-cancer.org/view/health-equity-a-key-theme-of-health-care-value-week 2022-02-02T16:25:28.000Z monthly 0.6 https://www.accc-cancer.org/view/the-long-road-to-recovery-part-iii-cancer-screening-in-the-u-s-christianacare-delaware 2022-01-26T20:07:12.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tebentafusp-tebn-for-unresectable-or-metastatic-uveal-melanoma 2022-01-26T19:04:01.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-community-oncology-research-institute-releases-groundbreaking-call-to-action-to-strengthen-and-diversify-cancer-research 2022-01-25T17:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-ep-75-developments-in-til-cell-therapy 2022-01-25T12:04:52.000Z monthly 0.6 https://www.accc-cancer.org/view/notes-on-nursing-the-real-work-of-nurses-relational-practice 2022-01-24T17:17:48.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-74-the-business-case-for-hiring-oncology-social-workers 2022-01-18T17:32:03.000Z monthly 0.6 https://www.accc-cancer.org/view/the-year-in-review-accc-financial-advocacy-network 2022-01-18T16:48:29.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-welcomes-matt-devino-mph-as-director-cancer-care-delivery-and-health-policy 2022-01-18T15:19:58.000Z monthly 0.6 https://www.accc-cancer.org/view/the-long-road-to-recovery-part-ii-cancer-screening-in-the-us-st-elizabeth-healthcare-kentucky 2022-01-13T20:55:14.000Z monthly 0.6 https://www.accc-cancer.org/view/the-long-road-to-recovery-a-snapshot-of-cancer-screening-in-the-u.s 2022-01-05T19:03:56.000Z monthly 0.6 https://www.accc-cancer.org/view/genetic-counseling-in-cancer-care 2021-12-21T18:29:40.000Z monthly 0.6 https://www.accc-cancer.org/view/equity-diversity-and-inclusion-in-cancer-care-delivery-statement 2021-12-21T15:15:26.000Z monthly 0.6 https://www.accc-cancer.org/view/vaccination-of-healthcare-workers-statement 2021-12-21T15:10:37.000Z monthly 0.6 https://www.accc-cancer.org/view/providing-high-quality-ovarian-cancer-care 2021-12-20T19:10:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-illuccix-for-prostate-cancer-imaging 2021-12-20T13:35:23.000Z monthly 0.6 https://www.accc-cancer.org/view/gsk-launches-target-the-future-for-the-multiple-myeloma-community 2021-12-16T15:24:10.000Z monthly 0.6 https://www.accc-cancer.org/view/spotlight-on-financial-advocates 2021-12-16T15:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/must-listen-podcasts-on-precision-medicine 2021-12-13T18:12:24.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ngs-based-cdx-for-non-small-cell-lung-cancer 2021-12-10T13:27:38.000Z monthly 0.6 https://www.accc-cancer.org/view/prospective-real-world-outcomes-study-in-patients-with-tumors-harboring-nrg1-fusions 2021-12-09T22:10:12.000Z monthly 0.6 https://www.accc-cancer.org/view/offering-free-patient-services-can-be-rewarding-and-compliant 2021-12-09T17:39:33.000Z monthly 0.6 https://www.accc-cancer.org/view/new-cms-data-shows-increased-medicare-telemedine-utilization-during-covid-19 2021-12-09T17:11:39.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-4033-multidisciplinary-provider-insights-to-promote-adoption-of-bispecific-antibodies-to-treat-cancer-in-the-community 2021-12-08T19:15:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-foundationone-cdx-as-a-companion-diagnostic-in-melanoma 2021-12-08T15:35:00.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-ep-73-biomarker-testing-advocacy 2021-12-07T12:32:32.000Z monthly 0.6 https://www.accc-cancer.org/view/leantaas-announces-transform-virtual-summit 2021-12-06T18:34:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-rituximab-chemotherapy-for-pediatric-cancer-indications 2021-12-06T13:33:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-iib-or-iic-melanoma-following-complete-resection 2021-12-06T13:25:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-s-precision-medicine-tools-help-guide-survivorship-care 2021-12-02T14:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-and-hyaluronidase-fihj-in-combination-for-r-r-mm 2021-12-02T13:51:30.000Z monthly 0.6 https://www.accc-cancer.org/view/roundtable-on-cms-innovation-center-health-equity-strategy 2021-11-30T14:31:36.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-72-genetic-counseling-advocacy 2021-11-30T14:20:40.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pafolacianine-for-the-detection-of-ovarian-cancer-lesions 2021-11-30T14:05:42.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-sirolimus-protein-bound-particles-for-pecoma 2021-11-23T13:25:54.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-71-leading-with-gratitude 2021-11-23T11:40:47.000Z monthly 0.6 https://www.accc-cancer.org/view/multiple-myeloma-colin-powell 2021-11-22T17:39:05.000Z monthly 0.6 https://www.accc-cancer.org/view/navigating-pricing-for-oncology-drugs 2021-11-18T14:00:10.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-renal-cell-carcinoma 2021-11-18T13:19:38.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-10-qi-for-advanced-nsclc 2021-11-18T12:43:13.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-lung-cancer-awareness-month 2021-11-17T20:29:33.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-launches-precision-medicine-resource-library 2021-11-17T14:40:20.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-70-a-new-deal-for-cancer-lessons-from-a-50-year-war 2021-11-16T19:02:17.000Z monthly 0.6 https://www.accc-cancer.org/view/u.s.-multi-society-task-force-releases-updated-colorectal-cancer-screening-recommendations 2021-11-16T13:52:48.000Z monthly 0.6 https://www.accc-cancer.org/view/do-good-initiative-share-your-insights- 2021-11-15T17:32:10.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ropeginterferon-alfa-2b-njft-for-polycythemia-vera 2021-11-15T15:58:21.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-09-precision-medicine-disparities 2021-11-11T17:24:36.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-staff-share-staffing-morale-concerns 2021-11-10T16:46:13.000Z monthly 0.6 https://www.accc-cancer.org/view/from-complex-to-clear-new-precision-medicine-tools 2021-11-09T17:02:03.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-precision-medicine-campaign 2021-11-04T19:22:57.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-the-radiation-oncology-model-final-rule 2021-11-03T14:10:02.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-granted-accelerated-approval-to-asciminib-for-chronic-myeloid-leukemia 2021-11-01T20:10:54.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-8-shared-decision-making-in-acute-myeloid-leukemia 2021-10-28T15:18:13.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-findings-of-national-initiative-to-support-quality-care-for-stage-iii-and-iv-nsclc 2021-10-27T14:57:39.000Z monthly 0.6 https://www.accc-cancer.org/view/new-small-group-ce-opportunities-offer-personalized-virtual-learning 2021-10-27T14:00:09.000Z monthly 0.6 https://www.accc-cancer.org/view/a-toxic-mixture-burnout-in-oncology-pharmacy 2021-10-26T13:50:48.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-and-pfizer-award-600-000-in-funding-for-quality-improvement-in-integration-of-biomarker-testing-into-personalized-treatment-selection-for-colorectal-cancer 2021-10-25T16:29:21.000Z monthly 0.6 https://www.accc-cancer.org/view/preparing-for-open-enrollment 2021-10-25T16:15:38.000Z monthly 0.6 https://www.accc-cancer.org/view/the-changing-landscape-of-breast-cancer 2021-10-22T18:00:28.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ventana-pd-l1-assay-as-a-companion-diagnostic-for-atezolizumab 2021-10-22T13:17:05.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-07-genetic-testing-telehealth 2021-10-21T15:13:35.000Z monthly 0.6 https://www.accc-cancer.org/view/adaptive-biotechnologies-launches-enhanced-clonoseq-assay-reports-for-patients-with-cll 2021-10-20T19:03:52.000Z monthly 0.6 https://www.accc-cancer.org/view/building-a-culture-of-deliberate-advocacy 2021-10-19T16:31:13.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-annual-innovator-award-winners 2021-10-18T19:57:53.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-as-adjuvant-treatment-for-nsclc 2021-10-18T15:23:31.000Z monthly 0.6 https://www.accc-cancer.org/view/barriers-to-liquid-biopsy-testing 2021-10-14T20:26:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-combination-for-cervical-cancer 2021-10-14T13:11:33.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-abemaciclib-with-endocrine-therapy-for-early-breast-cancer 2021-10-14T13:08:05.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-care-from-the-comfort-of-your-car 2021-10-07T17:18:46.000Z monthly 0.6 https://www.accc-cancer.org/view/bone-health-in-chronic-lymphocytic-leukemia 2021-10-07T00:46:55.000Z monthly 0.6 https://www.accc-cancer.org/view/exploring-the-role-of-pcsk9-in-regulating-an-immune-excluded-microenvironment-and-resistance-to-immune-checkpoint-blockade-in-nsclc 2021-10-06T22:29:34.000Z monthly 0.6 https://www.accc-cancer.org/view/impact-of-covid-19-pandemic-on-cancer-screening-in-eastern-north-carolina 2021-10-06T22:24:26.000Z monthly 0.6 https://www.accc-cancer.org/view/survival-outcomes-with-the-use-of-immunotherapy-in-patients-with-metastatic-non-small-cell-lung-cancer-at-a-large-hybrid-cancer-institute 2021-10-06T22:12:25.000Z monthly 0.6 https://www.accc-cancer.org/view/observed-survival-benefit-with-limited-exposure-of-durvalumab-in-unresectable-stage-iii-non-small-cell-lung-cancer-at-a-large-community-based-institution 2021-10-06T21:39:14.000Z monthly 0.6 https://www.accc-cancer.org/view/real-world-curative-intent-treatment-patterns-for-breast-cancer-in-an-hiv-prevalent-malawian-cohort 2021-10-06T21:05:39.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-pursues-health-equity-through-acori 2021-10-05T18:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-brexucabtagene-autoleucel-for-r-r-b-cell-precursor-all 2021-10-04T12:21:51.000Z monthly 0.6 https://www.accc-cancer.org/view/g1-therapeutics-announces-j-code-for-trilaciclib 2021-10-01T16:08:59.000Z monthly 0.6 https://www.accc-cancer.org/view/health-equity-summit-conversations-on-representation-in-clinical-trials 2021-09-30T18:30:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-cetuximab-in-combination-label-for-metastatic-colorectal-cancer 2021-09-29T12:20:26.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-unveils-new-tool-for-financial-advocates 2021-09-28T15:07:54.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-69-cancer-care-s-road-to-recovery-from-the-global-pandemic 2021-09-28T14:31:06.000Z monthly 0.6 https://www.accc-cancer.org/view/anemia-id-a-no-cost-genetic-testing-program-for-hereditary-anemias 2021-09-27T17:17:09.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-releases-five-abstracts-at-asco-quality-care-symposium 2021-09-24T21:05:58.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-271-assessing-effectiveness-of-a-self-guided-training-program-for-oncology-financial-advocates 2021-09-24T14:25:45.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-347579-use-of-a-delphi-process-to-develop-a-guideline-based-geriatric-oncology-gap-assessment-tool 2021-09-24T14:12:19.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-123-identifying-barriers-to-equitable-biomarker-testing-in-underserved-patients-with-nsclc-a-mixed-methods-study-to-inform-quality-improvement-opportunities 2021-09-24T14:06:24.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-348215-advanced-nsclc-learnings-from-a-multi-phase-mixed-methods-lung-cancer-quality-initiative-in-us-community-cancer-centers 2021-09-24T13:59:15.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-256-assessing-comprehensive-care-deficits-in-united-states-ovarian-cancer-programs-to-inform-quality-improvement-initiatives 2021-09-24T13:26:16.000Z monthly 0.6 https://www.accc-cancer.org/view/bayer-healthcare-shares-latest-analyses-of-vitrakvi-for-patients-with-trk-fusion-cancer 2021-09-21T16:12:31.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-68-supportive-care-in-radiation-oncology 2021-09-21T15:24:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-tisotumab-vedotin-tftv-for-cervical-cancer 2021-09-21T12:21:33.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cabozantinib-for-locally-advanced-or-metastatic-dtc 2021-09-20T12:33:37.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-06-financial-advocacy-playbook 2021-09-16T16:45:24.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-blood-cancer-awareness-month 2021-09-16T15:53:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-mobocertinib-for-nsclc-with-egfr-exon-20-insertion-mutations 2021-09-16T12:38:15.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-zanubrutinib-for-r-r-mzl 2021-09-15T12:25:32.000Z monthly 0.6 https://www.accc-cancer.org/view/updated-prescribing-information-for-neratinib-tablets 2021-09-14T21:29:18.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-prostate-cancer-awareness-month 2021-09-14T15:17:36.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-67-coping-with-pandemic-grief 2021-09-14T10:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-releases-report-at-iaslc-2021 2021-09-13T15:52:32.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-a-united-states-study-focused-on-patients-understanding-of-attitudes-towards-and-barriers-to-the-use-of-biomarker-testing-for-nsclc 2021-09-10T21:13:22.000Z monthly 0.6 https://www.accc-cancer.org/view/despite-setbacks-biosimilars-market-share-continues-to-increase 2021-09-10T16:26:34.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-zanubrutinib-or-waldenström-s-macroglobulinemia 2021-09-07T12:34:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-updated-pembrolizumab-indication-for-uc 2021-09-01T12:27:53.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-ep-66-cll-covid-19-and-why-patient-registries-matter 2021-08-31T17:34:55.000Z monthly 0.6 https://www.accc-cancer.org/view/building-a-team-during-the-darkest-days-of-covid-19 2021-08-30T16:46:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-companion-diagnostic-for-idh1-mutated-cholangiocarcinoma 2021-08-27T12:21:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ivosidenib-for-idh1-mutated-cholangiocarcinoma 2021-08-26T12:06:14.000Z monthly 0.6 https://www.accc-cancer.org/view/medical-nutrition-therapy-act-would-benefit-medicare-recipients 2021-08-24T16:36:39.000Z monthly 0.6 https://www.accc-cancer.org/view/new-permanent-j-code-for-melphalan-flufenamide 2021-08-24T14:10:19.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-for-high-risk-urothelial-carcinoma 2021-08-20T18:37:50.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-pandemic-era-returning-to-practice-series 2021-08-19T13:25:56.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-second-indication-for-dostarlimab-gxly 2021-08-18T13:23:16.000Z monthly 0.6 https://www.accc-cancer.org/view/how-quality-improvement-can-reduce-inequities-in-care 2021-08-17T20:13:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-belzutifan-for-von-hippel-lindau-disease-associted-tumors 2021-08-16T12:27:59.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-levnatinib-pembrolizumab-for-advanced-rcc 2021-08-16T12:22:01.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-principles-for-drug-diagnostics-and-biomarker-reimbursement 2021-08-12T20:47:06.000Z monthly 0.6 https://www.accc-cancer.org/view/grant-writing-as-a-means-to-fund-supportive-cancer-care-services 2021-08-12T17:35:49.000Z monthly 0.6 https://www.accc-cancer.org/view/legislation-aims-to-ease-patient-access-to-oral-oncolytics 2021-08-10T16:26:46.000Z monthly 0.6 https://www.accc-cancer.org/view/notes-on-nursing-learning-from-a-noble-expert 2021-08-05T17:52:15.000Z monthly 0.6 https://www.accc-cancer.org/view/state-by-state-colorado-expands-scope-of-practice-for-pharmacy-professionals 2021-08-03T17:24:49.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-65-integrating-advanced-practitioners-into-research 2021-08-03T16:33:11.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-releases-annual-report-on-current-state-of-immuno-oncology 2021-07-30T20:09:50.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-world-lung-cancer-day 2021-07-29T22:44:47.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-05-implementing-a-transportation-hub 2021-07-29T18:58:37.000Z monthly 0.6 https://www.accc-cancer.org/view/publication-immuno-oncology-in-2021-committed-to-the-cutting-edge-of-care 2021-07-29T16:49:37.000Z monthly 0.6 https://www.accc-cancer.org/view/using-medicaid-to-help-uninsured-patients-afford-their-care 2021-07-27T16:27:29.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-high-risk-early-stage-tnbc 2021-07-27T12:32:08.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-04-chronic-lymphocytic-leukemia-navigating-uncertainty 2021-07-22T17:46:51.000Z monthly 0.6 https://www.accc-cancer.org/view/early-palliative-care-program-proactively-meets-patient-needs 2021-07-22T16:19:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-lenvatinib-for-advanced-endometrial-cancer 2021-07-22T12:44:23.000Z monthly 0.6 https://www.accc-cancer.org/view/no-summer-covid-break-for-cancer-care-teams-new-cancer-buzz-podcast-episode-out-today 2021-07-20T19:02:33.000Z monthly 0.6 https://www.accc-cancer.org/view/catch-a-ride-save-a-life-transportation-program-reduces-no-shows 2021-07-20T15:42:03.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-notice-of-proposed-rulemaking-for-the-ro-model 2021-07-20T14:49:59.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-ep-64-a-summer-of-disconnect-for-cancer-professionals 2021-07-20T14:06:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-belumosudil-for-chronic-gvhd 2021-07-19T12:47:36.000Z monthly 0.6 https://www.accc-cancer.org/view/new-legislation-expands-access-to-clinical-trials 2021-07-14T17:18:08.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-ep-63-advanced-practitioners-role-in-research 2021-07-13T13:29:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-and-hyaluronidase-fihj-in-combination-for-mm 2021-07-12T17:14:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-granted-regular-approval-to-enfortumab-vedotin-ejfv 2021-07-09T19:58:25.000Z monthly 0.6 https://www.accc-cancer.org/view/integrating-community-paramedics-into-the-cancer-care-team 2021-07-08T17:59:39.000Z monthly 0.6 https://www.accc-cancer.org/view/managing-covid-oncology-patients-at-home-during-treatment 2021-07-07T16:40:34.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-ed-incidental-imaging-findings-through-navigation 2021-07-06T17:11:48.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-ep-62-oncology-billing-coding-fundamentals 2021-07-06T16:52:47.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-expanded-indication-for-pembrolizumab-for-cscc 2021-07-06T12:22:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-foundationone-cdx-as-companion-diagnostic-for-brigatinib 2021-07-01T19:24:56.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-component-of-chemotherapy-regimen-for-all-and-lbl 2021-07-01T12:14:17.000Z monthly 0.6 https://www.accc-cancer.org/view/state-by-state-advocacy-for-patient-access-to-quality-cancer-care 2021-06-30T18:39:26.000Z monthly 0.6 https://www.accc-cancer.org/view/mobile-app-eases-patient-cost-of-care-conversations 2021-06-29T17:37:08.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-ep-61-cll-patient-education-in-transitional-times 2021-06-29T17:34:58.000Z monthly 0.6 https://www.accc-cancer.org/view/pride-month-equality-in-cancer-care 2021-06-28T19:36:50.000Z monthly 0.6 https://www.accc-cancer.org/view/tips-for-helping-relieve-patients-of-financial-burden 2021-06-25T18:10:18.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-encourages-inclusion-of-patients-with-incurable-cancers-in-clinical-trials 2021-06-25T13:48:48.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-03-the-it-professional-as-a-multidisciplinary-team-member 2021-06-24T16:20:41.000Z monthly 0.6 https://www.accc-cancer.org/view/virtual-reality-brings-patient-education-to-life 2021-06-23T16:25:08.000Z monthly 0.6 https://www.accc-cancer.org/view/building-relationships-the-foundation-for-a-successful-service-line 2021-06-22T16:56:55.000Z monthly 0.6 https://www.accc-cancer.org/view/oncologist-needed---share-your-experience-with-managing-patients-with-cll-in-the-covid-19-post-covid-19-era 2021-06-22T16:14:55.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-on-juneteenth 2021-06-18T15:49:34.000Z monthly 0.6 https://www.accc-cancer.org/view/new-louisiana-law-bans-white-bagging 2021-06-17T17:48:27.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-cancer-buzz-tv 2021-06-17T12:56:45.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-avapritinib-for-advanced-systemic-mastocytosis 2021-06-17T12:39:01.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-survivors-share-their-stories 2021-06-15T17:46:49.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-advancing-clinical-trial-equity 2021-06-15T13:55:31.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-raises-awareness-for-national-black-family-cancer-awareness-week 2021-06-14T17:13:27.000Z monthly 0.6 https://www.accc-cancer.org/view/updated-data-for-durvalumab 2021-06-10T19:32:15.000Z monthly 0.6 https://www.accc-cancer.org/view/advocacy-in-action-putting-guardrails-around-step-therapy 2021-06-10T18:18:15.000Z monthly 0.6 https://www.accc-cancer.org/view/multiple-opportunities-available-for-social-workers 2021-06-10T16:20:51.000Z monthly 0.6 https://www.accc-cancer.org/view/notes-on-nursing-part-i 2021-06-08T16:09:31.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-virtual-hill-day-brings-together-members-lawmakers 2021-06-04T14:24:17.000Z monthly 0.6 https://www.accc-cancer.org/view/genetic-counseling-and-testing-rates-among-community-cancer-programs-for-patients-with-breast-cancer-following-site-directed-quality-improvement 2021-06-04T14:02:56.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-launches-institute-to-diversify-cancer-clinical-trials 2021-06-04T03:06:46.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-02-myeloma-care-strategies-covid-19 2021-06-03T16:33:30.000Z monthly 0.6 https://www.accc-cancer.org/view/state-by-state-advocacy-advances-pbm-reform-part-2 2021-06-03T13:53:41.000Z monthly 0.6 https://www.accc-cancer.org/view/state-by-state-advocacy-advances-pbm-reform-part-1 2021-06-02T14:09:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-accc-statement-on-medicare-multi-cancer-early-detection-screening-coverage-act-of-2021-2 2021-06-01T20:16:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-sotorasib-for-kras-g12c-mutated-nsclc 2021-06-01T14:57:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-infigratinib-for-cholangiocarcinoma 2021-06-01T12:40:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-guardant360-cdx-test-for-nsclc-with-kras-g12c-mutation 2021-06-01T12:32:33.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-sotorasib-for-nsclc 2021-06-01T12:27:17.000Z monthly 0.6 https://www.accc-cancer.org/view/zynlonta-added-to-nccn-guidelines 2021-05-27T19:20:14.000Z monthly 0.6 https://www.accc-cancer.org/view/adc-therapeutics-announces-data-from-lotis-2-study 2021-05-27T19:18:02.000Z monthly 0.6 https://www.accc-cancer.org/view/video-podcast-ep-01-real-world-lessons-from-covid-19 2021-05-27T14:50:01.000Z monthly 0.6 https://www.accc-cancer.org/view/new-patient-education-tools-for-skin-cancer-awareness-month 2021-05-26T20:07:33.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-2020-trending-now-in-cancer-care-report 2021-05-25T19:18:37.000Z monthly 0.6 https://www.accc-cancer.org/view/get-involved-with-accc-committees 2021-05-25T16:57:04.000Z monthly 0.6 https://www.accc-cancer.org/view/open-positions-accc-communications-committee 2021-05-25T16:50:00.000Z monthly 0.6 https://www.accc-cancer.org/view/open-positions-education-committee 2021-05-25T16:36:35.000Z monthly 0.6 https://www.accc-cancer.org/view/open-positions-membership-committee 2021-05-25T16:06:45.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-collaboration-and-innovation-in-the-time-of-covid-19 2021-05-25T12:48:45.000Z monthly 0.6 https://www.accc-cancer.org/view/multiple-advocacy-and-policy-opportunities 2021-05-24T20:41:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-guardant360-cdx-as-companion-diagnostic-for-amivantamab-vmjw 2021-05-24T19:41:10.000Z monthly 0.6 https://www.accc-cancer.org/view/volunteer-opportunities-open-in-sponsor-facing-engagement-roles 2021-05-24T17:37:00.000Z monthly 0.6 https://www.accc-cancer.org/view/building-systemness-through-service-lines 2021-05-24T16:41:46.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-releases-report-trending-now-in-cancer-care-2020 2021-05-24T16:12:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-amivantamab-vmjw-for-nsclc 2021-05-21T18:10:48.000Z monthly 0.6 https://www.accc-cancer.org/view/get-the-facts-about-bladder-cancer 2021-05-20T19:16:50.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-for-completely-resected-esophageal-or-gej-cancer 2021-05-20T18:52:33.000Z monthly 0.6 https://www.accc-cancer.org/view/new-legislation-aims-to-reimburse-essential-pharmacist-services 2021-05-19T17:55:22.000Z monthly 0.6 https://www.accc-cancer.org/view/uspstf-releases-updated-colorectal-cancer-screening-guidelines 2021-05-18T18:01:16.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-impact-of-covid-19-on-revenue-optimization-pt1 2021-05-18T14:11:17.000Z monthly 0.6 https://www.accc-cancer.org/view/enfortumab-vedotin-ejfv-data-from-asco-gu-2021 2021-05-17T18:03:50.000Z monthly 0.6 https://www.accc-cancer.org/view/extending-telehealth-beyond-the-pandemic 2021-05-17T16:29:58.000Z monthly 0.6 https://www.accc-cancer.org/view/the-leading-expert-views-on-the-role-of-mrd-in-patient-care 2021-05-14T18:09:37.000Z monthly 0.6 https://www.accc-cancer.org/view/positive-phase-3-cemiplimab-results-in-advanced-cervical-cancer 2021-05-12T21:13:56.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-covid-19-challenges-managing-patients-with-cll 2021-05-11T13:37:24.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-fam-trastuzumab-deruxtecan-nxki-for-her2-positive-gastric-cancer 2021-05-06T19:27:18.000Z monthly 0.6 https://www.accc-cancer.org/view/bill-to-improve-access-to-genetic-counseling-introduced-in-house-and-senate 2021-05-06T18:09:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-in-combination-for-her2-positive-gastric-cancer 2021-05-06T17:43:07.000Z monthly 0.6 https://www.accc-cancer.org/view/city-of-hope-s-investigational-covid-19-vaccine 2021-05-05T17:35:43.000Z monthly 0.6 https://www.accc-cancer.org/view/cost-of-care-and-prescription-meds-put-strain-and-stress-on-aya-survivors 2021-05-04T13:44:56.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-accc-piloting-test-tools-to-diversify-cancer-clinical-trials 2021-05-03T18:46:46.000Z monthly 0.6 https://www.accc-cancer.org/view/older-adults-with-cancer-clinical-trials 2021-04-27T18:44:58.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-what-comes-next-for-telehealth 2021-04-27T15:38:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-loncastuximab-tesirine-lpyl-for-r-r-lbcl 2021-04-26T12:31:40.000Z monthly 0.6 https://www.accc-cancer.org/view/managing-dermatologic-adverse-events-from-immunotherapy 2021-04-23T16:14:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-companion-diagnostic-for-immunotherapy-eligible-endometrial-cancer 2021-04-23T12:40:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-dostarlimab-gxly 2021-04-23T12:18:23.000Z monthly 0.6 https://www.accc-cancer.org/view/proposed-telehealth-legislation-at-forefront-of-accc-virtual-hill-day 2021-04-21T17:40:19.000Z monthly 0.6 https://www.accc-cancer.org/view/taking-action-on-disparities-in-prostate-cancer 2021-04-20T19:55:59.000Z monthly 0.6 https://www.accc-cancer.org/view/amgen-launches-assistance-program-for-nsclc-biomarker-testing 2021-04-19T18:33:15.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-in-combination-with-chemotherapy-for-three-indications 2021-04-16T17:27:50.000Z monthly 0.6 https://www.accc-cancer.org/view/helping-financial-advocates-track-patient-assistance-preauthorizations 2021-04-15T18:53:42.000Z monthly 0.6 https://www.accc-cancer.org/view/emergency-medicine-providers-key-partners-in-the-acute-care-of-iraes 2021-04-15T17:11:46.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-cd34-cell-dose-with-5-year-survival-after-peripheral-blood-allogeneic-hematopoietic-cell-transplantation-in-adults-with-hematologic-malignancies 2021-04-14T14:47:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-sacituzumab-govitecan-hziy-for-urothelial-cancer 2021-04-14T12:32:26.000Z monthly 0.6 https://www.accc-cancer.org/view/impact-of-body-mass-index-on-pathological-complete-response-after-neoadjuvant-chemotherapy-results-from-the-i-spy-2-trial 2021-04-13T01:54:02.000Z monthly 0.6 https://www.accc-cancer.org/view/busulfan-dose-recommendation-in-inherited-metabolic-disorders-population-pharmacokinetic-analysis 2021-04-13T01:46:18.000Z monthly 0.6 https://www.accc-cancer.org/view/successful-treatment-of-covid-19-vaccine-induced-idiopathic-thrombocytopenic-purpura-in-a-76-yo-gentleman-taking-apixaban 2021-04-13T01:43:48.000Z monthly 0.6 https://www.accc-cancer.org/view/predictors-and-outcomes-of-flares-in-chronic-graft-versus-host-disease-(cgvhd) 2021-04-13T01:39:36.000Z monthly 0.6 https://www.accc-cancer.org/view/impact-of-adjuvant-chemotherapy-on-outcomes-in-appendiceal-cancer 2021-04-13T01:37:45.000Z monthly 0.6 https://www.accc-cancer.org/view/high-self-efficacy-after-hematopoietic-stem-cell-transplant 2021-04-13T01:34:06.000Z monthly 0.6 https://www.accc-cancer.org/view/cytopenias-associated-with-covid-19-in-patients-with-hematologic-malignancy 2021-04-13T01:30:04.000Z monthly 0.6 https://www.accc-cancer.org/view/immunologic-context-of-pediatric-brain-tumors 2021-04-13T01:27:58.000Z monthly 0.6 https://www.accc-cancer.org/view/isavuconazonium-sulfate-use-in-multi-modal-management-of-invasive-mucormycosis-in-four-pediatric-allogeneic-hematopoietic-cell-transplant-patients 2021-04-13T01:25:37.000Z monthly 0.6 https://www.accc-cancer.org/view/enforced-expression-of-tcf3-or-bcl11b-enhances-t-progenitor-differentiation-from-human-induced-pluripotent-stem-cells 2021-04-13T01:14:43.000Z monthly 0.6 https://www.accc-cancer.org/view/new-geriatric-assessment-guide-gives-cancer-care-teams-tools-to-help-aging-patients 2021-04-08T18:18:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-sacituzumab-govitecan-hziy-for-triple-negative-breast-cancer 2021-04-08T12:32:55.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-cosigns-joint-letter-on-covid-19-and-cancer-on-world-health-day 2021-04-07T16:25:10.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-cosigns-joint-covid19-cancer-call-to-action-for-world-health-day 2021-04-07T14:18:43.000Z monthly 0.6 https://www.accc-cancer.org/view/aonn-leadership-council-shares-need-for-complete-cancer-care-team 2021-04-07T12:37:57.000Z monthly 0.6 https://www.accc-cancer.org/view/closing-care-gaps-for-lgbtqi-cancer-providers 2021-04-06T17:35:45.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-breakthrough-device-designation-to-mir-scientific-assay 2021-04-06T12:22:48.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-new-billing-codes-for-april-2021 2021-04-05T18:43:12.000Z monthly 0.6 https://www.accc-cancer.org/view/the-role-of-community-partners-in-serving-aya-patients 2021-04-01T18:22:18.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-isatuximab-in-combination-for-r-r-multiple-myeloma 2021-04-01T12:26:23.000Z monthly 0.6 https://www.accc-cancer.org/view/eisai-and-advocacy-leaders-launch-initiative-to-highlight-edometrial-cancer 2021-04-01T12:21:54.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daunorubicin-cytarabine-for-secondary-acute-myeloid-leukemia 2021-03-31T12:09:04.000Z monthly 0.6 https://www.accc-cancer.org/view/facilitating-shared-decision-making-in-cancer-care-effective-practices-and-the-role-of-navigation 2021-03-30T18:44:12.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-what-you-need-to-know-about-liquid-biopsy 2021-03-30T10:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-idecabtagene-vicleucel-for-r-r-multiple-myeloma 2021-03-29T12:44:33.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-colorectal-cancer-awareness-month-with-rfp 2021-03-24T16:02:18.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-and-pfizer-offer-grant-opportunities-focused-on-improving-quality-of-metastatic-colorectal-cancer-care-through-appropriate-biomarker-testing 2021-03-24T13:17:20.000Z monthly 0.6 https://www.accc-cancer.org/view/bayer-announces-no-cost-genetic-testing-programs-for-ntrk-gene-fusions 2021-03-24T12:36:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-chemotherapy-for-esophageal-or-gej-carcinoma 2021-03-23T12:33:18.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-signs-statement-on-medicare-mced-screening-coverage-act-of-2021 2021-03-22T18:46:13.000Z monthly 0.6 https://www.accc-cancer.org/view/what-does-the-american-rescue-plan-mean-for-health-care-coverage 2021-03-19T18:11:48.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-therasphere-y-90-glass-microspheres-for-patients-with-hcc 2021-03-19T12:10:53.000Z monthly 0.6 https://www.accc-cancer.org/view/applying-covid-19-lessons-learned-to-improve-cancer-care-research 2021-03-18T17:36:55.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-accc-statement-on-medicare-multi-cancer-early-detection-screening-coverage-act-of-2021 2021-03-17T19:33:08.000Z monthly 0.6 https://www.accc-cancer.org/view/why-social-workers-are-essential-a-q-a-with-accc-s-new-president 2021-03-17T18:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-new-executive-committee-leadership-and-board-members 2021-03-17T14:20:15.000Z monthly 0.6 https://www.accc-cancer.org/view/the-future-of-white-bagging-and-brown-bagging-in-oncology-pharmacy 2021-03-15T21:54:05.000Z monthly 0.6 https://www.accc-cancer.org/view/texas-medicaid-designates-pegfilgrastim-cbqv-on-the-preferred-drug-list 2021-03-15T13:40:54.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-trastuzumab-qyyp-biosimilar 2021-03-11T20:58:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-bevacizumab-bvzr-for-new-indication 2021-03-11T20:54:21.000Z monthly 0.6 https://www.accc-cancer.org/view/working-with-rheumatologists-to-manage-iraes 2021-03-11T20:24:13.000Z monthly 0.6 https://www.accc-cancer.org/view/transitioning-to-primary-care-after-io-treatment 2021-03-11T20:19:26.000Z monthly 0.6 https://www.accc-cancer.org/view/survivorship-care-in-the-era-of-immuno-oncology 2021-03-11T20:03:59.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tivozanib-for-r-r-advanced-rcc 2021-03-11T13:37:40.000Z monthly 0.6 https://www.accc-cancer.org/view/the-uspstf-announces-update-to-lung-cancer-screening-recommendations 2021-03-09T17:25:30.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-the-spiritual-side-of-cancer-care 2021-03-09T11:00:03.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-access-to-clinical-trials-for-rural-populations 2021-03-08T18:47:23.000Z monthly 0.6 https://www.accc-cancer.org/view/the-fda-approves-axicabtagene-ciloleucel-for-r-r-follicular-lymphoma 2021-03-08T13:39:10.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-names-new-president-krista-nelson-msw-lcsw-osw-c-faosw 2021-03-05T15:01:09.000Z monthly 0.6 https://www.accc-cancer.org/view/telehealth-and-reimbursement-issues-top-of-mind-at-amccbs 2021-03-04T15:41:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-lorlatinib-approval-to-include-alk-positive-nsclc 2021-03-04T13:28:27.000Z monthly 0.6 https://www.accc-cancer.org/view/day-1-at-amccbs-covid-fallout-and-policy-concerns 2021-03-02T14:56:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-issues-eua-for-third-covid-19-vaccine 2021-03-01T15:03:47.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-melphalan-flufenamide-for-r-r-mm 2021-03-01T13:42:38.000Z monthly 0.6 https://www.accc-cancer.org/view/new-on-demand-webinar-can-help-you-better-support-cancer-caregivers 2021-02-25T18:53:48.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-47th-annual-meeting-cancer-center-business-summit 2021-02-24T15:04:17.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-the-pd-l1-ihc-22c3-pharmdx-assay-for-nsclc 2021-02-23T13:37:25.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-telehealth-genetics-during-covid-19 2021-02-23T12:31:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cemiplimab-rwlc-monotherapy-for-advanced-nsclc 2021-02-22T20:01:51.000Z monthly 0.6 https://www.accc-cancer.org/view/beyond-covid-19-the-road-to-recovery 2021-02-22T18:56:38.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-virtual-day-4-managing-for-success 2021-02-18T19:38:34.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cemiplimab-rwlc-for-advanced-basal-cell-carcinoma 2021-02-17T14:23:08.000Z monthly 0.6 https://www.accc-cancer.org/view/new-administration-opens-aca-marketplace-for-special-enrollment-period 2021-02-16T19:37:37.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-trilaciclib-to-decrease-chemotherapy-induced-myelosuppression-incidence-in-es-sclc 2021-02-16T17:04:33.000Z monthly 0.6 https://www.accc-cancer.org/view/u.s.-hospitals-request-the-reversals-the-340b-drug-and-pay-cuts-rulings 2021-02-11T20:52:26.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-virtual-day-3-cancer-service-line-efficiency-and-revenue-optimization 2021-02-11T16:59:29.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-issues-eua-for-bamlanivimab-and-etesevimab-for-covid-19-treatment 2021-02-10T15:00:06.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cemiplimab-rwlc-as-first-immunotherapy-for-advanced-basal-cell-carcinoma 2021-02-10T13:12:45.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-end-of-life-health-disparities 2021-02-09T11:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-virtual-day-2-telehealth-virtual-care-models-and-remote-monitoring 2021-02-08T19:46:40.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lisocabtagene-maraleucel-for-r-r-large-b-cell-lymphoma 2021-02-08T13:18:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-umbralisib-for-two-indications 2021-02-08T13:07:30.000Z monthly 0.6 https://www.accc-cancer.org/view/world-cancer-day-i-am-i-will 2021-02-04T17:44:12.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tepotinib-for-metastatic-nsclc 2021-02-04T13:09:19.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-cultural-humility-sensitivity 2021-02-02T11:00:06.000Z monthly 0.6 https://www.accc-cancer.org/view/a-conversation-with-asco-s-dr-richard-schilsky 2021-01-28T20:55:22.000Z monthly 0.6 https://www.accc-cancer.org/view/poster-community-cancer-care-delivery-amid-covid-19 2021-01-28T19:24:43.000Z monthly 0.6 https://www.accc-cancer.org/view/statement-on-the-value-of-oncology-advanced-practitioners 2021-01-27T19:23:27.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-releases-latest-podcast-that-offers-tips-for-onco-pharmacy 2021-01-26T20:42:43.000Z monthly 0.6 https://www.accc-cancer.org/view/new-fda-approved-indication-for-crizotinib-capsules 2021-01-26T14:18:38.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-tracking-patient-adherence-to-oral-anti-cancer-medication 2021-01-26T11:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/the-role-of-patient-advocates-in-clinical-research 2021-01-25T17:56:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-cabozantinib-for-advanced-rcc 2021-01-22T19:55:26.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-releases-new-guidance-on-covid-19-vaccine-for-patients-with-cancer 2021-01-22T18:44:54.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-s-cancer-buzz-podcast-receives-best-healthcare-podcast-platinum-2020-ehealthcare-leadership-award 2021-01-19T18:42:47.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-fam-trastuzumab-deruxtecan-nxki-for-adenocarcinoma 2021-01-19T14:11:41.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-building-trust-with-marginalized-groups 2021-01-19T11:49:03.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-lawsuit-challenging-legality-of-hhs-most-favored-nation-placed-on-hold 2021-01-15T20:54:36.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-crizotinib-for-children-and-ya-patients-with-r-r-alcl 2021-01-15T15:35:25.000Z monthly 0.6 https://www.accc-cancer.org/view/community-outreach-to-address-disparities-in-cancer-care 2021-01-14T22:13:45.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-lgbtq-patients-with-cancer 2021-01-12T14:49:57.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-c-code-for-belantamab-mafodotin-blmf 2021-01-05T17:59:31.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ponatinib-tablets-for-adults-with-cp-cml 2021-01-05T16:35:52.000Z monthly 0.6 https://www.accc-cancer.org/view/leading-by-example 2021-01-04T20:42:07.000Z monthly 0.6 https://www.accc-cancer.org/view/kristin-ferguson-dnp-rn-ocn-joins-the-association-of-community-cancer-centers-as-senior-director-cancer-care-delivery-and-health-policy 2021-01-04T16:24:28.000Z monthly 0.6 https://www.accc-cancer.org/view/preliminary-injunction-follows-accc-lawsuit-challenging-legality-of-hhs-most-favored-nation 2020-12-31T18:57:50.000Z monthly 0.6 https://www.accc-cancer.org/view/the-best-and-worst-of-2020 2020-12-30T15:25:14.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-telehealth-after-covid-19 2020-12-30T04:31:00.000Z monthly 0.6 https://www.accc-cancer.org/view/statement-on-expanded-clinical-trials-coverage-for-medicaid-beneficiaries-ro-model-delay 2020-12-28T15:43:36.000Z monthly 0.6 https://www.accc-cancer.org/view/statement-on-accc-lawsuit-challenging-legality-of-hhs-most-favored-nation-rule 2020-12-23T22:33:46.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-supporting-caregivers-during-covid-19 2020-12-22T11:00:11.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-enters-2021 2020-12-21T19:51:31.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-osimertinib-for-the-adjuvant-treatment-of-egfrm-nsclc 2020-12-21T13:09:37.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-relugolix-for-advanced-prostate-cancer 2020-12-21T12:58:29.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-selinexor-for-r-r-multiple-myeloma 2020-12-21T12:50:04.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-issues-eua-for-moderna's-covid-19-vaccine 2020-12-19T01:16:47.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-amgen's-rituximab-biosimilar 2020-12-18T14:54:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-margetuximab-chemotherapy-for-metistatic-her2-breast-cancer 2020-12-17T18:34:26.000Z monthly 0.6 https://www.accc-cancer.org/view/durvalumab-dosing-update 2020-12-15T20:59:31.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-psychosocial-oncology-services-during-covid-19 2020-12-15T11:00:08.000Z monthly 0.6 https://www.accc-cancer.org/view/worta-mccaskill-stevens-md-ms-named-2020-accc-david-king-community-clinical-scientist-award-winner 2020-12-14T21:24:43.000Z monthly 0.6 https://www.accc-cancer.org/view/roy-s.-herbst-md-phd-named-accc-2020-clinical-research-award-winner 2020-12-14T21:23:05.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-issues-eua-for-first-covid-19-vaccine 2020-12-12T17:27:23.000Z monthly 0.6 https://www.accc-cancer.org/view/moving-immunotherapy-patients-into-survivorship-a-conversation 2020-12-11T05:10:02.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-(accc)-statement-on-h.r.-8845-the-multi-cancer-early-detection-screening-coverage-act 2020-12-09T20:43:03.000Z monthly 0.6 https://www.accc-cancer.org/view/addressing-racial-equity-in-the-c-suite 2020-12-08T21:27:58.000Z monthly 0.6 https://www.accc-cancer.org/view/statement-on-litigation-challenging-legality-of-most-favored-nation-rule 2020-12-04T22:18:46.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-pfs-final-rule-understanding-4-key-topics-call 2020-12-03T17:09:23.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-ro-model-updates 2020-12-03T16:56:50.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pralsetinib-for-ret-altered-thyroid-cancers 2020-12-02T12:51:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-psma-targeted-pet-imaging-drug-for-prostate-cancer 2020-12-01T20:01:56.000Z monthly 0.6 https://www.accc-cancer.org/view/moderna-announces-eua-request-to-fda-for-covid-19-vaccine-candidate 2020-12-01T18:41:40.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-resources-office-hours-for-ro-model-participants 2020-12-01T16:03:46.000Z monthly 0.6 https://www.accc-cancer.org/view/preventing-and-treating-hiv-related-cancers 2020-11-30T20:59:02.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-most-favored-nation-drug-pricing-model 2020-11-24T20:51:28.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-on-the-most-favored-nation-drug-pricing-model 2020-11-24T19:22:24.000Z monthly 0.6 https://www.accc-cancer.org/view/access-free-webinars-from-accc-s-financial-advocacy-network-virtual-summit 2020-11-24T16:45:34.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-the-promise-of-bispecific-antibodies 2020-11-24T11:00:09.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-issues-eua-for-casirivamab-imdevimab-antibodies-to-treat-covid-19 2020-11-23T14:42:17.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-biontech-announce-eua-request-to-fda-for-covid-19-vaccine 2020-11-20T22:44:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-issues-eau-for-monoclonal-antibody-to-treat-covid-19 2020-11-20T22:44:11.000Z monthly 0.6 https://www.accc-cancer.org/view/telemedicine-and-cancer-care-today-s-learnings-for-a-post-pandemic-world 2020-11-20T19:50:59.000Z monthly 0.6 https://www.accc-cancer.org/view/predictive-modeling-what-why-how 2020-11-20T19:31:38.000Z monthly 0.6 https://www.accc-cancer.org/view/covid-19-and-patients-receiving-anticancer-immunotherapy 2020-11-20T18:20:43.000Z monthly 0.6 https://www.accc-cancer.org/view/navigating-billing-for-pharmacy-services 2020-11-19T20:09:22.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-release-permanent-j-code-for-phesgo-injection 2020-11-19T19:04:34.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-lung-cancer-screening-during-covid-19 2020-11-17T11:00:04.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-quality-payment-program-extreme-and-uncontrollable-circumstances-application 2020-11-16T19:55:30.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-chemotherapy-for-tnbc 2020-11-16T13:25:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fostering-excellence-in-care-and-outcomes-for-patients-with-stage-iii-and-iv-nsclc 2020-11-13T19:00:55.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-releases-16-abstracts-this-fall 2020-11-13T16:17:33.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-reminder-to-update-billing-information-to-receive-apm-incentive-payments 2020-11-11T12:31:58.000Z monthly 0.6 https://www.accc-cancer.org/view/poster-490-an-immuno-oncology-census-assessment-of-clinician-knowledge-and-educational-needs-in-2020 2020-11-10T21:46:06.000Z monthly 0.6 https://www.accc-cancer.org/view/population-level-outcomes-of-chronic-lymphocytic-leukemia-in-the-era-of-targeted-agents--analysis-of-surveillance-epidemiology-and-end-results-(seer)-database 2020-11-10T19:37:29.000Z monthly 0.6 https://www.accc-cancer.org/view/secondary-myeloid-malignancies-after-autologous-stem-cell-transplantation-for-multiple-myeloma-are-associated-with-a-distinct-mutational-profile 2020-11-10T19:34:07.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-managing-oral-anti-cancer-medications 2020-11-10T12:01:02.000Z monthly 0.6 https://www.accc-cancer.org/view/high-pre-treatment-neutrophil-to-lymphocyte-ratio-is-associated-with-poor-distant-metastais-free-survival-in-patients-with-soft-tissue-sarcoma-of-the-extremity 2020-11-10T02:32:04.000Z monthly 0.6 https://www.accc-cancer.org/view/selection-of-targeted-therapeutics-in-colorectal-cancer-spheroids-for-clinical-prediction 2020-11-10T02:25:46.000Z monthly 0.6 https://www.accc-cancer.org/view/endocrinopathies-associated-with-ibrutinib---a-retrospective-analysis 2020-11-10T00:20:17.000Z monthly 0.6 https://www.accc-cancer.org/view/registration-open-jakafi--ruxolitinib--product-theater 2020-11-09T17:00:41.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-improving-non-small-cell-lung-cancer-care-delivery-findings-for-oncology-nurses-and-patient-navigation-from-a-national-quality-survey 2020-11-06T20:11:04.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-lung-cancer-awareness-month 2020-11-03T11:00:52.000Z monthly 0.6 https://www.accc-cancer.org/view/tips-and-tools-for-managing-medications-for-older-adults-with-cancer 2020-11-02T23:43:28.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-2021-federal-health-insuance-exchange-open-enrollment-period 2020-11-02T14:39:25.000Z monthly 0.6 https://www.accc-cancer.org/view/liver-cancer-heatmap-helps-organizations-tailor-outreach-and-research 2020-10-29T21:18:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-accepts-for-priority-review-cemiplimab-rwlc-for-advanced-nsclc 2020-10-29T18:50:56.000Z monthly 0.6 https://www.accc-cancer.org/view/navigating-in-a-new-era-crisis-and-opportunity 2020-10-28T20:04:50.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-comments-on-cms-radiation-oncology-final-rule-cms-delays-implementation 2020-10-27T21:37:43.000Z monthly 0.6 https://www.accc-cancer.org/view/presentation-2302-improving-care-for-patients-with-stage-iii-iv-nsclc-learnings-for-thoracic-surgeons-and-radiation-oncologists-from-a-national-quality-survey 2020-10-27T14:19:00.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-shared-decision-making 2020-10-27T10:00:29.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-radiation-oncology-model-delay 2020-10-22T11:48:26.000Z monthly 0.6 https://www.accc-cancer.org/view/learning-how-to-die 2020-10-20T13:49:20.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-biosimilars-what-patients-need-to-know 2020-10-20T10:00:19.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-webinar-series-on-oncology-pharmacy 2020-10-19T13:22:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-venetoclax-in-combination-for-untreated-aml 2020-10-19T12:03:49.000Z monthly 0.6 https://www.accc-cancer.org/view/poster-variable-definitions-of-unresectable-stage-iii-nsclc-among-lung-cancer-specialists 2020-10-16T20:46:50.000Z monthly 0.6 https://www.accc-cancer.org/view/poster-improving-care-for-patients-with-stage-iii-iv-nsclc-learnings-for-multidisciplinary-teams-at-iasclc 2020-10-16T20:41:18.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-statement-on-rise-of-cancer-mortality-and-advanced-cancer-rates-in-2020 2020-10-16T12:53:05.000Z monthly 0.6 https://www.accc-cancer.org/view/poster-assessing-educational-gains-and-gaps-for-advanced-practice-providers-in-immuno-oncology-2017-2020 2020-10-15T21:14:33.000Z monthly 0.6 https://www.accc-cancer.org/view/immunomedics-announces-new-c-code-for-trodelvy-effective-october-2020 2020-10-15T19:58:11.000Z monthly 0.6 https://www.accc-cancer.org/view/poster-oncology-advanced-practitioner-collaboration-for-the-conduct-of-a-clinical-research-project 2020-10-15T17:50:27.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-expanded-indication-of-pembrolizumab-for-r-r-chl 2020-10-15T12:28:07.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-comments-on-2021-proposed-opps-and-pfs-rules 2020-10-14T15:09:15.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-improving-community-clinical-trial-participation 2020-10-13T17:59:35.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-social-workers-promote-self-care-in-the-workplace 2020-10-12T22:41:55.000Z monthly 0.6 https://www.accc-cancer.org/view/presentation-improving-the-staging-and-diagnosis-of-patients-with-stage-iii-iv-non-small-cell-lung-cancer-findings-for-pathology-and-pulmonary-medicine-from-a-national-quality-survey 2020-10-10T18:50:00.000Z monthly 0.6 https://www.accc-cancer.org/view/-abstract-113-incorporating-telementoring-project-echo-into-practice-efficacy-of-point-of-service-testing-breast-cancer-epost-bc- 2020-10-09T18:13:09.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-care-for-patients-with-nsclc-learnings-for-multidisciplinary-teams-at-asco-qcs 2020-10-09T15:51:29.000Z monthly 0.6 https://www.accc-cancer.org/view/defining-high-quality-nsclc-care-at-us-cancer-centers 2020-10-09T14:26:00.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-180-shared-decision-making-attitudes-and-practices-in-multidisciplinary-cancer-care-teams 2020-10-09T13:46:37.000Z monthly 0.6 https://www.accc-cancer.org/view/role-of-oncology-advanced-practitioners-to-enhance-clinical-research 2020-10-09T13:34:00.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-31-resource-and-reimbursement-barriers-to-care-delivery-at-asco-qcs 2020-10-09T13:30:11.000Z monthly 0.6 https://www.accc-cancer.org/view/an-optimal-care-coordination-model-for-medicaid-patients-with-lung-cancer-results-from-the-beta-model-testing-phase-of-a-multisite-initiative-at-asco-qcs 2020-10-09T13:25:52.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-104-an-optimal-care-coordination-model-occm-for-medicaid-patients-with-lung-cancer-finalization-of-the-model-and-implications-for-clinical-practice-in-the-us 2020-10-09T13:18:35.000Z monthly 0.6 https://www.accc-cancer.org/view/know-your-state-interactive-tool 2020-10-07T16:15:24.000Z monthly 0.6 https://www.accc-cancer.org/view/clonoseq-receives-fda-clearance-for-mrd-assessment-in-cll 2020-10-07T16:09:17.000Z monthly 0.6 https://www.accc-cancer.org/view/ibrutinib-for-the-treatment-of-adult-patients-with-cll-sll 2020-10-07T16:04:15.000Z monthly 0.6 https://www.accc-cancer.org/view/mybeigene-patient-support-for-zanubrutinib 2020-10-07T14:16:56.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-center-brings-clinical-trials-to-diverse-population 2020-10-07T02:11:57.000Z monthly 0.6 https://www.accc-cancer.org/view/exelixis-access-services-ease 2020-10-06T21:45:46.000Z monthly 0.6 https://www.accc-cancer.org/view/cabozantinib-prescribing-information-and-resources 2020-10-06T21:42:34.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-ipilimumab-immunotherapy-treatment-for-mesothelioma 2020-10-05T14:33:30.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-financial-barriers-to-biomarker-testing 2020-09-29T10:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/reframing-financial-navigation-during-covid-19 2020-09-28T19:14:55.000Z monthly 0.6 https://www.accc-cancer.org/view/the-she-experience-accc-conference-promotes-women-in-oncology 2020-09-25T16:12:26.000Z monthly 0.6 https://www.accc-cancer.org/view/coa-position-statement-on-telehealth-in-cancer-care-post-covid-19 2020-09-25T14:34:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-two-liquid-biopsy-companion-diagnostics-for-osimertinib 2020-09-24T21:52:37.000Z monthly 0.6 https://www.accc-cancer.org/view/behind-the-curtain-2020-innovator-award-winners-and-their-champions-share-the-secrets-to-their-success 2020-09-22T16:22:11.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-social-worker-survey-closes-september-25 2020-09-21T22:14:28.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-recognizes-the-life-of-justice-ruth-bader-ginsburg 2020-09-21T15:07:47.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-radiation-oncology-model-final-rule 2020-09-18T19:57:24.000Z monthly 0.6 https://www.accc-cancer.org/view/sanofi-announces-permanent-j-code-for-isatuximab-irfc 2020-09-18T15:35:02.000Z monthly 0.6 https://www.accc-cancer.org/view/characterization-of-sociodemographic-and-clinicopathological-features-and-associated-outcomes-of-44-084-patients-with-anal-squamous-cell-cancer-in-the-national-cancer-database 2020-09-16T21:15:22.000Z monthly 0.6 https://www.accc-cancer.org/view/lilly-announces-thyroid-cancer-testing-program 2020-09-16T20:12:21.000Z monthly 0.6 https://www.accc-cancer.org/view/using-resiliency-to-drive-positive-change 2020-09-15T18:05:57.000Z monthly 0.6 https://www.accc-cancer.org/view/shifting-community-outreach-priorities-during-covid-19 2020-09-11T18:13:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pralsetinib-for-metastatic-ret-fusion-positive-nsclc 2020-09-08T11:54:42.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-closing-the-gender-gap-in-oncology 2020-09-08T08:00:03.000Z monthly 0.6 https://www.accc-cancer.org/view/talk-live-with-your-peers-about-outreach-and-prevention-efforts-in-a-covid-19-world 2020-09-04T15:07:24.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-fy2021-ipps-and-ltch-final-rule 2020-09-03T15:44:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-azacitidine-for-aml-continued-treatment 2020-09-02T14:08:10.000Z monthly 0.6 https://www.accc-cancer.org/view/dr.-ray-page-named-advocacy-champion-by-the-american-society-of-clinical-oncology 2020-08-31T16:08:22.000Z monthly 0.6 https://www.accc-cancer.org/view/latest-innovations-in-cancer-care-delivery-unveiled-at-the-accc-s-37th-virtual-national-oncology-conference 2020-08-26T14:23:29.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-immunotherapy-dermatology 2020-08-25T11:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/ngs-alert-for-pegfilgrastim-product-claims 2020-08-24T15:53:31.000Z monthly 0.6 https://www.accc-cancer.org/view/financial-advocacy-during-a-pandemic 2020-08-21T17:37:15.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-carfilzomib-and-dexamethasone-for-r-r-mm 2020-08-21T12:25:07.000Z monthly 0.6 https://www.accc-cancer.org/view/martin-palmeri-md-mba-named-advocacy-champion 2020-08-20T18:50:26.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-extends-auc-program-educational-operational-testing-period-to-2021 2020-08-19T20:08:18.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-adds-tafasitamab-cxix-to-guidelines-for-b-cell-lymphomas 2020-08-19T18:00:50.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-lessons-learned-from-covid-19 2020-08-18T11:00:02.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-opens-chart-model-overview-webinar-registration 2020-08-13T13:39:47.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-releases-lung-cancer-care-quality-improvement-model 2020-08-13T13:11:47.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-s-proposed-payment-rules-for-2021-what-you-need-to-know 2020-08-12T17:03:01.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-understanding-covid-19-data 2020-08-11T11:00:04.000Z monthly 0.6 https://www.accc-cancer.org/view/beyond-the-pandemic-a-long-term-view-of-medical-environments 2020-08-10T19:53:47.000Z monthly 0.6 https://www.accc-cancer.org/view/michael-mession-md-receives-prestigious-north-carolina-governor-s-award 2020-08-06T20:23:51.000Z monthly 0.6 https://www.accc-cancer.org/view/2020-accc-innovator-awards-making-outpatient-chemo-possible 2020-08-06T19:56:28.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-opens-pfs-listening-session-registration 2020-08-06T19:10:59.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-cy-2021-opps-and-pfs-proposed-rules 2020-08-06T14:00:04.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-belantamab-mafodotin-blmf-for-r-r-multiple-myeloma 2020-08-06T12:07:44.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-2020-innovator-award-recipients 2020-08-05T16:32:08.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-cy-2021-opps-proposed-rule 2020-08-04T21:59:23.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-cy-2021-pfs-proposed-rule 2020-08-04T21:58:59.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-surgical-oncology-during-covid-19 2020-08-04T11:00:08.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-responds-to-executive-orders-on-drug-pricing-reform 2020-08-03T22:49:35.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-on-trump-administration-s-executive-orders-addressing-prescription-drug-cost 2020-08-03T21:07:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tafasitamab-cxix-lenalidomide-for-relapsed-or-refractory-dlbcl 2020-08-03T12:48:49.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-statement-on-home-infusions-raises-safety-concerns 2020-07-31T15:26:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-plus-cobimetinib-vemurafenib-in-braf-advanced-melanoma 2020-07-31T14:05:35.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-report-reveals-dramatic-uptick-in-telehealth-during-pandemic 2020-07-31T13:50:58.000Z monthly 0.6 https://www.accc-cancer.org/view/2020-accc-innovator-awards-hospital-event-platform-better-monitors-patient-care 2020-07-30T19:45:09.000Z monthly 0.6 https://www.accc-cancer.org/view/upcoming-cms-covid-19-stakeholder-calls 2020-07-29T11:37:40.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-updated-data-on-covid-19's-impact-on-medicare-population 2020-07-29T11:34:41.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-reducing-cancer-drug-waste 2020-07-28T15:19:40.000Z monthly 0.6 https://www.accc-cancer.org/view/2020-accc-innovator-awards-pharmacists-expand-role-in-collaborative-practice-agreement 2020-07-27T14:59:04.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-brexucabtagene-autoleucel-car-t-cell-therapy-for-r-r-mcl 2020-07-24T19:54:57.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-accc-join-in-effort-to-increase-diversity-in-cancer-clinical-trials 2020-07-24T16:09:39.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-secretary-azar-extends-public-health-emergency 2020-07-24T13:39:50.000Z monthly 0.6 https://www.accc-cancer.org/view/physical-therapists-as-essential-members-of-the-cancer-care-team 2020-07-23T19:01:30.000Z monthly 0.6 https://www.accc-cancer.org/view/publication-io-wallet-card 2020-07-23T13:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-partners-with-echo-institute-for-virtual-telemedicine-learning-community 2020-07-21T23:10:39.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-accc-join-forces-to-increase-participation-of-racial-and-ethnic-minority-populations-in-cancer-treatment-trials 2020-07-21T16:01:19.000Z monthly 0.6 https://www.accc-cancer.org/view/2020-innovator-awards-meeting-the-demand-for-oncology-nurses 2020-07-20T21:59:25.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-cancer-screening-during-covid-19 2020-07-20T18:18:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-inqovi-tablets-for-adults-with-intermediate-and-high-risk-myelodysplastic-syndromes 2020-07-17T18:17:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-keytruda-for-patients-with-unresectable-or-metastatic-msi-h-or-dmmr-crc 2020-07-17T16:38:39.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-medication-reconciliation-in-ambulatory-oncology-patients 2020-07-16T22:02:44.000Z monthly 0.6 https://www.accc-cancer.org/view/event-free-survival-at-24-months-following-autologous-stem-cell-transplant-in-diffuse-large-b-cell-lymphoma 2020-07-16T21:58:58.000Z monthly 0.6 https://www.accc-cancer.org/view/acute-myeloid-leukemia-and-myelodysplastic-syndromes-in-patients-with-multiple-myeloma-assessment-of-risk-factors 2020-07-16T21:55:45.000Z monthly 0.6 https://www.accc-cancer.org/view/analysis-of-differential-methylation-patterns-associated-with-long-term-survival-in-glioblastoma 2020-07-16T17:39:36.000Z monthly 0.6 https://www.accc-cancer.org/view/2020-accc-innovator-awards-3d-model-helps-ease-patient-distress 2020-07-16T16:19:02.000Z monthly 0.6 https://www.accc-cancer.org/view/social-workers-promote-health-literacy-with-ask-me-3 2020-07-15T15:43:53.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-patients-with-recurrent-or-metastatic-cscc 2020-07-14T21:19:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-phesgo-injection-for-subcutaneous-use 2020-07-14T20:59:05.000Z monthly 0.6 https://www.accc-cancer.org/view/2020-accc-innovator-awards-creating-a-community-based-cardio-oncology-clinic 2020-07-14T17:34:36.000Z monthly 0.6 https://www.accc-cancer.org/view/2020-innovator-awards-creating-a-community-based-cardio-oncology-clinic 2020-07-14T17:23:44.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-the-needs-of-younger-adults-with-cancer 2020-07-14T10:00:03.000Z monthly 0.6 https://www.accc-cancer.org/view/2020-innovator-awards-reducing-readmissions-after-chemotherapy 2020-07-09T16:38:18.000Z monthly 0.6 https://www.accc-cancer.org/view/uspstf-draft-recommendation-expands-those-eligible-for-ldct-lung-cancer-screening 2020-07-07T21:11:49.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-decitabine-cedazuridine-oral-combo-for-adult-mds 2020-07-07T20:01:47.000Z monthly 0.6 https://www.accc-cancer.org/view/recent-layoffs-portend-higher-uninsured-rates 2020-07-07T18:39:10.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-staff-resiliency-during-covid-19 2020-07-07T07:30:07.000Z monthly 0.6 https://www.accc-cancer.org/view/eating-the-elephant 2020-07-06T16:16:28.000Z monthly 0.6 https://www.accc-cancer.org/view/update-covid-19-emergency-food-assistance-grant-amount-change 2020-07-02T17:13:37.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-avelumab-for-maintenance-treatment-in-advanced-urothelial-carcinoma 2020-07-01T15:52:57.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-first-line-treatment-of-metastatic-msi-h-or-dmmr-crc 2020-06-30T16:27:49.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-covid-19-testing-strategies 2020-06-30T07:00:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-new-fixed-dose-combination-for-her2-breast-cancer 2020-06-29T19:12:09.000Z monthly 0.6 https://www.accc-cancer.org/view/7-ways-covid-19-is-transforming-telehealth 2020-06-29T18:28:30.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-immuno-oncology-institute-releases-report-on-the-state-of-immuno-oncology 2020-06-29T14:25:46.000Z monthly 0.6 https://www.accc-cancer.org/view/mybeigene-patient-support 2020-06-26T14:37:27.000Z monthly 0.6 https://www.accc-cancer.org/view/june-is-cancer-immunotherapy-month 2020-06-25T20:39:14.000Z monthly 0.6 https://www.accc-cancer.org/view/statement-by-association-of-community-cancer-centers-president-regarding-negative-long-term-effect-of-pandemic-to-cancer-care 2020-06-25T17:53:45.000Z monthly 0.6 https://www.accc-cancer.org/view/live-discussion-cd38-directed-antibody-for-the-treatment-of-rrmm 2020-06-25T14:57:06.000Z monthly 0.6 https://www.accc-cancer.org/view/astellas-and-seattle-genetics-issue-product-specific-j-code-for-padcev 2020-06-25T14:25:32.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-recurrent-or-metastatic-cscc 2020-06-24T20:41:02.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-preliminary-data-on-covid-19 2020-06-23T21:49:54.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-new-office-of-burden-reduction-and-health-informatics 2020-06-23T21:21:01.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-immunotherapy-clinical-trials-during-covid-19 2020-06-23T07:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/elitek-pivotal-trial-overview 2020-06-22T21:46:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cyramza-for-first-line-treatment-of-metastatic-egfr-mutated-nsclc 2020-06-22T21:38:05.000Z monthly 0.6 https://www.accc-cancer.org/view/the-new-normal-seven-questions-program-leaders-are-asking-about-care-amid-covid-19 2020-06-22T21:37:47.000Z monthly 0.6 https://www.accc-cancer.org/view/taiho-oncology-patient-support-program 2020-06-22T21:15:55.000Z monthly 0.6 https://www.accc-cancer.org/view/lonsurf-efficacy-flashcard 2020-06-22T21:13:28.000Z monthly 0.6 https://www.accc-cancer.org/view/sanofi-introduces-the-libtayo-surround-online-portal 2020-06-22T21:07:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tabrecta-for-metastatic-nsclc-with-metex14 2020-06-22T20:54:09.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-wisconsin 2020-06-22T20:42:18.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-hawaii 2020-06-22T20:41:33.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-westvirginia 2020-06-22T20:40:51.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-newyork 2020-06-22T20:39:57.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-indiana 2020-06-22T20:39:14.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-iowa 2020-06-22T20:38:21.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-kansas 2020-06-22T20:37:33.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-missouri 2020-06-22T20:36:07.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-louisiana 2020-06-22T20:35:22.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-northcarolina 2020-06-22T20:33:18.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-montana 2020-06-22T20:32:16.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-minnesota 2020-06-22T20:31:40.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-colorado 2020-06-22T20:31:02.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-nevada 2020-06-22T20:30:17.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-southcarolina 2020-06-22T20:29:36.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-arizona 2020-06-22T20:28:53.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-tennessee 2020-06-22T20:28:12.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support-texas 2020-06-22T20:27:27.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-personalized-support 2020-06-22T20:26:32.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-selinexor-for-r-r-diffuse-large-b-cell-lymphoma 2020-06-22T17:01:41.000Z monthly 0.6 https://www.accc-cancer.org/view/curated-covid-19-resources-for-financial-advocates 2020-06-18T22:34:22.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-releases-preliminary-findings-from-survey-on-advanced-non-small-cell-lung-cancer-care 2020-06-18T20:32:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tazemetostat-for-r-r-follicular-lymphoma 2020-06-18T19:15:16.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-medicaid-nprm-aims-to-foster-value-based-payment-models-for-prescription-drugs 2020-06-17T22:51:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-treatment-of-tmb-h-solid-tumors 2020-06-17T15:42:11.000Z monthly 0.6 https://www.accc-cancer.org/view/maintaining-patient-connections-with-online-support-groups 2020-06-16T19:58:06.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-extends-indication-of-gemtuzumab-ozogamicin-to-newly-diagnosed-cd33-positive-aml-pediatric-patients 2020-06-16T15:47:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-lurbinectedin-for-metastatic-sclc 2020-06-16T15:39:25.000Z monthly 0.6 https://www.accc-cancer.org/view/immuno-oncology-in-2020 2020-06-16T14:32:10.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-personal-protection 2020-06-16T07:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-hpv-vaccine-gardasil-9-for-prevention-of-certain-head-neck-cancers 2020-06-15T17:02:09.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pegfilgrastim-apgf)-biosimilar-to-pegfilgrastim 2020-06-12T18:59:42.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-product-specific-j-code-for-adakveo 2020-06-12T16:10:10.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-for-previously-treated-advanced-scc 2020-06-11T17:51:40.000Z monthly 0.6 https://www.accc-cancer.org/view/astro-releases-new-clinical-guideline-for-radiation-therapy-to-treat-nonmetastatic-cervical-cancer 2020-06-10T20:35:52.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-improving-lung-cancer-care 2020-06-10T08:00:10.000Z monthly 0.6 https://www.accc-cancer.org/view/acs-updates-diet-and-physical-activity-guideline 2020-06-09T17:08:40.000Z monthly 0.6 https://www.accc-cancer.org/view/surgical-management-and-lymph-node-biopsy-of-rare-malignant-cutaneous-adnexal-carcinomas-a-population-based-analysis-of-7591-patients 2020-06-05T23:25:16.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-on-recent-events-impacting-our-communities 2020-06-05T15:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-for-adult-patients-with-metastatic-nsclc 2020-06-05T14:36:56.000Z monthly 0.6 https://www.accc-cancer.org/view/cmmi-adds-new-flexibilities-adjustments-to-oncology-care-model 2020-06-03T23:36:42.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-bevacizumab-for-previously-untreated-advanced-hcc 2020-06-02T16:32:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ramucirumab-erlotinib-for-first-line-treatment-of-metastatic-nsclc 2020-06-02T16:26:20.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-covid-19-vs-biocontainment 2020-06-02T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/leadership-panel-addresses-top-issues-in-cancer-care 2020-06-01T20:53:35.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-research-presented-at-asco-demonstrates-diverse-approaches-in-multidisciplinary-care 2020-05-29T18:06:29.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-improving-care-for-patients-with-stage-iii-iv-nsclc-learnings-for-multidisciplinary-teams-from-the-accc-national-quality-survey 2020-05-29T14:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-what-constitutes-high-quality-nsclc-care-overarching-quality-considerations-for-improving-nsclc-care-at-us-cancer-centers 2020-05-29T14:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/biomarker-live-using-consistent-terms-in-precision-medicine-to-eliminate-patient-confusion 2020-05-29T13:19:27.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-311763-resource-and-reimbursement-barriers-to-comprehensive-cancer-care-ccc-delivery-an-association-of-community-cancer-centers-accc-survey-research-analysis 2020-05-29T06:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-1526-brca-testing-concordance-with-national-guidelines-for-patients-with-breast-cancer-in-community-cancer-programs 2020-05-29T06:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-1575-population-genetic-screening-for-hereditary-breast-and-ovarian-cancer-in-at-risk-patients-a-novel-testing-and-prevention-model-for-community-hospitals-reveals-high-mutation-rates-rurally 2020-05-29T05:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/an-optimal-care-coordination-model-for-medicaid-patients-with-lung-cancer-lessons-learned-from-the-beta-testing-phase-of-a-multisite-initiative 2020-05-29T05:33:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-mourns-the-passing-of-john-w-yarbro-md-phd-accc-president-1984-1985 2020-05-28T20:19:20.000Z monthly 0.6 https://www.accc-cancer.org/view/pandemic-puts-financial-squeeze-on-patients 2020-05-28T16:32:09.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-ipilimumab-combo-as-1st-line-treatment-for-metastatic-nsclc 2020-05-27T15:01:55.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-immunotherapy-mental-health 2020-05-27T08:00:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pomalidomide-for-patients-with-aids-related-ks 2020-05-26T17:22:15.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-brigatinib-for-alk-positive-advanced-ncslc 2020-05-26T15:16:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olaparib-bevacizumab-as-maintenance-treatment-for-advanced-ovarian-cancer-1 2020-05-21T14:03:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olaparib-for-hrr-gene-mutated-mcrpc 2020-05-20T20:44:51.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-for-1st-line-treatment-in-some-advanced-nsclc 2020-05-19T17:42:29.000Z monthly 0.6 https://www.accc-cancer.org/view/new-name-for-takeda-oncology-patient-support-program 2020-05-19T14:16:59.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-covid-19-telemedicine 2020-05-19T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/twisting-out-cancer 2020-05-18T15:48:32.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ripretinib-for-previously-treated-advanced-gist 2020-05-15T23:22:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-rucaparib-for-pretreated-brca-mutated-mcrpc 2020-05-15T23:16:18.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-ipilimumab-combination-for-metastatic-nsclc 2020-05-15T23:06:34.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-pomalidomide-for-karposi-sarcoma 2020-05-15T17:39:34.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-asco-updated-guidelines-for-pegfilgrastim-cbqv 2020-05-14T21:02:50.000Z monthly 0.6 https://www.accc-cancer.org/view/astellas--covid-19-pandemic-response 2020-05-13T14:49:47.000Z monthly 0.6 https://www.accc-cancer.org/view/merck-s-response-to-covid-19 2020-05-13T14:12:07.000Z monthly 0.6 https://www.accc-cancer.org/view/covid-19-cancer-patient-registry-your-voice-matters 2020-05-12T20:01:57.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-capmatinib-tablets-for-metastatic-nsclc 2020-05-12T14:27:09.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-urban-cancer-care-during-covid-19 2020-05-12T05:00:06.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-darzalex-faspro-for-multiple-myeloma 2020-05-11T17:21:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olaparib-bevacizumab-as-maintenance-treatment-for-advanced-ovarian-cancer 2020-05-11T15:05:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-selpercatinib-for-lung-and-thyroid-cancers-with-ret-mutations-or-fusions 2020-05-11T13:42:12.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-interim-final-rule-2-covid-19-response-telehealth 2020-05-08T20:31:43.000Z monthly 0.6 https://www.accc-cancer.org/view/nursing-goes-back-to-basics 2020-05-07T15:39:56.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-capmatinib-for-adults-with-metastatic-nsclc 2020-05-06T19:15:01.000Z monthly 0.6 https://www.accc-cancer.org/view/the-year-of-the-nurse 2020-05-05T17:54:48.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-covid-19-rural-cancer-care 2020-05-05T11:00:10.000Z monthly 0.6 https://www.accc-cancer.org/view/nam-to-host-webinar-on-supporting-clinician-well-being-during-covid-19 2020-05-04T17:14:50.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-issues-emergency-use-authorization-for-remdesivir-for-severe-covid-19 2020-05-01T23:50:40.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-sweeping-regulatory-waivers-changes-to-further-expand-telehealth-options 2020-05-01T23:40:51.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-and-hyaluronidase-fihj-for-multiple-myeloma 2020-05-01T21:14:11.000Z monthly 0.6 https://www.accc-cancer.org/view/an-oncologist-s-prescription-for-managing-fear 2020-04-30T16:35:04.000Z monthly 0.6 https://www.accc-cancer.org/view/sanofi-genzyme-s-careassist-patient-assistance-program 2020-04-30T13:28:11.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-7765-improving-care-for-patients-with-advanced-non-small-cell-lung-cancer-findings-of-oncology-nurses-and-navigators-from-a-national-care-optimization-survey 2020-04-29T20:33:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-niraparib-for-frontine-maintenance-of-advanced-ovarian-cancer 2020-04-29T20:14:27.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tukysa-for-patients-with-her2-positive-metastatic-breast-cancer 2020-04-29T14:59:32.000Z monthly 0.6 https://www.accc-cancer.org/view/merck-broadens-patient-support-and-assistance-programs-as-part-of-overall-covid-19-relief-efforts 2020-04-29T13:05:38.000Z monthly 0.6 https://www.accc-cancer.org/view/biomarkerlive-project-from-the-association-of-community-cancer-centers-supports-providers-in-integration-of-precision-medicine-into-everyday-practice 2020-04-29T13:00:05.000Z monthly 0.6 https://www.accc-cancer.org/view/how-pfizer-oncology-together-is-addressing-patient-needs 2020-04-28T21:00:04.000Z monthly 0.6 https://www.accc-cancer.org/view/covid-19-healthcare-professional-information-update 2020-04-28T20:56:18.000Z monthly 0.6 https://www.accc-cancer.org/view/bms-patient-support-program-overview 2020-04-28T20:51:46.000Z monthly 0.6 https://www.accc-cancer.org/view/taked-oncology-1point-patient-support-program 2020-04-28T20:40:22.000Z monthly 0.6 https://www.accc-cancer.org/view/bms-patient-assistance-transportation-program 2020-04-28T20:29:49.000Z monthly 0.6 https://www.accc-cancer.org/view/genentech-s-response-to-covid-19 2020-04-28T20:27:48.000Z monthly 0.6 https://www.accc-cancer.org/view/abbvie-s-update-on-covid-19 2020-04-28T20:11:33.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-covid-19-music-therapy 2020-04-28T10:59:01.000Z monthly 0.6 https://www.accc-cancer.org/view/what-can-be-done 2020-04-27T19:58:03.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-re-evaluating-accelerated-payment-program-halting-advance-payment-program 2020-04-27T16:49:55.000Z monthly 0.6 https://www.accc-cancer.org/view/president-trump-signs-coronavirus-relief-package-bill 2020-04-24T19:57:08.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-oncology-announces-transition-of-ibrance--palbociclib--from-capsules-to-tablets 2020-04-24T13:55:20.000Z monthly 0.6 https://www.accc-cancer.org/view/house-passes-coronavirus-rescue-funding-package 2020-04-23T22:55:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-koselugo-for-neurofibromatosis-1-with-plexiform-neurofibromas 2020-04-23T17:53:32.000Z monthly 0.6 https://www.accc-cancer.org/view/immunotherapy-clinical-trials-during-covid-19 2020-04-23T17:15:26.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-launches-covid-19-workforce-virtual-toolkit 2020-04-22T19:32:56.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-sacituzumab-govitecan-hziy-in-previously-treated-metastatic-triple-negative-breast-cancer 2020-04-22T18:02:38.000Z monthly 0.6 https://www.accc-cancer.org/view/onc-cms-to-exercise-enforcement-discretion-for-interoperability-requirements 2020-04-22T17:49:18.000Z monthly 0.6 https://www.accc-cancer.org/view/senates-passes-emergency-funding-package-aimed-for-providers-and-small-businesses 2020-04-21T22:43:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ibrutinib-in-combination-with-rituximab-for-cll-or-sll 2020-04-21T20:18:15.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-drive-thru-covid-19-screening 2020-04-21T10:59:01.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-guidance-for-some-facilities-to-re-start-non-essential-services 2020-04-20T21:53:41.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pemigatinib-for-certain-unresectable-advanced-cholangiocarcinomas 2020-04-20T16:39:44.000Z monthly 0.6 https://www.accc-cancer.org/view/telehealth-billing-coding-during-covid-19 2020-04-20T15:58:01.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tucatinib-in-combination-for-advanced-her2-positive-breast-cancer 2020-04-17T20:18:25.000Z monthly 0.6 https://www.accc-cancer.org/view/white-house-guidance-suggests-phased-in-approach-for-easing-covid-19-restrictions 2020-04-17T19:46:20.000Z monthly 0.6 https://www.accc-cancer.org/view/bms-expands-patient-support-programs-for-newly-uninsured-patients-in-the-u-s 2020-04-17T19:41:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-eltrombopag-25-mg-powder-for-suspension-package-size 2020-04-17T18:59:15.000Z monthly 0.6 https://www.accc-cancer.org/view/covid-19-vidscrip 2020-04-16T19:32:41.000Z monthly 0.6 https://www.accc-cancer.org/view/trastuzumab-dttb-biosimilar-of-herceptin-launches-on-u.s.-market 2020-04-15T18:21:20.000Z monthly 0.6 https://www.accc-cancer.org/view/rural-cancer-care-during-a-pandemic 2020-04-14T21:44:09.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-covid-19-oral-oncolytics 2020-04-14T10:59:08.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-guidance-on-payer-covid-19-coverage 2020-04-13T15:20:10.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-launches-covid-19-registry 2020-04-13T14:22:11.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-starts-distribution-30-billion-dollars-in-provider-relief-funds 2020-04-10T19:30:58.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-adds-new-covid-19-workforce-flexibility-waivers 2020-04-10T16:38:54.000Z monthly 0.6 https://www.accc-cancer.org/view/no-change-to-open-payments-dispute-timeline-cms-says 2020-04-10T16:20:14.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-braftovi-in-combo-with-cetuximab-for-mcrc-with-braf-v600e-mutation 2020-04-09T17:14:53.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-updated-infection-control-guidance-for-inpatient-outpatient-care 2020-04-09T00:47:55.000Z monthly 0.6 https://www.accc-cancer.org/view/lessons-learned-from-cancer-patients 2020-04-07T21:44:12.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-patient-conversations-about-covid-19 2020-04-07T10:59:10.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-announces-upcoming-funding-to-provide-186-million-for-covid-19-response 2020-04-06T21:01:43.000Z monthly 0.6 https://www.accc-cancer.org/view/taking-care-in-a-pandemic 2020-04-03T21:44:21.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-clinical-research-during-the-covid-19-pandemic 2020-04-03T09:03:39.000Z monthly 0.6 https://www.accc-cancer.org/view/novartis-announces-new-c-code-for-adakveo-effective-april-1 2020-04-01T20:44:52.000Z monthly 0.6 https://www.accc-cancer.org/view/clinical-trials-covid-19-charting-new-territory 2020-03-31T18:47:03.000Z monthly 0.6 https://www.accc-cancer.org/view/mini-podcast-covid-19-self-care 2020-03-31T12:59:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-durvalumab-for-extensive-stage-small-cell-lung-cancer 2020-03-30T16:57:42.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-expands-accelerated-advance-payment-program-for-medicare-providers-suppliers 2020-03-30T00:35:31.000Z monthly 0.6 https://www.accc-cancer.org/view/president-trump-signs-cares-act 2020-03-27T21:22:27.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-13-financial-health-literacy 2020-03-25T12:44:03.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-announces-virtual-annual-meeting 2020-03-24T18:05:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-oce-message-to-oncology-providers-patients-on-covid-19 2020-03-24T16:19:08.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-faqs-on-medicare-provider-enrollment-relief-in-response-to-covid-19 2020-03-23T20:53:34.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-exceptions-extensions-for-quality-reporting-requirements 2020-03-23T20:05:02.000Z monthly 0.6 https://www.accc-cancer.org/view/staying-connected-in-an-uncertain-time 2020-03-20T20:18:00.000Z monthly 0.6 https://www.accc-cancer.org/view/waste-not-want-not 2020-03-18T22:32:46.000Z monthly 0.6 https://www.accc-cancer.org/view/amccbs-addresses-federal-healthcare-policy 2020-03-13T19:21:53.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-provides-faqs-on-essential-health-benefits-coverage-for-covid-19 2020-03-13T16:26:21.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-posts-fact-sheet-on-coverage-for-covid-19-tests 2020-03-13T15:00:41.000Z monthly 0.6 https://www.accc-cancer.org/view/report-to-the-nation-shows-overall-decline-in-cancer-death-rates 2020-03-12T19:57:08.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-guidance-to-help-ma-part-d-plans-respond-to-covid-19 2020-03-11T23:33:11.000Z monthly 0.6 https://www.accc-cancer.org/view/udenyca-well-prepared-to-meet-market-demand 2020-03-11T22:05:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-opdivo-plus-yervoy-combo-for-hcc-patients-previously-treated-with-sorafenib 2020-03-11T14:50:41.000Z monthly 0.6 https://www.accc-cancer.org/view/new-practice-models-new-tech-are-paving-the-future-of-cancer-care 2020-03-10T21:38:46.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-issues-final-interoperability-and-patient-access-rule 2020-03-10T20:11:08.000Z monthly 0.6 https://www.accc-cancer.org/view/-abstract-923-understanding-practices-and-gaps-in-multidisciplinary-hepatocellular-carcinoma-hcc-care-within-the-community-oncology-setting 2020-03-10T17:43:52.000Z monthly 0.6 https://www.accc-cancer.org/view/radiation-oncology-strategies-for-an-uncertain-future 2020-03-07T15:16:15.000Z monthly 0.6 https://www.accc-cancer.org/view/delivery-system-evolution-for-21st-century-cancer-care 2020-03-06T13:24:56.000Z monthly 0.6 https://www.accc-cancer.org/view/bringing-surgical-oncology-services-on-board 2020-03-05T07:54:17.000Z monthly 0.6 https://www.accc-cancer.org/view/mmr-msi-testing-guidelines-proposed-comments-due-march-13 2020-03-03T23:55:00.000Z monthly 0.6 https://www.accc-cancer.org/view/uspstf-new-guideline-calls-for-hcv-screening-for-adults-aged-18-to-79 2020-03-03T15:10:44.000Z monthly 0.6 https://www.accc-cancer.org/view/advocacy-in-action-anna-s-story 2020-03-02T20:37:15.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-sarclisa-for-relapsed-refractory-multiple-myeloma 2020-03-02T19:48:53.000Z monthly 0.6 https://www.accc-cancer.org/view/another-health-disparity-clinical-trials 2020-02-28T20:40:19.000Z monthly 0.6 https://www.accc-cancer.org/view/lung-cancer-screening-rates-still-low-cdc-reports 2020-02-28T17:14:46.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-12-what-s-trending-in-cancer-care 2020-02-26T14:45:10.000Z monthly 0.6 https://www.accc-cancer.org/view/cap-opens-comment-period-for-mmr-msi-testing-draft-recommendations 2020-02-24T22:26:19.000Z monthly 0.6 https://www.accc-cancer.org/view/building-a-case-for-registered-dietitian-nutritionists 2020-02-24T21:57:05.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-issues-final-report-on-reducing-administrative-regulatory-burden-of-hit-ehrs 2020-02-24T15:47:13.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-(accc)-46th-annual-meeting-cancer-center-business-summit-to-examine-most-important-topics-in-cancer-care-delivery-today 2020-02-21T13:55:49.000Z monthly 0.6 https://www.accc-cancer.org/view/enhancing-patient-care-by-promoting-health-literacy 2020-02-20T22:26:19.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-joins-coalition-letter-urging-inclusion-of-h-r-913-in-healthcare-extenders-package 2020-02-19T18:57:34.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-policy-update-part-2 2020-02-13T21:55:24.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-policy-update-part-1 2020-02-11T22:35:23.000Z monthly 0.6 https://www.accc-cancer.org/view/the-evolving-role-of-the-financial-navigator 2020-02-06T19:39:21.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-proposed-changes-to-medicare-advantage-part-d 2020-02-06T18:59:59.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-93-exploring-online-access-of-an-immuno-oncology-wallet-card-among-oncology-providers 2020-02-06T15:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-96-identifying-obstacles-to-optimal-integration-of-cancer-immunotherapies-in-the-community-setting 2020-02-06T15:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-quality-improvement-workshops-address-the-need-for-improved-chronic-lymphocytic-leukemia-care 2020-02-05T16:38:54.000Z monthly 0.6 https://www.accc-cancer.org/view/world-cancer-day-together-we-are-stronger 2020-02-04T17:28:57.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-host-mips-value-pathway-webinar 2020-02-03T15:58:11.000Z monthly 0.6 https://www.accc-cancer.org/view/immuno-oncology-brings-new-considerations-for-survivorship-care 2020-01-30T21:52:10.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-11-sustaining-whole-patient-cancer-care 2020-01-29T15:10:31.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-s-landmark-cancer-community-survey-turns-10 2020-01-28T19:07:04.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-coverage-of-ngs-diagnostic-tests 2020-01-28T14:57:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tazverik-for-advanced-epithelioid-sarcoma-in-adults-and-patients-aged-16-and-older 2020-01-24T17:04:19.000Z monthly 0.6 https://www.accc-cancer.org/view/kentucky-healthcare-system-reaches-lung-cancer-screening-milestone 2020-01-23T21:02:56.000Z monthly 0.6 https://www.accc-cancer.org/view/how-targeted-therapies-are-affecting-the-cancer-care-team-a-conversation-with-dr-firas-el-chaer 2020-01-21T19:02:00.000Z monthly 0.6 https://www.accc-cancer.org/view/rep-john-lewis-continues-his-fight-for-civil-rights-while-battling-cancer 2020-01-17T20:09:38.000Z monthly 0.6 https://www.accc-cancer.org/view/the-association-of-community-cancer-centers-welcomes-colleen-cancio-to-the-development-team 2020-01-17T18:30:00.000Z monthly 0.6 https://www.accc-cancer.org/view/virtual-toxicity-team-cleveland-clinic 2020-01-17T16:50:01.000Z monthly 0.6 https://www.accc-cancer.org/view/virtual-toxicity-team-jefferson-health 2020-01-17T16:50:01.000Z monthly 0.6 https://www.accc-cancer.org/view/practice-profiles-johns-hopkins 2020-01-17T16:49:53.000Z monthly 0.6 https://www.accc-cancer.org/view/gao-report-calls-for-more-oversight-of-340b-hospital-eligibility 2020-01-15T20:35:21.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-10-the-immunotherapy-patient-perspective 2020-01-15T15:12:13.000Z monthly 0.6 https://www.accc-cancer.org/view/update-to-asco-cap-guideline-on-er-and-pgr-testing-in-breast-cancer 2020-01-14T19:53:41.000Z monthly 0.6 https://www.accc-cancer.org/view/io-institute-roundtable-focuses-on-telemedicine-solutions 2020-01-13T22:16:28.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-applauds-oncology-care-providers-for-contribution-record-drop-cancer-deaths 2020-01-10T22:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-avapritinib-for-gist-subset 2020-01-10T00:21:08.000Z monthly 0.6 https://www.accc-cancer.org/view/acs-report-finds-largest-one-year-drop-in-cancer-deaths 2020-01-09T17:44:54.000Z monthly 0.6 https://www.accc-cancer.org/view/bolstering-patient-care-with-decision-support-tools 2020-01-09T16:18:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-treatment-of-subset-of-bladder-cancer-patients 2020-01-08T23:31:59.000Z monthly 0.6 https://www.accc-cancer.org/view/targeting-the-patient-as-consumer-for-better-outcomes 2020-01-06T22:46:06.000Z monthly 0.6 https://www.accc-cancer.org/view/perspective-on-managing-immune-related-adverse-events 2019-12-30T22:56:59.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olaparib-for-pancreatic-cancer 2019-12-30T16:19:28.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-9-the-front-lines-of-rural-cancer-care 2019-12-26T09:00:05.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-enhertu-for-previously-treated-unresectable-or-metastatic-her2-breast-cancer 2019-12-20T23:54:35.000Z monthly 0.6 https://www.accc-cancer.org/view/is-oncology-care-ripe-for-disruption 2019-12-20T18:43:22.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-responds-to-cmmi-rfi-on-oncology-care-first-model 2019-12-19T19:37:59.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-padcev-(enfortumab-vedotin-ejfv)-for-advanced-urothelial-cancer 2019-12-19T16:41:14.000Z monthly 0.6 https://www.accc-cancer.org/view/publication-survivorship-care-plans-for-patients-receiving-immunotherapy 2019-12-18T20:48:50.000Z monthly 0.6 https://www.accc-cancer.org/view/trump-administration-issues-proposed-rule-on-importation-of-prescription-drugs 2019-12-18T15:42:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-enzalutamide-for-metastatic-castration-sensitive-prostate-cancer 2019-12-17T18:20:01.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-calls-attention-to-importance-of-geriatric-assessment-in-caring-for-older-adults-with-cancer 2019-12-16T23:47:14.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-extends-open-enrollment-deadline-to-dec.-18 2019-12-16T23:38:15.000Z monthly 0.6 https://www.accc-cancer.org/view/pursuing-quality-cancer-care-for-sexual-and-gender-minority-patients 2019-12-16T21:35:24.000Z monthly 0.6 https://www.accc-cancer.org/view/senate-confirms-dr.-stephen-hahn-as-u.s.-fda-commissioner 2019-12-12T20:07:17.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-stays-the-course 2019-12-12T19:27:19.000Z monthly 0.6 https://www.accc-cancer.org/view/inside-health-policy-reports-cms-to-repay-hospitals-for-2019-site-neutral-pay-cut 2019-12-12T18:43:36.000Z monthly 0.6 https://www.accc-cancer.org/view/astro-issues-new-clinical-guideline-for-radiation-therapy-for-bcc-and-cscc 2019-12-10T21:11:43.000Z monthly 0.6 https://www.accc-cancer.org/view/supporting-survivors-with-exercise-and-nutrition-programs 2019-12-09T22:26:05.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-updates-genetic-testing-guidelines-for-assessing-breast-ovarian-and-pancreatic-cancer-risk 2019-12-06T16:21:36.000Z monthly 0.6 https://www.accc-cancer.org/view/a-weekend-of-their-own 2019-12-05T21:37:51.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-plus-chemotherapy-for-metastatic-non-squamous-nsclc 2019-12-04T18:37:29.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-experts-explore-strategies-for-navigating-step-therapy 2019-12-02T21:26:22.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-project-focuses-on-multidisciplinary-cutaneous-squamous-cell-carcinoma-care 2019-12-02T15:08:11.000Z monthly 0.6 https://www.accc-cancer.org/view/lecture-series-explores-fail-first-approach-to-cutting-cancer-costs 2019-11-27T20:10:12.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-dec.-5-webinar-on-cy2020-medicare-final-payment-rules 2019-11-27T16:21:43.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-8-immunotherapy-and-emergency-medicine 2019-11-27T09:00:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-reblozyl-for-anemia-in-adults-with-beta-thalassemia 2019-11-25T18:43:54.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-new-treatment-option-for-cll-under-international-collaboration 2019-11-21T19:36:03.000Z monthly 0.6 https://www.accc-cancer.org/view/celebrate-movember 2019-11-21T16:30:11.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-plans-dec.-3-call-on-hospital-price-transparency-final-rule 2019-11-21T14:38:02.000Z monthly 0.6 https://www.accc-cancer.org/view/step-therapy-in-oncology-it-s-complicated 2019-11-18T21:23:22.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-rules-on-price-transparency-for-hospitals-and-health-insurance-issuers 2019-11-15T16:45:41.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-accelerated-approval-to-zanubrutinib-for-mantle-cell-lymphoma 2019-11-15T15:39:20.000Z monthly 0.6 https://www.accc-cancer.org/view/the-hairstylist-melanoma-challenge 2019-11-14T20:48:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-honors-ethan-basch-md-msc-with-clinical-research-award 2019-11-13T20:39:57.000Z monthly 0.6 https://www.accc-cancer.org/view/perspective-on-the-modern-cancer-patient 2019-11-12T15:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-presents-annual-achievement-award-posthumously-to-arti-hurria-md-fasco 2019-11-11T21:09:18.000Z monthly 0.6 https://www.accc-cancer.org/view/cmmi-extends-ocf-comment-deadline 2019-11-07T19:56:22.000Z monthly 0.6 https://www.accc-cancer.org/view/acp-issues-new-guidance-for-colorectal-cancer-screening 2019-11-06T18:52:02.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-office-of-hematology-oncology-products-now-called-office-of-oncologic-diseases 2019-11-06T18:10:35.000Z monthly 0.6 https://www.accc-cancer.org/view/why-the-stories-we-tell-matter 2019-11-05T23:42:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-biosimilar-ziextenzo-(pegfilgrastim-bmez) 2019-11-05T16:47:19.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-honors-seven-cancer-programs-with-innovator-awards-at-36th-national-oncology-conference 2019-11-04T21:17:05.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-informal-rfi-on-oncology-care-first-model 2019-11-04T15:52:56.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-hold-nov--6-call-on-pfs-and-opps-final-rules 2019-11-04T15:33:19.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-cy-2020-final-medicare-payment-rules 2019-11-01T22:20:40.000Z monthly 0.6 https://www.accc-cancer.org/view/36th-national-oncology-conference-opener-how-to's-for-deconstructing-team-drama 2019-11-01T13:28:46.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-pre-conference-affirms-growing-role-of-the-financial-navigator 2019-10-31T12:22:39.000Z monthly 0.6 https://www.accc-cancer.org/view/evolving-oncology-pharmacy-practice-in-value-based-environment 2019-10-31T05:41:19.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-7-the-evolution-of-oncology-pharmacy 2019-10-29T14:49:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-niraparib-for-hrd-positive-advanced-ovarian-cancer 2019-10-24T15:38:42.000Z monthly 0.6 https://www.accc-cancer.org/view/cosponsors-for-h.r.-3502-surprise-billing-legislation-reach-102 2019-10-24T15:21:15.000Z monthly 0.6 https://www.accc-cancer.org/view/blood-cancer-patients-covered-by-medicare-often-delay-or-skip-treatment-study-finds 2019-10-23T22:09:29.000Z monthly 0.6 https://www.accc-cancer.org/view/nam-issues-report-on-systems-approach-to-supporting-clinician-well-being 2019-10-23T21:05:31.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-celebrates-american-pharmacists-month 2019-10-22T17:00:14.000Z monthly 0.6 https://www.accc-cancer.org/view/cmmi-plans-public-listening-session-on-potential-future-oncology-payment-model 2019-10-17T22:40:01.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-36th-national-oncology-conference-provides-how-to-strategies-for-the-cancer-care-team 2019-10-16T14:30:00.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-6-clinical-trial-access-in-rural-areas 2019-10-16T14:08:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fighting-cancer-at-the-molecular-level 2019-10-15T18:34:46.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-october-14-2019 2019-10-14T04:00:05.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-joins-in-letter-urging-cms-to-protect-timely-patient-access-to-advanced-diagnostics 2019-10-10T14:43:27.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-metastatic-breast-cancer-summit-addresses-resource-disparities 2019-10-09T18:30:19.000Z monthly 0.6 https://www.accc-cancer.org/view/three-scientists-receive-nobel-prize-in-medicine-for-work-on-cells-and-oxygen 2019-10-07T20:01:11.000Z monthly 0.6 https://www.accc-cancer.org/view/hiring-a-genetic-counselor-in-a-lean-labor-market 2019-10-01T18:35:06.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-comments-to-cms-on-proposed-2020-opps-pfs-rules 2019-09-30T12:21:25.000Z monthly 0.6 https://www.accc-cancer.org/view/backyard-gardening-rx-for-cancer-survivors 2019-09-27T15:09:24.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-in-combination-for-frontline-multiple-myeloma 2019-09-26T19:29:38.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-5-rural-cancer-care 2019-09-25T13:22:56.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-non-invasive-crc-screening-test-for-eligible-individuals-ages-45-to-49 2019-09-24T17:54:13.000Z monthly 0.6 https://www.accc-cancer.org/view/whose-burnout-is-it 2019-09-23T20:51:54.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-comments-to-cms-on-proposed-ro-model 2019-09-23T17:19:13.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-september-23-2019 2019-09-23T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/pelosi-unveils-price-negotiation-bill-similar-to-draft-plan 2019-09-19T16:42:58.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-progress-report-finds-record-number-of-approvals-for-cancer-treatments 2019-09-18T19:29:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-apalutamide-for-certain-metastatic-prostate-cancers 2019-09-18T16:01:51.000Z monthly 0.6 https://www.accc-cancer.org/view/under-project-orbis-collaboration-initiative-fda-approves-new-treatment-for-endometrial-carcinoma 2019-09-17T18:23:05.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-consumer-information-on-respiratory-illnesses-associated-with-vaping-products 2019-09-13T13:00:21.000Z monthly 0.6 https://www.accc-cancer.org/view/have-you-heard-the-latest-buzz 2019-09-12T16:32:32.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-survivorship-care-after-immunotherapy 2019-09-11T13:37:58.000Z monthly 0.6 https://www.accc-cancer.org/view/september-is-blood-cancer-awareness-month 2019-09-10T19:12:42.000Z monthly 0.6 https://www.accc-cancer.org/view/-abstract-186-multidisciplinary-cancer-teams-and-utilization-of-resources-for-metastatic-breast-cancer-mbc-a-landscape-analysis 2019-09-07T20:01:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-support-for-florida-in-preparation-for-hurricane-dorian 2019-08-30T21:08:04.000Z monthly 0.6 https://www.accc-cancer.org/view/they-re-here-cancer-biosimilars-enter-u.s.-market 2019-08-30T19:59:28.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-3-why-comprehensive-cancer-care-services-matter 2019-08-28T17:44:38.000Z monthly 0.6 https://www.accc-cancer.org/view/from-top-gun-to-top-doc 2019-08-27T20:43:25.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-august-26-2019 2019-08-26T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/age-disparities-in-cancer-clinical-trials-continue-to-grow 2019-08-23T18:28:37.000Z monthly 0.6 https://www.accc-cancer.org/view/uspstf-updates-recommendation-on-screening-counseling-testing-for-brca-related-cancer 2019-08-20T21:14:03.000Z monthly 0.6 https://www.accc-cancer.org/view/virtual-multidisciplinary-conference-expands-patient-access-to-specialists 2019-08-16T18:41:10.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-fedratinib-for-intermediate-2-or-high-risk-myelofibrosis 2019-08-16T15:07:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-entrectinib-for-adults-with-ros1-positive-metastatic-nsclc 2019-08-16T14:50:54.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-acalabrutinib--calquence--breakthrough-therapy-designation 2019-08-15T18:21:23.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-august-12-2019 2019-08-12T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/long-awaited-much-debated-proposed-opps-pfs-rules 2019-08-09T18:01:01.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-finalizes-ncd-for-car-t-cell-therapy 2019-08-07T22:11:50.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-debuts-cancer-buzz-podcast 2019-08-06T21:39:59.000Z monthly 0.6 https://www.accc-cancer.org/view/post-learning-lab-a-focus-on-metrics-data-and-common-ground 2019-08-01T20:50:30.000Z monthly 0.6 https://www.accc-cancer.org/view/new-nccn-guidelines-address-small-intestine-cancers 2019-08-01T19:26:09.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-issues-plan-outlining-2-paths-for-prescription-drug-importation 2019-07-31T14:49:05.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-episode-2-fostering-cancer-care-team-resiliency-well-being 2019-07-31T14:43:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-pd-l1-positive-advanced-scc-of-esophagus 2019-07-31T14:19:27.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-darolutamide-for-non-metastatic-castration-resistant-prostate-cancer 2019-07-31T14:03:10.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-proposed-2020-opps-and-pfs-rules 2019-07-29T22:32:35.000Z monthly 0.6 https://www.accc-cancer.org/view/learning-labs-assessing-improving-financial-advocacy-services 2019-07-29T21:36:10.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-july-29-2019 2019-07-29T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-requests-recall-of-certain-textured-breast-implants 2019-07-24T17:37:20.000Z monthly 0.6 https://www.accc-cancer.org/view/senate-finance-committee-reveals-drug-pricing-legislation 2019-07-24T16:24:28.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ruxience-(rituximab-pvvr)-for-adult-nhl-cll-some-auto-immune-conditions 2019-07-24T15:21:20.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-members-respond-to-coc-s-draft-standards 2019-07-22T19:53:09.000Z monthly 0.6 https://www.accc-cancer.org/view/acs-launches-geriatric-surgery-verification-program 2019-07-22T13:44:13.000Z monthly 0.6 https://www.accc-cancer.org/view/post-learning-lab-broader-stakeholder-engagement-proactive-steps 2019-07-18T15:53:02.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-proposes-cy-2020-2021-new-home-infusion-therapy-benefit 2019-07-18T13:48:02.000Z monthly 0.6 https://www.accc-cancer.org/view/learning-lab-focuses-on-better-integration-of-patient-financial-advocacy-services 2019-07-15T21:31:05.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-summary-of-ro-model-highlights-key-considerations 2019-07-15T19:11:56.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-july-15-2019 2019-07-15T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/administration-withdraws-proposed-drug-rebate-rule 2019-07-11T15:18:54.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-proposed-radiation-oncology-model-rule 2019-07-10T18:55:51.000Z monthly 0.6 https://www.accc-cancer.org/view/take-action-tell-congress-to-support-the-clinical-treatment-act 2019-07-09T17:57:20.000Z monthly 0.6 https://www.accc-cancer.org/view/partnering-to-address-food-insecurity 2019-07-08T21:05:02.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-selinexor-for-multiple-myeloma 2019-07-03T19:39:47.000Z monthly 0.6 https://www.accc-cancer.org/view/information-on-pembrolizumab--keytruda--dosing-testing-requirements 2019-07-03T17:16:25.000Z monthly 0.6 https://www.accc-cancer.org/view/healthcare-costs-are-high-but-even-higher-for-cancer-survivors 2019-07-01T17:46:11.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-july-1-2019 2019-07-01T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-for-multiple-myeloma-ineligible-for-autologous-stem-cell-transplant 2019-06-28T22:38:37.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-bevacizumab-bvzr-(zirabev-)-avastin-biosimilar 2019-06-28T15:29:05.000Z monthly 0.6 https://www.accc-cancer.org/view/podcast-zeroing-in-on-patient-symptom-management 2019-06-26T17:23:00.000Z monthly 0.6 https://www.accc-cancer.org/view/bringing-genetic-testing-closer-to-home 2019-06-26T14:22:12.000Z monthly 0.6 https://www.accc-cancer.org/view/senate-help-committee-more-drug-pricing-reform-measures-to-s.1895 2019-06-25T21:12:12.000Z monthly 0.6 https://www.accc-cancer.org/view/president-trump-signs-executive-order-requiring-healthcare-price-disclosure 2019-06-25T17:12:39.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-geriatric-assessment-adoption-in-community-cancer-centers-trends-barriers-and-recommendations 2019-06-22T19:51:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-metastatic-sclc 2019-06-18T15:31:00.000Z monthly 0.6 https://www.accc-cancer.org/view/diagnosis-in-prime-time 2019-06-17T20:03:17.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-june-17-2019 2019-06-17T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-biosimilar-trastuzumab-anns-for-all-reference-product-indications 2019-06-14T14:12:08.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-joins-in-comment-letter-on-medicare-ngs-ncd 2019-06-13T21:53:13.000Z monthly 0.6 https://www.accc-cancer.org/view/making-the-workplace-a-drama-free-zone 2019-06-13T20:19:06.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-joins-in-support-for-s.-946-legislation-to-improve-access-to-clinical-trials 2019-06-11T19:52:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-first-line-pembrolizumab-for-metastatic-or-unresectable-hnscc 2019-06-11T17:04:14.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-collaborates-with-astrazeneca-to-launch-national-initiative-to-support-quality-care-initiative-for-stage-iii-and-iv-non-small-cell-lung-cancer 2019-06-11T16:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/her-best-resort 2019-06-10T21:42:02.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-polatuzumab-vedotin-piiq-br-for-diffuse-large-b-cell-lymphoma 2019-06-10T16:49:06.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-financial-toxicity-and-cancer-proactive-screening-assessment-and-treatment 2019-06-07T18:51:00.000Z monthly 0.6 https://www.accc-cancer.org/view/ma-prior-auth-bill-would-simplify-process-increase-transparency 2019-06-06T20:37:48.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-rfi-on-reducing-administrative-burden 2019-06-06T17:45:36.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-congratulates-krista-nelson-msw-lcsw-osw-c-bcd-recipient-of-leadership-in-oncology-social-work-award 2019-06-06T15:16:49.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-chief-learning-officer-amanda-kramar-named-40-under-40-in-cancer-awardee 2019-06-04T20:31:21.000Z monthly 0.6 https://www.accc-cancer.org/view/proactive-precertification-pays-off 2019-06-03T20:40:06.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-june-3-2019 2019-06-03T11:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/young-adult-patients-tap-into-long-distance-support 2019-05-30T18:15:45.000Z monthly 0.6 https://www.accc-cancer.org/view/annual-cancer-report-to-the-nation-overall-cancer-mortality-decline-continues 2019-05-30T17:11:17.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lenalidomide-in-combination-for-follicular-and-marginal-zone-lymphoma 2019-05-28T19:34:49.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-care-reimagined 2019-05-28T19:20:02.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-alpelisib-for-metastatic-breast-cancer 2019-05-28T14:19:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ruxolitinib-for-acute-graft-versus-host-disease 2019-05-24T18:26:28.000Z monthly 0.6 https://www.accc-cancer.org/view/don-t-fry-this-friday-or-any-other-day 2019-05-23T20:35:40.000Z monthly 0.6 https://www.accc-cancer.org/view/radiation-oncology-apm-sooner-or-later 2019-05-23T19:37:28.000Z monthly 0.6 https://www.accc-cancer.org/view/administration-slows-timeline-for-ipi-rebate-regulatory-action 2019-05-23T19:14:43.000Z monthly 0.6 https://www.accc-cancer.org/view/verma-car-t-ncd-new-ground-for-cms-agency-needs-more-time 2019-05-23T18:44:22.000Z monthly 0.6 https://www.accc-cancer.org/view/there-s-an-app-for-that 2019-05-20T14:50:35.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-finalized-medicare-advantage-part-d-rule 2019-05-17T14:56:09.000Z monthly 0.6 https://www.accc-cancer.org/view/geriatric-assessment-one-size-does-not-fit-all 2019-05-16T21:25:30.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-venetoclax-plus-obinutuzumab-for-cll-and-sll 2019-05-15T20:16:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-avelumab-plus-axitinb-for-advanced-rcc 2019-05-15T14:00:53.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-issues-final-guidance-to-manufacturers-on-biosimilars'-pathway-to-interchangeability 2019-05-13T21:38:48.000Z monthly 0.6 https://www.accc-cancer.org/view/polypharmacy-the-other-drug-problem 2019-05-13T20:41:44.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-may-13-2019 2019-05-13T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ramucirumab-for-hcc 2019-05-10T20:01:12.000Z monthly 0.6 https://www.accc-cancer.org/view/technology-s-role-in-streamlining-financial-advocacy 2019-05-06T20:49:53.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ado-trastuzumab-emtansine-for-her2-breast-cancer 2019-05-03T21:05:41.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ivosidenib-for-aml 2019-05-03T13:41:09.000Z monthly 0.6 https://www.accc-cancer.org/view/here-comes-the-sun 2019-05-02T21:27:51.000Z monthly 0.6 https://www.accc-cancer.org/view/aua-releases-new-guidance-for-testicular-cancer-radiotherapy-after-prostatectomy 2019-05-02T17:51:40.000Z monthly 0.6 https://www.accc-cancer.org/view/acs-more-than-half-of-americans-report-medical-financial-hardship 2019-05-02T17:43:07.000Z monthly 0.6 https://www.accc-cancer.org/view/managing-io-toxicities-three-keys-to-success 2019-05-01T15:15:52.000Z monthly 0.6 https://www.accc-cancer.org/view/communication-key-to-addressing-toxicity-and-recurrence-risks 2019-05-01T15:15:43.000Z monthly 0.6 https://www.accc-cancer.org/view/predictive-modeling-to-inform-io-regimen-choice 2019-05-01T14:14:19.000Z monthly 0.6 https://www.accc-cancer.org/view/the-oncology-pharmacist's-role-in-io-delivery 2019-05-01T14:12:18.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-april-29-2019 2019-04-29T19:01:00.000Z monthly 0.6 https://www.accc-cancer.org/view/enabling-fertility-discussions-with-young-adult-male-oncology-patients 2019-04-29T18:59:09.000Z monthly 0.6 https://www.accc-cancer.org/view/assessing-the-unique-needs-of-geriatric-patients-with-cancer 2019-04-25T16:57:03.000Z monthly 0.6 https://www.accc-cancer.org/view/aha-releases-scientific-statement-on-cardio-oncology-rehabilitation 2019-04-25T14:53:13.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-ipps-proposed-rule 2019-04-23T21:24:52.000Z monthly 0.6 https://www.accc-cancer.org/view/illustrating-the-patient-experience-a-graphic-artists-cancer-narrative 2019-04-22T14:42:33.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-axitinib-for-advanced-renal-cell-carcinoma 2019-04-22T14:08:21.000Z monthly 0.6 https://www.accc-cancer.org/view/nih-foa-optimizing-management-outcomes-for-survivors-transiting-to-follow-up-care 2019-04-17T22:36:41.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-cancer-care-for-geriatric-patients 2019-04-17T19:50:30.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-and-ash-updated-guidelines-for-managing-biosimilar-esas 2019-04-17T18:01:42.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-erdafitinib-for-metastatic-urothelial-carcinoma 2019-04-12T18:44:12.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-pembrolizumab-indication-to-include-first-line-nsclc-treatment 2019-04-12T14:03:02.000Z monthly 0.6 https://www.accc-cancer.org/view/combatting-fatigue-with-exercise-a-pilot-study 2019-04-11T20:15:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-palbociclib-use-to-include-male-breast-cancer-patients 2019-04-05T14:22:03.000Z monthly 0.6 https://www.accc-cancer.org/view/special-age-related-challenges-of-an-all-diagnosis 2019-04-04T18:15:47.000Z monthly 0.6 https://www.accc-cancer.org/view/more-from-accc-45th-annual-meeting-cancer-center-business-summit 2019-03-29T16:57:43.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-proposes-policy-changes-to-update-mammography-services 2019-03-27T21:47:42.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-updates-colorectal-cancer-guidelines-to-include-braftovi-and-mektovi 2019-03-26T16:13:28.000Z monthly 0.6 https://www.accc-cancer.org/view/the-digital-health-revolution 2019-03-22T21:13:38.000Z monthly 0.6 https://www.accc-cancer.org/view/the-power-of-creativity-dr.-mayer-hope-explores-the-intersection-of-art-and-medicine 2019-03-22T18:25:14.000Z monthly 0.6 https://www.accc-cancer.org/view/seeing-with-new-eyes-the-future-is-what-we-make-it 2019-03-21T19:12:04.000Z monthly 0.6 https://www.accc-cancer.org/view/radiation-oncology-pre-conference-spotlight-on-change 2019-03-21T18:42:55.000Z monthly 0.6 https://www.accc-cancer.org/view/bringing-surgical-oncology-services-to-your-community-cancer-center 2019-03-21T00:01:19.000Z monthly 0.6 https://www.accc-cancer.org/view/making-our-voices-heard-capitol-hill-day-2019 2019-03-20T22:16:53.000Z monthly 0.6 https://www.accc-cancer.org/view/hcpcs-assigns-j-code-and-asp-for-imfinzi 2019-03-19T17:50:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-for-small-cell-lung-cancer 2019-03-19T13:53:23.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-annual-meeting-cancer-center-business-summit-will-bring-future-into-focus 2019-03-15T12:09:50.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-updates-drug-dashboards-wiith-drug-pricing-and-spending 2019-03-14T18:49:57.000Z monthly 0.6 https://www.accc-cancer.org/view/nci-director-appointed-as-acting-commissioner-of-fda 2019-03-12T17:03:36.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-trastuzumab-qyyp-as-biosimilar-to-herceptin 2019-03-12T15:03:42.000Z monthly 0.6 https://www.accc-cancer.org/view/leveraging-technology-for-coordinated-consistent-patient-education 2019-03-11T13:53:47.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-plus-nab-paclitaxel-for-tnbc 2019-03-08T20:07:37.000Z monthly 0.6 https://www.accc-cancer.org/view/changes-ahead-resilience-helps-make-the-leap 2019-03-07T16:31:35.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-seeks-suggestions-for-eliminating-barriers-to-selling-health-insurance-across-state-lines 2019-03-06T23:01:28.000Z monthly 0.6 https://www.accc-cancer.org/view/extinguishing-burnout-step-1-awareness 2019-03-04T20:32:55.000Z monthly 0.6 https://www.accc-cancer.org/view/smoldering-burnout-among-cancer-care-team-members 2019-03-01T18:14:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-trastuzumab-and-hyaluronidase-oysk-for-breast-cancer 2019-02-28T17:14:32.000Z monthly 0.6 https://www.accc-cancer.org/view/you've-got-to-have-heart-creating-a-cardio-oncology-program-in-the-community 2019-02-28T15:05:45.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-trifluridine-and-tipiracil-for-gastric-gej-adenocarcinoma 2019-02-25T18:33:52.000Z monthly 0.6 https://www.accc-cancer.org/view/dr.-joanie-mayer-hope-the-healing-power-of-music 2019-02-25T17:48:59.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-brings-dr.-hope-to-dc 2019-02-21T19:04:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-melanoma 2019-02-19T16:07:44.000Z monthly 0.6 https://www.accc-cancer.org/view/mips-more-support-for-radiation-oncology 2019-02-18T18:09:45.000Z monthly 0.6 https://www.accc-cancer.org/view/asbs-recommends-genetic-testing-for-all-breast-cancer-patients 2019-02-15T15:59:42.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-proposed-ncd-for-car-t-cell-therapy 2019-02-15T15:24:11.000Z monthly 0.6 https://www.accc-cancer.org/view/incorporating-health-literacy-in-all-patient-education 2019-02-14T14:51:56.000Z monthly 0.6 https://www.accc-cancer.org/view/minimal-residual-disease-in-adult-all 2019-02-11T13:05:01.000Z monthly 0.6 https://www.accc-cancer.org/view/the-art-of-managing-all 2019-02-05T18:26:21.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-joins-groups-expressing-concerns-over-cms'-interpretation-of-ncd-for-ngs 2019-02-04T19:50:02.000Z monthly 0.6 https://www.accc-cancer.org/view/accc's-new-publication-helps-provide-insights-to-incorporate-cancer-immunotherapies-into-practice 2019-02-04T16:52:29.000Z monthly 0.6 https://www.accc-cancer.org/view/world-cancer-day-spreading-awareness-sharing-hope 2019-02-04T16:12:45.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-proposes-rule-to-end-middleman-drug-pricing-rebates 2019-02-01T16:51:06.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pemetrexed-for-metastatic-nsclc 2019-01-31T14:26:34.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-hold-two-webinars-on-part-d-payment-modernization-model 2019-01-29T20:25:37.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ibrutinib-plus-obinutuzumab-for-cll-sll 2019-01-28T15:07:22.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-joins-in-letter-to-cms-expressing-concerns-with-proposed-part-d-ma-rule 2019-01-25T23:30:29.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-establishing-a-multi-location-quality-improvement-initiative 2019-01-24T21:19:00.000Z monthly 0.6 https://www.accc-cancer.org/view/medicare-coverage-established-for-mrd-testing-for-all-multiple-myeloma 2019-01-23T17:27:02.000Z monthly 0.6 https://www.accc-cancer.org/view/member-monday-january-21-2019 2019-01-21T21:02:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-third-biosimilar-to-trastuzumab 2019-01-18T21:21:01.000Z monthly 0.6 https://www.accc-cancer.org/view/-abstract-390-understanding-practices-and-gaps-in-multidisciplinary-hepatocellular-carcinoma-hcc-care-within-the-community-oncology-setting 2019-01-18T21:15:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cmmi-to-test-part-d-payment-model-update-to-ma-vbid-model 2019-01-18T17:03:52.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-2018-survey-finds-multiple-barriers-to-cancer-program-growth 2019-01-16T21:09:33.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cabozantinib-for-previously-treated-hcc 2019-01-15T18:07:06.000Z monthly 0.6 https://www.accc-cancer.org/view/speak-out-accc-capitol-hill-day-2019 2019-01-14T18:21:33.000Z monthly 0.6 https://www.accc-cancer.org/view/u.s.-cancer-death-rate-continues-25-year-decline-acs-report-finds 2019-01-08T23:40:27.000Z monthly 0.6 https://www.accc-cancer.org/view/cancer-and-telemedicine 2019-01-04T20:28:47.000Z monthly 0.6 https://www.accc-cancer.org/view/checkpoint-inhibitors-for-those-with-complex-medical-needs 2019-01-04T19:46:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-intestinal-microbiome-and-cancer-immunotherapy 2019-01-04T19:02:00.000Z monthly 0.6 https://www.accc-cancer.org/view/big-data-deep-analytics-better-outcomes 2019-01-04T18:52:48.000Z monthly 0.6 https://www.accc-cancer.org/view/virtual-navigation-to-clinical-trials 2019-01-04T12:12:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-opens-data-submission-period-for-mips-eligible-clinicians 2019-01-03T15:52:20.000Z monthly 0.6 https://www.accc-cancer.org/view/what-just-happened-2018 2018-12-31T21:31:46.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-tagraxofusp-erzs-for-blastic-plasmacytoid-dendritic-cell-neoplasm 2018-12-26T14:41:10.000Z monthly 0.6 https://www.accc-cancer.org/view/hyperprogressive-disease-in-patients-treated-with-pd-1-pd-l1-inhibitors 2018-12-20T21:21:36.000Z monthly 0.6 https://www.accc-cancer.org/view/clinical-application-of-tumor-pseudoprogression-in-patients-treated-with-immunotherapy 2018-12-20T21:21:36.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-calaspargase-pegol-mknl-for-pediatric-aya-all 2018-12-20T20:18:17.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olaparib-for-ovarian-fallopian-peritoneal-cancers 2018-12-19T21:35:03.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-merkel-cell-carcinoma 2018-12-19T21:31:36.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-assigns-unique-hcpcs-code-for-imfinzi 2018-12-19T15:01:03.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-issues-policy-statement-on-administration's-medicare-advantage-part-d-proposal-to-tackle-drug-prices 2018-12-17T15:48:06.000Z monthly 0.6 https://www.accc-cancer.org/view/lee-s-legacy 2018-12-17T15:20:44.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-trastuzumab-pkrb-for-treatment-of-her2-positive-breast-cancer 2018-12-17T14:07:55.000Z monthly 0.6 https://www.accc-cancer.org/view/ptac-votes-to-recommend-mason-model 2018-12-12T21:21:32.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-signs-letter-opposing-proposed-medicare-part-b-ipi-model 2018-12-11T16:56:39.000Z monthly 0.6 https://www.accc-cancer.org/view/the-association-of-community-cancer-centers-welcomes-leigh-m.-boehmer-pharmd-bcop-as-medical-director-education 2018-12-11T15:15:04.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-assigns-new-j-codes-for-rituxan-and-rituxan-hycela 2018-12-07T18:02:19.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-atezolizumab-for-metastatic-nsq-nsclc 2018-12-07T15:13:14.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-strengthens-federal-support-to-alaska-following-earthquake 2018-12-06T18:21:28.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-and-pfizer-award-$1.8-million-in-funding-for-quality-improvement-in-breast-cancer-care-through-evidence-based-brca-genetic-testing 2018-12-05T20:31:48.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-mourns-the-loss-of-lee-e.-mortenson-dpa-mpa-ms 2018-12-05T15:18:36.000Z monthly 0.6 https://www.accc-cancer.org/view/the-association-of-community-cancer-centers-mourns-the-loss-of-lee-e-mortenson-dpa-mpa-ms 2018-12-04T19:25:39.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-to-host-12-5-webinar-on-part-b-proposed-changes 2018-11-29T18:49:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-first-biosimilar-to-rituxan 2018-11-28T20:35:04.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-gilteritinib-for-acute-myeloid-leukemia 2018-11-28T20:32:42.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-larotrectinib-for-solid-tumors-with-ntrk-gene-fusion 2018-11-27T14:19:15.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-medicare-part-c-and-part-d-proposed-rules 2018-11-26T22:03:36.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-signs-letter-of-support-for-clinical-treatment-act 2018-11-26T19:13:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-venetoclax-for-acute-myeloid-leukemia 2018-11-26T14:06:24.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-glasdegib-for-acute-myeloid-leukemia 2018-11-26T14:04:17.000Z monthly 0.6 https://www.accc-cancer.org/view/imfinzi-assigned-unique-hcpcs-code-for-reimbursement-by-cms 2018-11-20T16:57:46.000Z monthly 0.6 https://www.accc-cancer.org/view/acs-releases-report-on-current-state-of-cancer-screening 2018-11-19T22:17:43.000Z monthly 0.6 https://www.accc-cancer.org/view/feel-more-like-you-program-to-help-cancer-patients-with-physical-changes 2018-11-19T22:08:57.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-assessing-cancer-program-alignment-with-health-literacy-metrics-a-tool-from-the-association-of-community-cancer-centers 2018-11-19T18:39:00.000Z monthly 0.6 https://www.accc-cancer.org/view/presentation-momentum-discussion-multidisciplinary-approaches-to-caring-for-geriatric-patients-with-cancer 2018-11-17T18:56:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-brentuximab-vedotin-for-peripheral-t-cell-lymphoma 2018-11-16T18:29:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-strengthens-federal-support-to-californians-affected-by-wildfires 2018-11-14T22:12:20.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-host-november-19-pfs-final-rule-open-call 2018-11-14T20:54:41.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-cy-2019-mpfs-and-opps-final-rule-summaries 2018-11-13T19:19:40.000Z monthly 0.6 https://www.accc-cancer.org/view/powering-personalized-immuno--oncology-big-data-s-role 2018-11-13T16:25:03.000Z monthly 0.6 https://www.accc-cancer.org/view/telehealth-partner-in-innovation 2018-11-12T19:32:32.000Z monthly 0.6 https://www.accc-cancer.org/view/io-reimbursement-be-proactive-and-prepared 2018-11-12T19:19:45.000Z monthly 0.6 https://www.accc-cancer.org/view/harnessing-real-time-real-world-data-to-improve-care 2018-11-12T19:00:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-hepatocellular-carcinoma 2018-11-12T14:36:00.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-empowering-healthcare-professionals-to-proactively-address-cancer-related-financial-toxicity 2018-11-11T19:51:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-unveil-mandatory-medicare-cancer-payment-model-in-coming-weeks 2018-11-09T16:24:06.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-elotuzumab-pomalidomide-dexamethasone-for-multiple-myeloma 2018-11-07T15:57:29.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lorlatinib-for-alk-metastatic-nsclc 2018-11-05T14:20:15.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-second-biosimilar-to-neulasta 2018-11-02T19:19:40.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-cy-2019-opps-rule 2018-11-02T14:26:44.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-2019-pfs-and-qpp-final-rule 2018-11-01T22:44:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-kyprolis-once-weekly-dosing-option-for-multiple-myeloma 2018-10-31T15:13:19.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-metastatic-nsclc 2018-10-31T14:44:34.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-statement-in-response-to-administration-s-part-b-drug-pricing-anprm 2018-10-26T21:33:11.000Z monthly 0.6 https://www.accc-cancer.org/view/administration-proposes-using-cmmi-to-test-drug-pricing-reform-plan 2018-10-25T20:04:59.000Z monthly 0.6 https://www.accc-cancer.org/view/president-trump-to-make-announcement-on-medicare-part-b-changes 2018-10-25T15:32:04.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-honors-three-distinguished-oncology-leaders 2018-10-25T14:43:15.000Z monthly 0.6 https://www.accc-cancer.org/view/journey-to-the-big-e 2018-10-24T22:40:59.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-honors-patricia-a.-ganz-md-with-clinical-research-award 2018-10-23T14:37:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-honors-community-oncologist-with-national-award 2018-10-23T14:35:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-levoleucovorin-for-injection-for-mcrc-osteosarcoma 2018-10-23T14:19:07.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-national-oncology-conference-takeaway-youve-got-the-power 2018-10-22T21:36:39.000Z monthly 0.6 https://www.accc-cancer.org/view/secretary-azar-provides-updates-to-drug-pricing-blueprint 2018-10-17T01:44:59.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-talazoparib-for-gbrcam-her2--breast-cancer 2018-10-16T15:57:58.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-drug-pricing-transparency-proposed-rule 2018-10-15T21:04:27.000Z monthly 0.6 https://www.accc-cancer.org/view/new-clinical-guideline-issued-for-early-stage-prostate-cancer-patients-treated-with-ebrt 2018-10-12T17:06:54.000Z monthly 0.6 https://www.accc-cancer.org/view/rulemaking-rules-regulatory-authority 2018-10-12T14:22:56.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-acts-to-support-georgia-in-response-to-hurricane-michael 2018-10-11T22:33:54.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-steps-to-support-florida-in-response-to-hurricane-michael 2018-10-10T19:59:34.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-releases-new-guidelines-for-neuroendocrine-tumors 2018-10-10T14:56:02.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-expands-approval-of-hpv-vaccine-to-people-aged-27-to-45 2018-10-08T14:34:51.000Z monthly 0.6 https://www.accc-cancer.org/view/medpac-suggests-expansion-of-dvp-to-inpatient-setting 2018-10-05T16:13:06.000Z monthly 0.6 https://www.accc-cancer.org/view/nobel-prize-in-medicine-awarded-to-two-cancer-immunotherapy-researchers 2018-10-02T19:41:40.000Z monthly 0.6 https://www.accc-cancer.org/view/modernizing-the-patient-experience-through-technology-the-experience-engine 2018-10-02T17:49:15.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-oig-report-raises-concerns-about-medicare-advantage-step-therapy 2018-10-02T15:53:28.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ngs-test-to-detect-mrd-in-all-and-myeloma 2018-10-01T21:34:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-cemiplimab-rwlc-for-cutaneous-squamous-cell-carcinoma 2018-10-01T13:29:26.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-creating-an-optimal-care-coordination-model-for-lung-cancer-patients-on-medicaid 2018-09-28T20:19:00.000Z monthly 0.6 https://www.accc-cancer.org/view/imfinzi-demonstrates-overall-survival-benefit-in-stage-iii-lung-cancer 2018-09-28T17:47:52.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-dacomitinib-for-metastatic-nsclc 2018-09-28T14:49:04.000Z monthly 0.6 https://www.accc-cancer.org/view/house-approves-legislation-banning-pharmacist-gag-clauses 2018-09-25T22:19:58.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-duvelisib-for-cll-sll-fl 2018-09-25T13:26:21.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-submits-comments-to-proposed-2019-opps-rule 2018-09-24T19:59:43.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-announces-emergency-relief-for-cancer-patients-affected-by-hurricane-florence 2018-09-24T18:53:02.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-12318-creating-an-optimal-care-coordination-model-to-improve-multidisciplinary-care-for-lung-cancer-patients-on-medicaid 2018-09-23T20:33:00.000Z monthly 0.6 https://www.accc-cancer.org/view/hogan-lovells-to-host-10-3-webinar-on-legal-considerations-of-telehealth 2018-09-20T16:31:33.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-cy-2019-proposed-rule-aimed-at-efficiency-transparency-clinician-burden 2018-09-17T19:10:59.000Z monthly 0.6 https://www.accc-cancer.org/view/taking-a-practice-based-immuno-oncology-program-to-the-next-level 2018-09-17T14:03:21.000Z monthly 0.6 https://www.accc-cancer.org/view/house-of-representatives-passes-transparency-reforms-to-medicare-lcds 2018-09-13T19:40:31.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-new-treatment-for-hairy-cell-leukemia 2018-09-13T19:31:58.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-supports-north-carolina-and-south-carolina-ahead-of-hurricane-florence 2018-09-13T18:41:00.000Z monthly 0.6 https://www.accc-cancer.org/view/aacr-releases-annual-cancer-progress-report 2018-09-13T18:31:22.000Z monthly 0.6 https://www.accc-cancer.org/view/selecting-patients-for-combination-immunotherapies 2018-09-12T17:29:00.000Z monthly 0.6 https://www.accc-cancer.org/view/improving-the-lives-of-advanced-cancer-patients-with-a-dedicated-palliative-radiotherapy-team 2018-09-12T14:11:00.000Z monthly 0.6 https://www.accc-cancer.org/view/managing-iraes-into-post-treatment-survivorship 2018-09-11T20:31:00.000Z monthly 0.6 https://www.accc-cancer.org/view/managing-survivorship-care-after-immunotherapy 2018-09-11T20:28:31.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-submits-comments-to-cy2019-proposed-pfs-rule 2018-09-11T17:34:00.000Z monthly 0.6 https://www.accc-cancer.org/view/io-trials-are-accruing-where-are-the-patients 2018-09-10T22:43:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-memos-signal-significant-changes-for-ma-part-d-plans 2018-09-07T15:59:23.000Z monthly 0.6 https://www.accc-cancer.org/view/three-foundations-commit-30-million-dollars-to-nonprofit-generic-drug-company 2018-09-06T14:02:34.000Z monthly 0.6 https://www.accc-cancer.org/view/unc-combats-rising-drug-prices-by-reducing-expensive-waste 2018-09-05T14:54:12.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-changes-to-part-d-formulary-options-in-2020 2018-08-29T22:39:59.000Z monthly 0.6 https://www.accc-cancer.org/view/24-hour-cancer-clinic-addresses-missing-piece-care-for-cancer-patients-urgent-needs 2018-08-28T15:24:22.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-to-honor-seven-cancer-programs-with-innovator-awards-at-35th-national-oncology-conference 2018-08-27T15:07:21.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ibrutinib-plus-rituximab-for-rare-blood-cancer 2018-08-27T13:42:19.000Z monthly 0.6 https://www.accc-cancer.org/view/crushing-cancer-through-prevention-and-early-detection 2018-08-24T17:13:12.000Z monthly 0.6 https://www.accc-cancer.org/view/managing-medications-in-cancer-programs-a-new-best-practice-model 2018-08-21T19:24:28.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-chemotherapy-for-nsqnsclc 2018-08-20T18:19:57.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-updates-prescribing-information-for-keytruda-and-tecentriq 2018-08-20T15:39:36.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-for-previously-treated-sclc-patients 2018-08-17T13:09:41.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lenvatinib-for-unresectable-hepatocellular-carcinoma 2018-08-17T12:56:31.000Z monthly 0.6 https://www.accc-cancer.org/view/healthwell-foundation-opens-fund-for-gastric-cancer-patients 2018-08-14T15:50:30.000Z monthly 0.6 https://www.accc-cancer.org/view/beyond-burnout 2018-08-13T19:47:53.000Z monthly 0.6 https://www.accc-cancer.org/view/nccn-publishes-guidelines-for-rare-cancers-associated-with-pregnancy 2018-08-09T14:38:22.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-mogamulizumab-kpkc-for-mycosis-fungoides-sézary-syndrome 2018-08-08T18:06:04.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-gives-medicare-advantage-plans-option-to-utilize-step-therapy 2018-08-07T23:28:42.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-proposed-cy-2019-opps-rule-top-line-takeaways 2018-08-03T19:32:23.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-warns-against-long-term-azithromycin-use-for-lung-condition-in-cancer-patients 2018-08-03T17:38:11.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-hold-8-22-listening-session-on-understanding-cy-2019-pfs-proposed-rule 2018-08-02T15:41:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-lusutrombopag-for-thromocytopenia 2018-08-01T17:01:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-azedra-for-treatment-of-rare-adrenal-tumors 2018-07-31T22:11:24.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-cy-2019-proposed-opps-rule 2018-07-25T21:32:44.000Z monthly 0.6 https://www.accc-cancer.org/view/gao-report-compares-characteristics-of-340b-and-non-340b-hospitals 2018-07-25T16:38:09.000Z monthly 0.6 https://www.accc-cancer.org/view/house-of-representatives-passes-pcheta-three-other-workforce-bills 2018-07-24T16:49:08.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-filgrastim-biosimilar-for-aml 2018-07-23T13:08:34.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-host-webinar-series-on-2017-mips-feedback-2018-performance-categories 2018-07-20T18:17:39.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ivosidenib-for-r-r-aml 2018-07-20T16:01:56.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-ribociclib-in-combination-for-advanced-metastatic-breast-cancer 2018-07-18T18:11:09.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-and-advisory-board-launch-9th-annual-trends-in-cancer-care-survey 2018-07-18T15:29:12.000Z monthly 0.6 https://www.accc-cancer.org/view/it-s-here-cms-2019-proposed-physician-fee-schedule-rule 2018-07-17T14:26:33.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-submits-comments-to-administration's-drug-pricing-blueprint 2018-07-16T22:04:57.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-enzalutamide-for-castration-resistant-prostate-cancer 2018-07-16T15:06:01.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-proposed-cy2019-physician-fee-schedule-qpp-rule 2018-07-12T22:12:11.000Z monthly 0.6 https://www.accc-cancer.org/view/top-immuno-oncology-takeaways 2018-07-11T17:01:00.000Z monthly 0.6 https://www.accc-cancer.org/view/car-t-cell-therapy-gave-me-back-my-life 2018-07-11T16:54:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-plus-ipilimumab-for-metastatic-colorectal-cancer 2018-07-11T12:25:23.000Z monthly 0.6 https://www.accc-cancer.org/view/acs-launches-series-to-outline-21st-century-blueprint-for-cancer-control 2018-07-10T20:12:15.000Z monthly 0.6 https://www.accc-cancer.org/view/nci-va-collaborate-to-boost-veterans'-access-to-cancer-clinical-trials 2018-07-10T19:45:13.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-joins-sustainable-healthy-communities-llc-diverse-cancer-communities-working-group 2018-07-09T13:22:18.000Z monthly 0.6 https://www.accc-cancer.org/view/gao-reports-calls-for-more-oversight-of-340b-contract-pharmacies 2018-07-03T14:52:48.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-posts-mips-final-scores-and-performance-feedback-for-participating-clinicians-groups 2018-07-02T20:54:34.000Z monthly 0.6 https://www.accc-cancer.org/view/abstract-the-unique-support-path-for-metastatic-breast-cancer-patients 2018-06-30T19:20:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-submits-comments-to-cms-on-fy2019-ipps-proposed-rule 2018-06-29T14:33:02.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-advances-demonstration-to-waive-mips-requirements-for-clinicians-in-certain-at-risk-medicare-advantage-plans 2018-06-29T14:30:07.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-encorafenib-binimetinib-combo-for-advanced-melanoma-with-braf-mutation 2018-06-27T19:23:30.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-convenes-thought-leaders-to-talk-burnout-resilience 2018-06-26T15:17:18.000Z monthly 0.6 https://www.accc-cancer.org/view/policy-update-senate-hearings-on-administration-drug-pricing-plan 2018-06-22T16:54:33.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-restricts-use-of-keytruda-and-tecentriq-for-urothelial-cancer 2018-06-21T14:00:58.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-submits-comments-to-cms-on-nca-for-car-t-therapy 2018-06-20T14:12:44.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-s-biosimilar-retacrit-receives-q-codes 2018-06-19T19:19:56.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-treatment-of-pmbcl 2018-06-19T14:20:16.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-bevacizumab-in-combination-with-chemotherapy-for-ovarian-cancer 2018-06-13T20:10:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-pembrolizumab-for-advanced-cervical-cancer 2018-06-13T14:25:05.000Z monthly 0.6 https://www.accc-cancer.org/view/interviews-with-accc-leadership-at-asco-2018 2018-06-13T13:46:41.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-venetoclax-for-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma 2018-06-11T20:58:13.000Z monthly 0.6 https://www.accc-cancer.org/view/doj-trump-administration-will-not-defend-aca-s-pre-existing-coverage 2018-06-08T17:55:56.000Z monthly 0.6 https://www.accc-cancer.org/view/beyond-the-blueprint-more-on-cap-part-b-340b 2018-06-07T14:41:32.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-first-biosimilar-to-neulasta 2018-06-05T21:06:35.000Z monthly 0.6 https://www.accc-cancer.org/view/after-months-of-debate-president-trump-signs-right-to-try-into-law 2018-05-31T18:00:22.000Z monthly 0.6 https://www.accc-cancer.org/view/nasem-publishes-workshop-proceedings-on-effective-patient-navigation-in-oncology 2018-05-31T15:28:32.000Z monthly 0.6 https://www.accc-cancer.org/view/american-cancer-society-updates-colorectal-cancer-screening-guideline 2018-05-30T19:02:35.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-abiraterone-acetate-to-treat-mcrpc 2018-05-24T14:56:05.000Z monthly 0.6 https://www.accc-cancer.org/view/pfizer-s-biosimilar-retacrit-sup-sup--epoetin-alfa-epbx--approved-by-u-s--fda 2018-05-23T15:49:58.000Z monthly 0.6 https://www.accc-cancer.org/view/nih-releases-annual-report-to-the-nation-on-the-status-of-cancer 2018-05-22T14:15:14.000Z monthly 0.6 https://www.accc-cancer.org/view/decreased-survival-in-clinical-trials-for-some-patients-receiving-keytruda-or-tecentriq-as-monotherapy-for-urothelial-cancer 2018-05-21T19:04:26.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-drug-for-thrombocytopenia-in-adults-with-chronic-liver-disease 2018-05-21T18:47:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-and-pfizer-offer-grant-opportunities-focused-on-improving-quality-of-breast-cancer-care-through-evidence-based-brca-genetic-testing 2018-05-21T16:53:05.000Z monthly 0.6 https://www.accc-cancer.org/view/aua-updates-guideline-on-castration-resistant-prostate-cancer 2018-05-18T19:46:18.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-biosimilar-to-epoetin-alfa-for-anemia 2018-05-15T17:56:21.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-issues-formal-rfi-for-drug-pricing-blueprint 2018-05-14T19:52:26.000Z monthly 0.6 https://www.accc-cancer.org/view/administration-releases-drug-pricing-and-cost-containment-plan 2018-05-11T22:54:20.000Z monthly 0.6 https://www.accc-cancer.org/view/president-trump-unveils-blueprint-to-lower-drug-prices 2018-05-11T19:21:27.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-releases-rural-health-strategy 2018-05-08T18:36:42.000Z monthly 0.6 https://www.accc-cancer.org/view/uspstf-issues-final-recommendation-on-screening-for-prostate-cancer 2018-05-08T17:55:48.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-daratumumab-for-treatment-of-multiple-myeloma 2018-05-08T15:35:11.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-dabrafenib-and-trametinib-for-treatment-of-thyroid-cancer 2018-05-07T16:32:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-kymriah-to-treat-certain-r-r-patients-with-large-b-cell-lymphoma 2018-05-01T21:48:44.000Z monthly 0.6 https://www.accc-cancer.org/view/care-coordination-and-immune-related-adverse-events-building-an-immuno-oncology-toxicity-team 2018-05-01T20:14:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-host-webinar-on-participation-criteria-for-year-2-of-qpp 2018-05-01T15:37:34.000Z monthly 0.6 https://www.accc-cancer.org/view/nasem-publishes-workshop-proceedings-on-cancer-survivorship-care-health-professional-education 2018-05-01T15:27:34.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-dabrafenib-and-trametinib-for-treatment-of-melanoma 2018-05-01T14:19:28.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-proposed-fy2019-hospital-ipps-rule 2018-04-25T15:51:41.000Z monthly 0.6 https://www.accc-cancer.org/view/an-update-from-cms-on-new-direction-for-innovation-center 2018-04-24T15:27:40.000Z monthly 0.6 https://www.accc-cancer.org/view/president-trump's-speech-on-drug-pricing-postponed 2018-04-23T14:08:31.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-fostamatinib-tablets-for-itp 2018-04-18T22:02:20.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nivolumab-and-ipilimumab-for-treatment-of-renal-cell-carcinoma 2018-04-16T16:34:44.000Z monthly 0.6 https://www.accc-cancer.org/view/hhs-secretary-names-new-leader-of-cmmi 2018-04-13T17:53:32.000Z monthly 0.6 https://www.accc-cancer.org/view/recognizing-your-cancer-registrars 2018-04-12T16:42:38.000Z monthly 0.6 https://www.accc-cancer.org/view/acs-can-releases-report-on-barriers-to-enrollment-in-clinical-trials 2018-04-11T14:30:25.000Z monthly 0.6 https://www.accc-cancer.org/view/how-can-administrators-support-patient-navigators 2018-04-09T15:14:06.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-rucaparib-for-treatment-of-recurrent-ovarian-fallopian-tube-peritoneal-cancer 2018-04-06T19:46:40.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-adcetris-plus-chemotherapy-for-first-line-treatment-of-chl 2018-04-06T15:15:23.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-begins-mailing-out-new-medicare-cards 2018-04-04T19:47:30.000Z monthly 0.6 https://www.accc-cancer.org/view/astro-updates-guideline-for-palliative-lung-radiation 2018-04-04T17:29:25.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-reports-11.9-million-enrolled-in-health-insurance-exchanges 2018-04-04T15:28:45.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-issues-final-rule-on-cy2019-policy-changes-and-updates-to-ma-part-d 2018-04-03T15:34:38.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-blinatumomab-for-b-cell-precursor-all-with-mrd 2018-03-29T19:50:42.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-extends-mips-2017-data-submission-deadline-to-april-3 2018-03-29T17:26:28.000Z monthly 0.6 https://www.accc-cancer.org/view/the-omnibus-spending-bill-winners-losers 2018-03-27T15:24:41.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-nilotinib-for-pediatric-cml 2018-03-23T17:27:10.000Z monthly 0.6 https://www.accc-cancer.org/view/uspstf-issues-recommendation-on-skin-cancer-prevention 2018-03-21T17:26:44.000Z monthly 0.6 https://www.accc-cancer.org/view/cms's-ocm-team-to-host-may-3-public-forum 2018-03-20T19:19:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-adcetris-combined-with-chemotherapy-for-first-line-treatment-of-stage-iii-or-iv-classical-hodgkin-lymphoma-in-combination 2018-03-20T18:55:43.000Z monthly 0.6 https://www.accc-cancer.org/view/thomas-a.-gallo-ms-mda-becomes-accc-president-2018-2019 2018-03-20T17:52:19.000Z monthly 0.6 https://www.accc-cancer.org/view/innovation-in-cancer-care-delivery-what-s-in-the-way 2018-03-19T22:15:27.000Z monthly 0.6 https://www.accc-cancer.org/view/advocating-for-the-future-hill-day-2018 2018-03-15T15:52:38.000Z monthly 0.6 https://www.accc-cancer.org/view/imbruvica-approved-in-new-formulation-as-one-pill-once-daily 2018-03-14T14:50:40.000Z monthly 0.6 https://www.accc-cancer.org/view/president's-cancer-panel-urges-collaboration-to-better-align-drug-prices-with-value 2018-03-13T22:22:22.000Z monthly 0.6 https://www.accc-cancer.org/view/astro-issues-clinical-guideline-for-wbrt-for-breast-cancer 2018-03-13T21:42:54.000Z monthly 0.6 https://www.accc-cancer.org/view/trump-administration-announces-myhealthedata-initiative 2018-03-07T17:02:25.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-authorizes-first-direct-to-consumer-test-for-3-brca-mutations 2018-03-06T18:02:53.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-abemaciclib-for-hr-her2--advanced-breast-cancer 2018-02-27T17:06:13.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-durvalumab-for-stage-iii-unresectable-nsclc 2018-02-20T22:52:15.000Z monthly 0.6 https://www.accc-cancer.org/view/reading-between-the-line-items 2018-02-15T17:59:28.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-erleada-for-certain-prostate-cancer-patients 2018-02-14T21:50:21.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-nccn-release-guidance-on-management-of-immunotherapy-side-effects 2018-02-14T16:23:47.000Z monthly 0.6 https://www.accc-cancer.org/view/staying-independent-what-it-takes-to-succeed 2018-02-13T22:19:25.000Z monthly 0.6 https://www.accc-cancer.org/view/final-proceedings-from-nasem-workshop-on-weight-management-exercise-across-cancer-continuum-now-available 2018-02-12T18:25:38.000Z monthly 0.6 https://www.accc-cancer.org/view/white-house-issues-report-on-reforming-drug-pricing 2018-02-12T16:29:20.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-to-host-2017-mips-submission-q-a-sessions 2018-02-09T19:39:32.000Z monthly 0.6 https://www.accc-cancer.org/view/policy-prognosis-will-2018-be-another-wild-ride 2018-02-09T19:20:58.000Z monthly 0.6 https://www.accc-cancer.org/view/mips-reporting-deadlines-coming-soon 2018-02-08T18:54:55.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-zytiga-plus-prednisone-for-metastatic-high-risk-prostate-cancer 2018-02-08T18:52:44.000Z monthly 0.6 https://www.accc-cancer.org/view/asco-reviews-commercial-clinical-pathways-landscape 2018-02-08T18:51:07.000Z monthly 0.6 https://www.accc-cancer.org/view/grow-locally-deliver-care-regionally 2018-02-06T15:44:30.000Z monthly 0.6 https://www.accc-cancer.org/view/closing-the-gap-the-promise-of-patient-navigation-for-developing-countries 2018-02-02T21:00:01.000Z monthly 0.6 https://www.accc-cancer.org/view/immuno-oncology-connection-communication-change 2018-01-31T22:46:27.000Z monthly 0.6 https://www.accc-cancer.org/view/new-report-offers-strategies-for-multidisciplinary-care-coordination-communication-in-delivery-of-immunotherapies 2018-01-31T21:28:49.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-new-treatment-for-certain-digestive-tract-cancers 2018-01-26T22:20:00.000Z monthly 0.6 https://www.accc-cancer.org/view/alex-azar-to-head-hhs 2018-01-25T22:19:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cap-iaslc-amp-release-updated-lung-biomarker-guideline 2018-01-25T22:19:00.000Z monthly 0.6 https://www.accc-cancer.org/view/mac-operations-to-continue-during-government-shutdown 2018-01-22T16:50:55.000Z monthly 0.6 https://www.accc-cancer.org/view/medpac-recommends-eliminating-mips 2018-01-19T16:50:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers'-2017-survey-shows-cost-of-treatment-is-once-again-top-threat-to-cancer-program-growth 2018-01-16T20:34:49.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-olaparib-for-germline-brca-mutated-metastatic-breast-cancer 2018-01-12T16:49:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-grants-broadened-indication-for-afatinib-in-first-line-treatment-of-certain-patients-with-metastatic-nsclc 2018-01-12T16:49:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-mourns-the-passing-of-long-time-member-marsha-fountain-woznuck-rn-msn 2018-01-10T16:47:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-approves-denosumab-for-prevention-of-skeletal-related-events-in-multiple-myeloma 2018-01-05T16:48:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cap-issues-guideline-to-ensure-accurate-hpv-testing-in-head-and-neck-cancers 2018-01-03T16:47:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fda-updates-nilotinib-label-to-include-treatment-discontinuation-recommendations-for-cml-with-sustained-molecular-responses 2018-01-02T16:46:00.000Z monthly 0.6 https://www.accc-cancer.org/view/popular-accc-resources-a-snapshot-of-2017 2017-12-29T21:50:00.000Z monthly 0.6 https://www.accc-cancer.org/view/tax-reform-update 2017-12-22T17:56:00.000Z monthly 0.6 https://www.accc-cancer.org/view/heading-in-the-right-direction 2017-12-21T18:01:00.000Z monthly 0.6 https://www.accc-cancer.org/view/tax-reform-bill-moves-to-conference-committee 2017-12-08T18:23:00.000Z monthly 0.6 https://www.accc-cancer.org/view/are-your-patients-understanding-you 2017-12-05T18:26:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-cancer-registrys-role-in-creating-survivorship-care-plans 2017-12-01T22:32:00.000Z monthly 0.6 https://www.accc-cancer.org/view/moving-beyond-silos 2017-11-29T19:47:04.000Z monthly 0.6 https://www.accc-cancer.org/view/the-visiting-experts-experience-st-agnes-cancer-institute-baltimore-md 2017-11-29T19:43:37.000Z monthly 0.6 https://www.accc-cancer.org/view/2018-quality-payment-program-rule-highlights 2017-11-13T20:27:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-finalizes-cy2018-opps-pfs-rules 2017-11-09T20:30:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-role-of-the-human-microbiome-in-immunotherapy 2017-11-02T21:42:16.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-honors-clinical-research-team-and-oncologist-with-national-awards-at-34th-national-oncology-conference 2017-10-31T00:15:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-honored-medical-oncologist-and-ama-president-elect-barbara-l-mcaneny-with-national-award 2017-10-27T00:15:00.000Z monthly 0.6 https://www.accc-cancer.org/view/ehrs-expensive-hideous-required 2017-10-26T19:34:00.000Z monthly 0.6 https://www.accc-cancer.org/view/national-oncology-conferencewhats-new-about-how-to 2017-10-23T14:28:00.000Z monthly 0.6 https://www.accc-cancer.org/view/just-breathelistening-to-the-patients-perspective 2017-10-12T14:28:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-ongoing-journey-improving-molecular-biomarker-testing-in-nsclc 2017-10-05T14:29:00.000Z monthly 0.6 https://www.accc-cancer.org/view/go-to-gemba-heres-why 2017-10-03T14:32:00.000Z monthly 0.6 https://www.accc-cancer.org/view/reaching-out-cancer-program-community-collaborations-for-health-equity 2017-09-26T14:28:00.000Z monthly 0.6 https://www.accc-cancer.org/view/360-degree-perspective-from-the-accc-institute-for-clinical-immuno-oncology-policy-summit 2017-09-11T14:29:00.000Z monthly 0.6 https://www.accc-cancer.org/view/staying-the-course-the-role-of-oral-oncology-nurse-navigators 2017-09-08T14:30:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-comments-to-cms-on-quality-payment-program-proposed-rule 2017-09-06T19:44:00.000Z monthly 0.6 https://www.accc-cancer.org/view/dietitian-as-navigator-a-winning-combination 2017-08-31T19:54:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-proposed-2018-medicare-rules-what-lies-ahead 2017-08-25T14:33:00.000Z monthly 0.6 https://www.accc-cancer.org/view/taking-lung-cancer-screening-on-the-road 2017-08-23T20:02:00.000Z monthly 0.6 https://www.accc-cancer.org/view/chemotherapy-drug-specific-education-putting-information-at-the-patients-fingertips 2017-08-18T20:06:00.000Z monthly 0.6 https://www.accc-cancer.org/view/providing-support-to-oncology-professionals 2017-08-04T20:07:00.000Z monthly 0.6 https://www.accc-cancer.org/view/clinical-trials-in-immunotherapy 2017-07-27T17:03:12.000Z monthly 0.6 https://www.accc-cancer.org/view/creating-a-navigation-intake-assessment-tool 2017-07-26T14:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-collaborates-with-advisory-board-to-conduct-8th-annual-trends-in-cancer-care-survey 2017-07-24T21:27:00.000Z monthly 0.6 https://www.accc-cancer.org/view/turning-on-the-light-switch 2017-06-29T15:19:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-statement-on-the-better-care-reconciliation-act-of-2017 2017-06-26T14:27:00.000Z monthly 0.6 https://www.accc-cancer.org/view/navigation-caseload-quandary 2017-06-23T14:44:00.000Z monthly 0.6 https://www.accc-cancer.org/view/from-asco-to-iclio-to-your-programimmunotherapy-moves-into-the-community 2017-06-16T15:19:00.000Z monthly 0.6 https://www.accc-cancer.org/view/desperately-seeking-oncology-nurses 2017-06-13T14:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/iclio-delivers-immunotherapy-education-in-the-community-setting 2017-06-07T18:55:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-journey-to-ehr-optimization 2017-06-02T14:39:00.000Z monthly 0.6 https://www.accc-cancer.org/view/challenges-to-ehr-optimization-for-cancer-programsworkload-cost-and-interoperability 2017-05-30T14:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/creating-a-caregiver-toolkit-24-tips-for-caregivers 2017-05-24T14:41:00.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-centered-cancer-care-personal-pain-goals 2017-05-16T14:41:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-expresses-serious-concern-over-the-ahca 2017-05-10T14:32:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-financial-advocacy-boot-camp-in-response-to-catastrophic-cancer-costs 2017-05-02T18:50:00.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-navigation-creating-a-toolkit-for-caregivers 2017-05-01T14:41:00.000Z monthly 0.6 https://www.accc-cancer.org/view/going-the-distance-what-we-heard-at-the-ocm-workshop 2017-04-21T14:32:00.000Z monthly 0.6 https://www.accc-cancer.org/view/mark-s-soberman-md-mba-facs-named-president-of-the-association-of-community-cancer-centers 2017-04-13T18:55:00.000Z monthly 0.6 https://www.accc-cancer.org/view/drug-pricing-in-the-crosshairs 2017-04-07T14:32:00.000Z monthly 0.6 https://www.accc-cancer.org/view/next-steps-for-value-frameworks 2017-04-05T14:33:00.000Z monthly 0.6 https://www.accc-cancer.org/view/journeying-beyond-the-physical-addressing-a-patients-spiritual-concerns 2017-03-27T15:33:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-appoints-five-members-to-the-2017-board-of-trustees 2017-03-22T17:51:00.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-social-workers-role-in-patient-centered-care 2017-03-15T15:33:00.000Z monthly 0.6 https://www.accc-cancer.org/view/navigation-metrics-value-based-care-measuring-up 2017-03-09T20:26:00.000Z monthly 0.6 https://www.accc-cancer.org/view/does-your-cancer-program-have-a-registered-dietitian1 2017-03-07T20:30:00.000Z monthly 0.6 https://www.accc-cancer.org/view/whats-in-a-name-is-tumor-registry-an-outdated-term 2017-02-23T19:53:00.000Z monthly 0.6 https://www.accc-cancer.org/view/ocm-evolving-best-practices-lessons-to-date 2017-02-17T20:21:00.000Z monthly 0.6 https://www.accc-cancer.org/view/on-the-road-to-value-based-care-operational-cultural-change 2017-02-15T21:30:00.000Z monthly 0.6 https://www.accc-cancer.org/view/what-happened-in-vegas-highlights-from-the-2017-cancer-center-business-summit 2017-02-14T21:32:00.000Z monthly 0.6 https://www.accc-cancer.org/view/enhancing-the-value-proposition-embedding-palliative-care-services-in-the-oncology-setting 2017-02-08T20:40:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cooling-down-icer-five-questions-to-consider 2017-01-25T20:29:00.000Z monthly 0.6 https://www.accc-cancer.org/view/how-navigation-can-help-in-decreasing-readmission-rates-and-er-visits 2017-01-19T20:20:00.000Z monthly 0.6 https://www.accc-cancer.org/view/iclio-white-paper-highlights-the-challenges-progress-and-priorities-in-immunotherapy 2017-01-17T18:54:00.000Z monthly 0.6 https://www.accc-cancer.org/view/8-ways-your-cancer-registry-can-support-your-cancer-committee 2017-01-12T17:48:00.000Z monthly 0.6 https://www.accc-cancer.org/view/immuno-oncology-moving-forward-together 2017-01-10T20:47:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-2016-survey-finds-cancer-drug-costs-remain-the-most-critical-challenge-to-care 2017-01-05T18:50:00.000Z monthly 0.6 https://www.accc-cancer.org/view/fasten-your-seat-belts 2016-12-29T19:52:00.000Z monthly 0.6 https://www.accc-cancer.org/view/medicare-oncology-care-model-opportunities-for-social-work-participation 2016-12-21T23:05:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-new-online-resource-for-metastatic-breast-cancer-multidisciplinary-care 2016-12-13T20:02:00.000Z monthly 0.6 https://www.accc-cancer.org/view/a-message-to-new-oncology-nurses 2016-11-22T16:58:00.000Z monthly 0.6 https://www.accc-cancer.org/view/radiation-therapists-role-in-patient-centered-care 2016-11-15T19:47:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-white-paper-on-challenges-and-opportunities-for-delivery-of-patient-centered-care 2016-11-02T19:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/2016-accc-honors-community-oncologist-with-national-award 2016-10-26T20:03:00.000Z monthly 0.6 https://www.accc-cancer.org/view/internationally-recognized-specialist-receives-the-2016-accc-clinical-research-award 2016-10-26T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-announces-6th-annual-innovator-award-winners 2016-10-25T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/open-pre-conference-highlights 2016-10-20T21:01:00.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-navigation-how-patient-and-family-focus-groups-can-help 2016-10-16T18:47:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-oncology-pharmacists-role-in-patient-centered-care 2016-10-14T19:49:00.000Z monthly 0.6 https://www.accc-cancer.org/view/helping-aya-patients-to-be-loud 2016-10-11T18:55:00.000Z monthly 0.6 https://www.accc-cancer.org/view/financial-advocates-sharing-insights-strategies 2016-10-05T19:38:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-33rd-national-oncology-conference-how-tos-for-patient-centered-care 2016-10-05T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-to-host-twitter-chat-on-metastatic-breast-cancer 2016-09-21T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers'-resources-support-cancer-moonshot-recommendations 2016-09-13T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-eases-macra-quality-payment-program-timeline 2016-09-12T19:46:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-mourns-the-loss-of-robert-w-frelick-md-facp-community-oncology-leader-and-accc-past-president 2016-09-12T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/whats-the-skinny-on-skin 2016-09-01T13:57:00.000Z monthly 0.6 https://www.accc-cancer.org/view/patient-navigationprocess-mapping-by-disease-site 2016-07-13T14:23:00.000Z monthly 0.6 https://www.accc-cancer.org/view/cms-announces-oncology-care-model-ocm-participants-accc-offers-resources-and-expertise 2016-06-30T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/financial-advocacy-servicesa-patients-perspective 2016-06-23T18:56:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-president-jennie-r-crews-md-mmm-facp-to-participate-in-cancer-moonshot-summit-in-nations-capital-2016 2016-06-22T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/snapshot-of-a-case-based-financial-advocacy-network-workshop 2016-06-15T19:17:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-online-community-to-support-oncology-care-model-ocm-practices 2016-06-03T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-initiative-to-address-communications-challenges-faced-by-metastatic-breast-cancer-patients 2016-06-01T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-members-bring-sun-safety-awareness-to-their-communities 2016-05-27T13:55:00.000Z monthly 0.6 https://www.accc-cancer.org/view/financial-advocates-helping-to-close-the-gap 2016-05-17T19:28:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-collaborating-with-the-joint-commission-and-cdc-to-improve-patient-safety-in-outpatient-medical-settings 2016-05-03T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/caring-for-the-whole-patienttwo-cancer-programs-two-approaches 2016-03-22T18:47:00.000Z monthly 0.6 https://www.accc-cancer.org/view/jennie-r-crews-md-facp-named-president-of-the-accc 2016-03-16T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-voices-strong-opposition-to-cms-part-b-drug-payment-model 2016-03-09T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-42nd-annual-meeting-to-provide-perspective-on-pressing-issues-facing-cancer-care-today 2016-02-23T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/financial-advocatesworking-to-curb-the-economic-impact-of-cancer 2016-02-16T20:14:00.000Z monthly 0.6 https://www.accc-cancer.org/view/usp-chapter-800-readiness-is-all 2016-02-11T22:04:00.000Z monthly 0.6 https://www.accc-cancer.org/view/collision-ahead-precision-medicine-cost 2016-02-02T19:47:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-awarded-grant-to-develop-care-coordination-model-to-address-disparities-faced-by-medicaid-patients-with-lung-cancer 2016-02-01T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-2016-patient-assistance-and-reimbursement-guide 2016-01-14T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-experts-share-essential-actions-to-achieve-a-positive-impact-on-patient-care-in-the-integrated-healthcare-environment 2015-10-22T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-2015-survey-finds-reimbursement-biggest-challenge-despite-increased-efforts-to-measure-and-communicate-quality-care-and-value 2015-09-15T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-launches-pioneering-immuno-oncology-program-for-community-based-cancer-care-providers 2015-07-07T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-applauds-bipartisan-bicameral-effort-to-ease-financial-burden-for-cancer-patients 2015-06-15T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-care-model-updates-from-cms 2015-05-06T19:50:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-applauds-historic-vote-repealing-medicare-sgr 2015-04-15T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/steven-l-damato-bspharm-bcop-becomes-president-of-the-association-of-community-cancer-centers 2015-03-23T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-41st-annual-meeting-to-focus-on-policy-value-quality 2015-03-10T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/8-strategies-to-help-gastric-cancer-patients-cope-with-nutrition-problems-during-treatment 2015-02-02T19:47:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-2015-patient-assistance-and-reimbursement-guide 2015-01-27T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/sandra-vassos-mpa-joins-accc-as-chief-development-officer 2015-01-20T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/strong-leaders-critical-to-navigating-shifting-landscape-in-oncology-care 2014-11-12T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/oncology-stakeholders-agree-in-a-shifting-healthcare-environment-communicating-quality-is-critical 2014-11-06T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-announces-new-provider-resources-for-improving-myelofibrosis-patient-care 2014-11-04T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/discussing-personalized-medicine-at-accc2014 2014-10-29T19:17:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-to-develop-comprehensive-immuno-oncology-program-for-providers 2014-10-21T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/delaware-researcher-and-surgeon-to-receive-acccs-2014-clinical-research-award 2014-10-06T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/from-distress-screening-to-solutions-patient-centered-support 2014-09-24T19:21:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-takes-aim-at-tough-challenges-in-u-s-cancer-care-delivery 2014-09-23T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-expands-its-reach 2014-08-18T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-launches-oncology-drug-database 2014-08-07T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/new-provider-resources-for-improving-gastric-cancer-patient-care 2014-07-08T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-announces-2014-innovator-award-recipients 2014-06-23T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/is-your-cancer-program-indispensable 2014-05-02T19:18:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-association-of-community-cancer-centers-accc-concerned-with-release-of-medicare-payment-data 2014-04-11T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/becky-l-dekay-mba-becomes-president-of-the-association-of-community-cancer-centers 2014-04-07T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-honors-researcher-and-community-oncologist-with-national-award 2014-03-31T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-and-leukemia-and-lymphoma-society-to-honor-four-leading-oncology-professionals-active-in-grassroots-advocacy 2014-03-28T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/lessening-the-financial-side-effects-of-care 2014-02-03T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-releases-2014-patient-assistance-and-reimbursement-guide 2014-02-03T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/new-accc-survey-says-cancer-care-suffers-from-sequesters-ripple-effect 2013-12-04T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-institute-encourages-expansion-adoption-of-electronic-health-information-exchange 2013-11-04T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-institute-calls-for-collaboration-adaptation-to-maximize-patient-care-delivery-amid-consolidation 2013-10-03T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-to-honor-leading-cancer-prevention-and-screening-advocate-and-researcher 2013-09-30T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-statement-on-the-iom-report-on-delivering-high-quality-cancer-care 2013-09-17T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-survey-finds-cancer-centers-striving-to-measure-quality-reduce-costs-and-increase-services 2013-07-16T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/accc-survey-shows-impact-of-sequester-across-all-sites-of-service 2013-06-12T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/the-association-of-community-cancer-centers-launches-small-population-cancers-community-resource-centers-for-providers 2013-05-30T04:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/virginia-vaitones-oncology-social-worker-to-become-president-of-the-association-of-community-cancer-centers 2013-03-04T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-to-honor-founder-of-psycho-oncology 2013-02-25T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/association-of-community-cancer-centers-to-recognize-minnesota-researcher-and-community-oncologist 2013-02-25T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/view/navigating-the-road-map-to-quality-cancer-care 2013-02-05T05:00:00.000Z monthly 0.6 https://www.accc-cancer.org/education-and-resources/financial-navigation 2026-03-30T16:28:48.357Z weekly 0.7 https://www.accc-cancer.org/education-and-resources/patient-centered-care 2026-03-30T16:28:48.357Z weekly 0.7 https://www.accc-cancer.org/education-and-resources/research 2026-03-30T16:28:48.357Z weekly 0.7 https://www.accc-cancer.org/education-and-resources/cancer-types 2026-03-30T16:28:48.357Z weekly 0.7 https://www.accc-cancer.org/education-and-resources/practice-management-operations 2026-03-30T16:28:48.357Z weekly 0.7 https://www.accc-cancer.org/education-and-resources/health-equity-access 2026-03-30T16:28:48.357Z weekly 0.7 https://www.accc-cancer.org/education-and-resources/clinical-practice-treatment 2026-03-30T16:28:48.357Z weekly 0.7